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Abstract
High-Throughput Data Analysis: Application to Micronuclei Frequency and T-
cell Receptor Sequencing
by Mateusz Makowski
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2015
Major Director: Kellie J. Archer, Ph.D., Professor, Department of Biostatistics
The advent of high-throughput sequencing has brought about the creation of an unprece-
dented amount of research data. Analytical methodology has not been able to keep pace
with the plethora of data being produced. Two assays, ImmunoSEQ and the cytokinesis-
block micronucleus (CBMN), that both produce count data and have few methods available
to analyze them are considered .
ImmunoSEQ is a sequencing assay that measures the β T-cell receptor (TCR) reper-
toire. The ImmunoSEQ assay was used to describe the TCR repertoires of patients’ that
have undergone hematopoietic stem cell transplantion (HSCT). Several different methods
for spectratype analysis were extended to the TCR sequencing setting then applied to these
data to demonstrate different ways the data set can be analyzed. The different methods in-
clude CDR3 distribution perturbation, Oligoscores, Simpson’s diversity, Shannon diversity,
Kullback-Leibler divergence, a non-parametric method and a proportion logit transformation
method. Herein we also demonstrate adapting compositional data analysis methods to the
TCR sequencing setting. The various methods were compared when analyzing a set of 13
subjects who underwent hematopoietic stem cell transplantation. The eight subjects who
developed graft versus host disease were compared to the five who did not. There was no
little overlap in the results of the different methods showing that researchers must choose
the appropriate method for their research question of interest.
viii
The CBMN assay measures the rate of micronuclei (MN) formation in a sample of cells
and can be paired with gene expression or methylation assays to determine association be-
tween MN formation and other genetic markers. Herein we extended the generalized mono-
tone incremental forward stagewise (GMIFS) method to the situation where the response is
count data and there are more independent variables than there are samples. Our Poisson
GMIFS method was compared to a popular alternative, glmpath, by using simulations and
applying both to real data. Simulations showed that both methods perform similarly in ac-
curately choosing truly significant variables. However, glmpath appears to overfit compared
to our GMIFS method. Finally, when both methods were applied to two data sets GMIFS
appeared to be more stable than glmpath.
ix
1 T-Cell Receptors and the Adaptive Immune System
1.1 T-cell Biology
The adaptive immune system is responsible for recognizing foreign and self antigens and
mounting the proper response. This is known as acquired immunity because the body “re-
members” the specific antigen and can mount a quicker and more potent response each
subsequent time the body encounters that antigen. T and B cells are responsible for main-
taining an acquired immunity. T cells are a type of cell that maintains the body’s immunity
by activating genes that create cell surface receptors that recognize foreign and self antigens.
These genes and subsequently receptor proteins are passed on to future generations of cells
during cell division. T-cell receptors (TCR) are heterodimers that contain an α and a β
chain or a γ and a δ chain. The chains are made up of several different regions; a constant
region, a variable region, a transmembrane domain and a short cytoplasmic tail. Further,
the variable region of the β chain of TCR’s is made up of the variable (V), joining (J) and
diversity (D) gene segments [Robins et al., 2009, Rudolph et al., 2006].
T-cells are activated when the TCR recognizes an antigen bound to a major histocompat-
ibility complex (MHC) molecule presented to it by an antigen presenting cell (APC) [Avent,
2012]. Once the antigen is recognized an immune response is launched. The first step in a
memory response is to have a TCR that recognizes a specific antigen. Because there is a
large diversity of antigens the human body can come in contact with, the immune system
must have a way to generate a large diversity of TCR’s. Producing a large diversity of TCR’s
is accomplished by a process called VDJ recombination (Figure 1). VDJ recombination is
the joining of different gene segments to create unique amino acid sequences. Specifically,
V, D and J segments that are spread across human chromosomes 2,14 and 22 are combined
to make a unique VDJ combination.
In this review we are only interested in VDJ recombination of the β chain of TCR’s
(TCRβ). There are 52 known V gene segments, 2 D gene segments and 13 J gene segments
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[Janeway et al., 2001] in the TCRβ chain. All possible VDJ combinations yield 13×2×52 =
1352 possible combinations. This is not a large variety and further diversity in TCR’s is
added by the amino acid sequence encoded in the third complementary-determining region
(CDR3) [Robins et al., 2009]. The CDR3 region occurs at the VDJ junction. As can be
seen in Figure 2, this junction includes part of the V segment, all of the D segment and
the J segment. The CDR3 region undergoes template-independent additions and deletions
of nucleotides during TCR gene rearrangement. This greatly increases TCRβ diversity.
Arstila et al. [1999] reported estimates of 106 unique TCRβ CDR3 sequences per person.
By measuring the abundance of each clone a better understanding of the human immune
response can be gained [Carlson et al., 2013].
Figure 1: VDJ Recombination: A schematic of how separate V,D and J segments are re-
combined into a functional TCR protein (Adapted from Janeway et al. [2001]).
2
Figure 2: CDR3 Region: A diagram of where the CDR3 region occurs in a recombined VDJ
segment.
1.2 Technology for Measuring TCRβ Clones
Historically, measuring TCR abundance was done by spectratype analysis, a process that
measures relative abundance of TCR clones. Unfortunately, spectratyping can only distin-
guish a particular V, D or J segment. For a specific V or J gene the clones are separated
by size rather than sequence [Kepler et al., 2005]. This is useful in general terms to monitor
TCR diversity. A more detailed review of spectratype analysis methodology can be found
in section 1.6.
Figure 4 shows a schematic of how spectratyping assay is done. First a sample is collected
and the T-cells are isolated. PCR is then used to replicate only a specific TCRβ gene segment
(V, D or J) by using primers specific to a TCRβ segment. The mixture of CDR3 region
clones is then separated by size using electrophoresis. The results are then presented on
histograms with number of TCR’s at each specific size [Kepler et al., 2005]. Note that
spectratyping separates CDR3 regions by size, if two different CDR3 sequences are of the
same length they will be counted in the same bin. Figure 3 shows examples of some common
CDR3 length distributions that result from spectratype analysis.
Recent improvements in sequencing technology allow for much greater detail in measuring
TCR diversity [Robins et al., 2009]. Adaptive Biotechnologies developed an immune profiling
assay, ImmunoSEQ, that uses parallel sequencing to capture 48 possible V segments, 13 J
segments and 2 D segments by simultaneous use of PCR primers for each segment [Robins
et al., 2009]. This allows for simultaneous sequencing of a large portion of the human T-cell
3
Figure 3: TCR distributions: (A) Shows a typical Gaussian polyclonal distribution. (B)
Shows a non-Gaussian distribution that is also polyclonal. (C) shows a non-Gaussian distri-
bution that is monoclonal [Miqueu et al., 2007] with permission.
reportoire. The assay maximizes throughput by only amplifying and sequencing the region
of the TCR that contains the CDR3 region. This allows for short reads, 60 nucleotides in
length, to be used to identify each sequence. Further, the assay can be used on both cDNA
and genomic DNA [Robins et al., 2009]. Recently, Adaptive Biotechnologies developed a new
method to correct for PCR bias caused by using so many different primers [Carlson et al.,
2013]. By using sequencing, researchers can distinguish TCRβ clones down to the level of
unique CDR3 clones.
Figure 4: Spectratype Schematic Shows steps taken to run to generate spectratype data.
(A) shows using electrophoresis to separate the mRNA by size. (B) shows measuring the
band intensity. (C and D) show translating the band intensities into a distribution by size
[Miqueu et al., 2007] with permission.
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Figure 5 shows a schematic of a generic PCR product used by the ImmunoSEQ assay.
13 reverse J primers and 48 forward V primers were designed to capture 13× 2× 48 = 1248
possible VDJ combinations. All sequences contain small portions of the V and J segments
as well as the CDR3 region. This allows not only for gene segment family identification but
also unique CDR3 identification.
Figure 5: Sequencing Assay Strategy Schmatic A generic TCRβ CDR3 PCR product is
shown. Primers include parts of the V and J segments and also the Genome Analyzer Cluster
station (GA F and GA R). The NDN region represents the CDR3 region. The primers were
designed to capture just enough of the J and V segments to allow identification [Robins
et al., 2012] with permission.
1.3 ImmunoSEQ Precision, Accuracy and Sensitivity
Robins et al. [2012] conducted experiments using the ImmunoSEQ platform to determine
its precision, accuracy and specificity. Samples containing spiked-in clones of known con-
centration ranging from 10 to 100,000 cells per million were created. The experiments show
that the assay can detect clones reliably at a level of one cell per 100,000.
The spike-in experiments were designed to test the assay’s accuracy and sensitivity. Dif-
ferent mixtures of five CD4+ T-cell clones specific for GAD65 were spiked into a background
of one million CD4+ T cells. Three different mixtures were made using these five clones.
Two other T-cell clones that targeted tumor-associated NY-ESO-1 antigen were also used.
These were spiked directly into autologous peripheral blood mononuclear cells instead of sep-
arated cells. The titrations that were used were 1/100,000, 1/10,000, 1/1000 and 1/100. The
different mixtures were then sequenced using the method described in section 1.2. The raw
data results in counts for each unique CDR3 region. Finally, a nearest neighbor alogrithm
was used to merge closely related sequences to remove PCR and sequencing errors. The pro-
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cessed data were then used to estimate the frequencies of each spiked in clone. The results
show that 6 out of 7 of the clones had an observed frequency very close to the expected. The
7th clone was not detected at all because it contained a 16 nucleotide deletion and the assay
is designed to capture all clones with deletions of 14 nucleotides or fewer (this deletion length
accounts for 99% of TCRβ’s) [Robins et al., 2012]. Thus, the assay is extremely accurate in
detecting clones even at low concentrations.
Finally, the reproducibility of the assay was tested. Blood was drawn from one subject
and DNA was extracted two independent times (DNA A and DNA B). The DNA A sample
was then PCR amplified two independent times (PCR A1 and PCR A2) while the DNA B
sample was only PCR amplified once (PCR B1). Finally, sample PCR A1 was sequenced
two independent times (SeqA1a and SegA1b) while samples PCR A2 and PCR B1 were only
sequenced once (SegA2a and SeqB1a). Robins et al. [2012] showed that sequencing from the
the same PCR library is highly reproducible. Robins et al. [2012] showed that sequencing
from different PCR libraries is also reproducible but not quite as much. Finally, Robins
et al. [2012] showed that sequencing different DNA extractions is also reproducible but
again not quite as much as the other two conditions. In the different blood draw samples,
approximately 55 % of all reads were obtained from shared sequences. This is probably due
to a blood draw being a finite sample so each one is a random subset of all clones [Robins
et al., 2012].
1.4 Unseen Species and Estimating the TCRβ Repertoire using
ImmunoSEQ data
1.4.1 Unseen Species Problem
The unseen species problem is one that has been tackled several times over the years. Efron
and Thisted [1976] described a method for estimating unseen species. The unseen species
problem was first considered in ecology, where researchers needed to estimate the number
6
of different types of species in a given area assuming they could not sample every organism.
That is, if a given area is sampled and n species are found, the unseen species problem
is to estimate how many more unique species are in the area that were missed by the
sample. A different application that may help elucidate this concept is to consider William
Shakespeare’s vocabulary. Given all the different words he used in his writing, we may want
to estimate how many words Shakespeare actually knew assuming he did not use all of them
in his works. The unseen species estimation problem in this case is, if a new work from
Shakespeare is found, to estimate the number of new words not used in his previous works.
Shakespeare’s works are comprised of 884,647 total words, 31,534 of which are unique [Efron
and Thisted, 1976]. Let nx represent the number of words occuring x times (x= 1 to∞). The
method described by Efron and Thisted [1976] says, assuming the new works are the same
size as the old, 11,460 new words would be expected. The basic model uses an empirical Bayes
approach and is described later in this section. Recently, this method has been modified to
genome sequencing [Ionita-Laza et al., 2009] and T-cell receptor sequencing [Robins et al.,
2009].
The methodology described by Efron and Thisted [1976] can be thought about using
species trapping terminology. Suppose there exist S species and after trapping for one unit of
time we capture xs members of species s. We then assume that xs has a Poisson distribution
with a mean of λs. It is convenient to consider the time period to be [−1, 0] and we wish to
extrapolate to a time t in the future. Let xs(t) be the number of times species s appears in
[−1, t].
Before moving on, it is of relevance to review the Poisson distribution. The Poisson
distribution is a widely used discrete distribution for modeling count data. For example, the
Poisson distribution can be used to model the number of occurences of a phenomenon in a
given time period [Casella and Berger, 2002]. In this case, the number of species seen in a
given area in a given time period. The basic assumption the Poisson distribution is built on
is that the probability of occurence is proportional to length of waiting time. So the Poisson
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distribution has one parameter λ, sometimes called the intensity parameter [Casella and
Berger, 2002]. A random variable, X has a Poisson(λ) distribution if
P (X = x|λ) = e
−λλx
x!
, x = 0, 1, 2, ...
where the E(X) = λ and var(X) = λ. Two useful characteristics of the Poisson distribution
are that the sum of independent Poisson random variables is itself Poisson distributed and
a Poisson random variable conditioned on a sum of Poisson variables is binomial. More
formally,
Theorem 1. If X ∼ Poisson(θ) and Y ∼ Poisson(λ) and X and Y are independent, then
X + Y ∼ Poisson(θ + λ) [Casella and Berger, 2002].
The Poisson distribution assumption implies, using Theorem 1, that xs(t) is distributed
Poisson(λs(1+t)). Furthermore, we can say that
xs|xs(t) ∼ Binomial
(
xs(t),
1
1 + t
)
.
Proof. Assuming
xs ∼ Poisson (λs)
Then
xs(t) ∼ Poisson(λs(1 + t))
given there are 1 + t time points in the [−1, t] and by Theorem 1. Next to show xs|xs(t) is
binomially distributed, let xs(t) = xs+xs(t−1) where xs(t−1) does not include the interval
[−1, 0]. Note that Pr(xs(t − 1) = xs(t) − xs | xs) = Pr(xs(t − 1) = xs(t) − xs) because
xs(t − 1) does not include the interval [−1, 0] and therefore is not dependent on xs. So we
have
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Pr(xs | xs(t)) = Pr(xs, xs(t) = xs + xs(t− 1))
Pr(xs(t) = xs + xs(t− 1))
=
Pr(xs) Pr(xs(t− 1) = xs(t)− xs | xs)
Pr(xs(t) = xs + xs(t− 1))
=
Pr(xs) Pr(xs(t− 1) = xs(t)− xs)
Pr(xs(t) = xs + xs(t− 1))
=
exp(−λs)λxss
xs!
× exp(−λst)(λst)
xs(t−1)
xs(t− 1)! ×
xs(t)!
exp(−λs(1 + t))(λs(1 + t))xs(t)
=
(
xs(t)
xs
)
exp(−λs)λxss exp(−λst)(λst)xs(t)−xs
exp(−λs(1 + t))(λs(1 + t))xs(t)
=
(
xs(t)
xs
)
λxss (λst)
xs(t)−xs
(λs(1 + t))xs(t)
=
(
xs(t)
xs
)
λxss (λst)
xs(t)−xs
(λs(1 + t))xs(t)−xs+xs
=
(
xs(t)
xs
)(
1
1 + t
)xs ( t
1 + t
)xs(t)−xs
=
(
xs(t)
xs
)(
1
1 + t
)xs (
1− 1
1 + t
)xs(t)−xs
This is a binomial distribution with n = xs(t) and p =
1
1+t
.
Let G(λ) be the empirical cumulative distribution function of λ1, ..., λS. If nx is the
number of species observed x times in [−1, 0], let
ηx = E(nx) = S
∞∫
0
(
e−λλx
x!
)dG(λ), (1)
where λ is the λ associated with G(λ). Next, let ∆(t) be the expected number of species in
(0, t] but not in [−1, 0]. Note that using equation 1 the probability of not seeing a species
in a given interval (observing x = 0) is given by exp(−λ). Likewise, the probability of not
seeing a species in the interval [−1, 0] is exp(−λ) so that the probability of seeing a species
in the interval (0, t] is 1− exp(−λt). Thus,
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∆(t) = S
∞∫
0
exp−λ(1− exp−λt)dG(λ).
To estimate ∆(t) we can use a Taylor series expansion of 1− exp−λt,
1− exp−λt = λt− λ
2t2
2!
+
λ3t3
3!
− ...
and substituting the right hand expression into the expression for ∆(t) we get
∆(t) = S
∞∫
0
exp−λ(λt− λ
2t2
2!
+
λ3t3
3!
− ...)dG(λ)
which can be rexpressed as
∆(t) = S
∞∫
0
(
exp−λ λt
1!
− exp
−λ λ2t2
2!
+
exp−λ λ3t3
3!
− ...
)
dG(λ).
Substituting equation 1 into the right hand side we get
∆(t) = η1t− η2t2 + η3t3 − ...
Thus an estimate for ∆(t) is
∆ˆ(t) = n1t− n2t2 + n3t3 − . . . .
This estimate works well when t = 1 but when t > 1 the tx values cause wild oscillations
which may cause convergence issues. Euler’s transformation is one way to force the series to
converge. Euler’s transformation is defined [Knopp, 2013] as
∞∑
k=0
(−1)kak =
∞∑
n=0
∆na0
2n+1
where
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∆ka0 =
k∑
m=0
(−1)m
(
k
m
)
ak−m
which is the form that the unseen species estimate takes. That is
∞∑
k=0
(−1)kak =
∞∑
x=1
(−1)x+1ηxtx.
Application of this transformation is discussed further in section 1.4.2.
1.4.2 TCRβ CDR3 Diversity
Robins et al. [2009] used the unseen species method described in section 1.4.1 to estimate
the human TCRβ repertoire. Using the same terminology as in 1.4.1, the total number of
unique TCRβ CDR3 sequences in the reportoire is represented by S. Let xs represent the
number of a specific CDR3 sequence, s, observed in an experiment. Further, assuming T-cells
circulate freely in the blood, it can be assumed that each CDR3 count, xs, is distributed
Poisson(λs). Let xs(t) represent the number of times a CDR3 sequence was observed in
sequencing experiment t and every previous experiment. Here, t represents the numbered
experiment, 1, 2, ..., that was sequenced. Finally, let nx represent the number of CDR3
sequences observed exactly x times. Once again, we need to estimate ∆(t), the number of
CDR3 sequences expected to be observed in all sequencing experiments except the first one,
t = 1. This gives us an estimate of the total number of unique CDR3 sequences that could
be observed in one subject. Once again the estimate for ∆(t) is
∆ˆ(t) = n1t− n2t2 + n3t3 − ...
By letting t = u
2−u the following relationship is derived using Euler’s transformation from
section 1.4.1
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∞∑
x=1
(−1)x+1ηxtx =
∞∑
y=1
ξyu
y
where
ξy =
∞∑
x=1
(
y − 1
x− 1
)
(−1)x+1
2y
ηx =
1
2y
δy(η1)
and
δ0 = η1, δ
1 = η1 − η2, δ2 = η1 − 2η2 + η3, . . . .
Let
∆x0(t) =
∞∑
x=1
(−1)x+1ηxtx
∆x0(u) =
∞∑
y=1
ξyu
y
∆(t) = lim
x0→∞
∆x0(t)
∆(u) = lim
x0→∞
∆x0(u).
By definition ∆(t) = ∆(u) if both limits exist. Here ∆x0(u) converges much more quickly to
the common limit [Efron and Thisted, 1976]. We can estimate ξy by substituting nx for ηx
and then estimate ∆(t) using
∆x0(u) =
∞∑
y=1
ξyu
y =
x0∑
y=1
1
2y
δy(η1)u
y, u =
2t
1 + t
.
Using the results from their sequencing experiments, Robins et al. [2009] estimated the
human TCRβ repertoire to be 105 CDR3 sequences. This result is similar to that obtained
by Arstila et al. [1999] who estimated it to be 106.
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1.4.3 Models for Estimating Population T-cell Diversity
Section 1.6 describes several T-cell receptor analysis methods in detail. This section will
briefly describe several other methods present in the literature. Specifically, models to esti-
mate overall T-cell diversity rather than just sample T-cell diversity will be presented.
Sepu´lveda et al. [2010] described a series of Poisson abundance models that can be used
to estimate the diversity in the original T-cell population. The clonal size distribution can
be described by the following Multinomial law
P [mx|D,η] = D!
(D −M)
n∏
x=1
mx!
[
pη(0)
]D−M n∏
x=1
[
pη(x)
]mx
, (2)
where D is the number of distinct clonotypes in the population which is the population
diversity in this case. mx is the number of clonotypes with x copies in the sample and pη(x)
is the probabilty of a clonotype being sampled x times and is described by a model with
parameter vector η. M is the sample diversity and n is the sample size. By assuming pη
follows a Poisson distribution, one can obtain the class of Poisson abundance models.
The simplest Poisson abundance model is assuming a homogeneous Poisson distribution
for all clonotypes. That is
pλ(x) =
e−λλx
x!
(3)
where λ is the sampling rate. This can then be plugged back into equation 2 for pη. However,
it is very simplistic to assume all clonotypes have the same sampling rate. Thus, different
distribution can be obtained by applying a distribution to λ.
The first model to consider is the Poisson-Gamma model where λ follows the Gamma
distribution. This assumes clonotypes have different sampling rates based on their clonal
size (the number of times a clonotype appears in the sample). By mixing equation 3 with a
Gamma distribution for λ we get
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pα,β(x) =
∫ ∞
0
e−λλx
x!
βαλα−1e−λβ
Γ(α)
dλ =
Γ(x+ α)
Γ(x+ 1)Γ(α)
(
β
β + 1
)α(
1
β + 1
)x
, (4)
where α and β are the shape and scale parameters of the Gamma distribution.
Another model is the Poisson-lognormal model. This model assumes that λ follows a
lognormal distribution with parameters µ and σ2. Using this model the sampling probability
is
pµ,σ2(x) =
∫ ∞
0
e−λλi
x!
e
(log λ−µ)2
2σ2√
2piσ2
dλ. (5)
This does not have a closed form and a numerical algorithm can be used such as the Newton-
Raphson to calculate the probabilities.
The final model assumes λ follows an exponential distribution with paramter µ = e−ω/(1−
e−ω). Further, ω follows an exponential distribution with parameter ρ. Thus we get the fol-
lowing sampling distribution
pρ(x) = ρ
Γ(x+ 1)Γ(ρ+ 1)
Γ(x+ ρ+ 2)
. (6)
Using the sampling probability equations, the diversity, D, can be estimated by maxi-
mizing equation 2. Rempala et al. [2011] and Greene et al. [2013] expand these models to
the multivariate setting to estimate population diversity. To choose the model that best fits
the data goodness of fit tests can be computed such as the Pearson chi-squared test and AIC
measure. Once an appropriate model is chosen, reportoires can be compared. The diversities
can be compared by tests such as the Chi-squared or Kolmogorov-Smirnov tests. Because
these tests are very sensitive to sample size, Mehr et al. [2012] suggest using machine learning
methods such as repoirtoire clustering by similarity.
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1.5 Application of TCRβ Studies
1.5.1 Hematopoietic stem cell transplantation
Hematopoietic stem cell transplantation (HSCT) is used to treat hematological disorders
such as blood cancers. The procedure involves replacing diseased host cells with healthy
donor cells. A result of this procedure is graft-versus-tumor effect (GVT), which is when the
reconstituted T-cells recognize the blood cancer and mount an immune response. Conversely,
the reconstituted T-cells can recognize the new host and mount an autoimmune response
known as graft-versus-host-disease (GVHD) [Avent, 2012]. Because GVHD is potentially
lethal, it is extremely important to match donors to recipients to minimize the risk of donor
T-cells recognizing the recipients cells. The ability to measure TCRβ clone abundance can
greatly help in understanding the immune system’s requirement for initiating GVT versus
GVHD.
1.5.2 Case Studies
Several studies have used the ImmunoSEQ assay to describe the T-cell repertoire in a variety
of circumstances such as monitoring minimal residual disease (MRD), measuring diversity
pre- and post-treatment and describing the T-cell repertoire during viral infection. This
section will briefly describe six studies that have utilized the ImmunoSEQ assay.
Weng et al. [2013] studied the ability of high-throughput sequencing to monitor MRD in
T-cell lymphoma patients. Samples from 10 patients were examined using the ImmunoSEQ
assay. Tumor clones were identified prior to HSCT treatment and monitored using high-
throughput sequencing. By using the ImmunoSEQ, Weng et al. [2013] were able to monitor
recurrence of tumor clones that were a precursor of disease relapse using plots of percentage
of malignant clone. Spike-in experiments were also performed that showed the assay could
detect tumor clones with a sensitivity of 1:150,000.
Cooper et al. [2013] studied how BRAF inhibition affects the T-cell repertoire in patients
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with metastatic melanoma. Serial biopsies from 8 patients were sequenced prior to treatment
and 10-14 days after treatment using the ImmunoSEQ assay. T-cell diversity was calculated
pre- and post-treatment and the study found that treatment with BRAF inhibitors (BRAFi)
resulted in an increase in T-cell diversity in 7 out of 8 patients. The study also found that
approximately 80% of the clones found in patients post-treatment were not present before
treatment suggesting BRAFi treatment results in an influx of T-cells. Finally, the study
found that the proportion of dominant clones present both pre- and post-treatment had an
association with patient outcome. Patients with a high-proportion of pre-existing clones
post-treatment had a better clinical outcome. It was unclear what specific statistical tests
were performed.
Robert et al. [2014] also studied patients with metastatic melanoma but investigated
treatment with drugs that inhibit cytotoxic T-lymphocyte-associated protein 4 (CTLA4)
instead of BRAFi. CTLA4 inhibition can result in tumor remissions due to a T-cell response
but this response has not been fully described. This study had two major conclusions. First,
T-cell diversity increases post-treatment but does not seem to be related to the patients’
ability to fight cancer. Diversity was calculated using the Shannon diversity index which is
defined as
H = −
L∑
i=1
pi log(pi) (7)
where pi is the probabiltiy of CDR3 length i. Second, patients with toxicity had a signifi-
cantly higher number of unique productive sequences after treatment. Because the authors
had a large enough sample the Wilcoxon signed-rank test was used to compare diversity mea-
sures pre- and post-treatment. The authors concluded that these results point to a general
activation of the immune system rather than a specific anti-cancer immune response.
Muraro et al. [2014] studied the T cell repertoire post-HSCT in 24 multiple sclerosis
(MS) patients. HSCT can be used as a way to reset the immune system in MS patients that
have autoimmune disease (an organisms immune response to its own cells). The end point
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of interest is a non-autoimmune repertoire. Samples were sequenced prior to treatment, two
months after treatment and one year after treatment. The study found that patients that
had a higher T-cell diversity at two months had a better clinical outcome. In this case
diversity was the percentage of T cell repertoire that the top 100 clones included. It was
unclear what statistical tests were performed to test for differences.
Finally, Zhu et al. [2013] and Neller et al. [2012] used the ImmunoSEQ assay to examine
the T-cell repertoire in patients with herpes virus infection. Both studies showed that virus
specific clonotypes are persistent in the patient’s T-cell repertoire. This suggests that there
is a mechanism to promote a prompt response to viral recurrence.
1.6 Overview of Statistical Methods for CDR3 Data
Spectratype analysis is universally accepted as a procedure to monitor and calculate CDR3
length distributions. However, no agreement has been reached on a method to statisti-
cally compare individual repertoires. There are two major hurdles when analyzing CDR3
spectratype data. The first is extracting information from each CDR3 distribution and the
second is integrating all of the information from all the CDR3 distributions [Miqueu et al.,
2007]. Initially, spectratype analysis was done by “eye-balling” the distribution and plac-
ing it into a descriptional category. However, this methodology suffers from variation due
to researchers having different ideas about which categories different distributions should
fit into. Visual inspection and categorization is also an extremely time consuming method.
Hence, researchers have used several computational methods to describe CDR3 distributions.
Gorochov et al. [1998] described a method for measuring CDR3 distribution perturbation
from a control distribution. This method is applied to T-cell repertoires during progression
of AIDS and describes the distributions as a whole. Collette et al. [2003] took this a step
further and described an OligoScore which describes each peak individually. This method
can be used to identify recurrent peaks in different samples. Venturi et al. [2007] adapted
a method from ecology called Simpson’s diversity index to measure the diversity in a CDR3
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distribution. This method was applied to assess the T-cell repertoire recovery after HSCT
by van Heijst et al. [2013]. All these methods assign scores to which statistical methods can
then be applied. Kepler et al. [2005] described a statistical method that used the Kullback-
Leibler divergence as a measure of how different CDR3 length distributions are from each
other. Most recently, Bolkhovskaya et al. [2014] described a non-parametric method for
comparing TCR distributions. In the following subsections each method is clearly described.
1.6.1 CDR3 Distribution Perturbation
The CDR3 length distribution measure was applied to measure T-cell repertoires during pro-
gression to AIDS. This is a measure of how different TCR distributions are from each other.
Gorochov et al. [1998] used data that was translated into a probability distribution from
Immunoscope analysis. The area under each peak was measured to calculate a probability
using the following formula
pi =
Ai∑
i
Ai
(8)
where A is the area under each peak (CDR3 length) and i = 1, . . . , L where L is the number
of amino acid lengths in the data. Modifying this notation, let pfik represent the probability
of peak i of TCRβ family f (VDJ combination) from sample k. The method then calls for
a control distribution for each TCRβ family. This was done by taking the average of the
control samples denoted by
pfic =
∑
k∈c
pfik
|c| (9)
where c represents the indices of the control samples and |c| is the cardinality of c. The
perturbation of each peak from the control for sample k is then defined as
Dfik = p
f
ik − pfic. (10)
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The sum of the absolute value of the peak perturbations is then
Dfk = 100×
∑
i
|Dfik|
2
(11)
for sample k and TCRβ family f which yields an overall measure of perturbation for that
TCR profile in percentages for each TCRβ family. This is the generalized Hamming distance
and measures the distance between two strings of equal size. This measure ranges from 0 to
100 where 0 represents no difference from the control and 100 represents no overlap with the
control distribution. A further measure of overall perturbation for a sample k is defined as
Dk =
F∑
f=1
Dfk
F
(12)
where F is the number of TCRβ families.
Different statistical tests can then be applied to the measures of perturbation to compare
different groups. Gorochov et al. [1998] chose to use the Wilcoxon Rank sum test to compare
groups. However, depending on sample size and distributional assumptions, a t-test may be
appropriate as well. The the null hypothesis for this test, assuming a Gaussian distribution,
would be that the mean Dk is the same across all groups and the alternative hypothesis
is that at least one group’s mean is different. The hypotheses would be the same when
using Dfk except there would be many tests done, one for each TCRβ family. In this case
a multiple comparisons adjustment needs to be applied. For a more detailed discussion of
multiple comparisons see section 1.6.8.
1.6.2 OligoScores
Collette et al. [2003] described a score to measure each peak within a group. The OligoScore
is defined for the ith peak of the kth sample as
OligoScore(i) = exp(1)× N
√√√√ N∏
k=1
pik exp(−nk) (13)
19
where pik is probability of the i
th peak for the kth sample (as described in section 1.6.1),
nk is the number of peaks in each sample and N the number of samples [Collette and Six,
2002]. This score gives a measure of each peak within a group for each TCRβ family, f .
Oligoscores can be interpreted as a score that measures if the distribution has a major peak or
not (higher scores mean a peak is major). Collette and Six [2002] did not do any hypothesis
testing and instead ranked all oligoscores within each group. The highest oligoscore peaks
were then looked at graphically. This score can be adapted to compute peaks for each VDJ
combination.
1.6.3 Simpson’s Diversity Index
Slow T-cell recovery and low TCR diversity are risk factors for infection, cancer relapse and
graft-versus-host-disease (GVHD) after hematopoietic stem cell transplantation (HSCT) [van
Heijst et al., 2013]. See section 1.5.1 for a detailed description of GVHD and HSCT. Hence,
measuring TCR diversity post-HSCT is an important way to monitor patient health. van
Heijst et al. [2013] suggested using the inverse Simpson’s diversity index ( 1
DS
). This measure
ranges from 1 to∞ where 1 is no diversity and∞ is high diversity. The Simpson’s diversity
index in terms of TCR diversity using unique CDR3 length is the probability that any two
TCR’s chosen at random from the sample will have different CDR3 lengths and is defined
as
DS = 1−
L∑
i=1
nikf (nikf − 1)
nkf (nkf − 1) (14)
where nikf is the size of the i
th TCR CDR3 length (the number of copies of each TCR within
a CDR3 length and equivalent to the peak described in section 1.6.1) for the kth sample in
TCRβ family, f . L is the number of different TCR CDR3 lengths in the sample and nkf is
the total number of TCR sequences sampled in sample k of TCRβ family, f . The diversity
index is computed for each TCRβ family. This measure can then be used to compare groups
using t-tests or other inferential methods. Further, it can be adjusted to be computed for
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each VDJ combination.
van Heijst et al. [2013] were not interested in comparing groups but time points. Using
paired t-tests they found the patient TCR diversity did not change over time. However, using
correlations they did find that the composition of the TCR distribution changed drastically.
For example, the dominant peak from one time point to the next could be completely different
depending on what antigens the patient was in contact with recently.
1.6.4 Kullback-Leibler Divergence Method
Kepler et al. [2005] described this method directly for spectratype data which results in
relative abundance measures as described in section 1.2. Let’s consider the multinomial
distribution in terms of CDR3 length distribution. In this case, L is the number of unique
CDR3 lengths, q is a vector of probabilities of each CDR3 length occuring, mi is the number
of counts of the ith CDR3 length and nk is the total number of counts within a sample.
Thus, the probability mass function (pmf) of the relative abundance of the lengths of CDR3
clones, p = m
n
is
fp(p|nk,q) = nL−1k Cnk(nkp)
L∏
i=1
qpinki , (15)
where Cnk(nkp) is the multinomial coefficient and q is a vector of probabilities corresponding
to each category i.
Cnk(nkp) =
Γ(nk + 1)
L∏
i=1
Γ(nkpi + 1)
(16)
for
L∑
i=1
nkpi = n and zero otherwise.
The Stirling approximation can then be applied to the multinomial coefficient to simplify
its form assuming that for each i, nkpi is large enough.
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logCnk(nkp) = log Γ(nk + 1)−
L∑
i=1
log Γ(pink + 1) (17)
=
L∑
i=1
[
−nkpi log pi − 1
2
log pi
]
− L− 1
2
log 2pink +O(
1
nk
) (18)
Plugging this back into the pmf for p we get
fr(p|nk,q) = n
(L−1)/2
k e
−nkD(p;q)√
(2pi)L−1ΠLi=1pi
δ(0) (19)
where δ is the Dirac delta, p. = Σipi and D(p; q) is the Kullback-Leibler divergence.
D(p; q) = ΣLi=1pi log
pi
qi
(20)
where p. = q. = 1.
To determine the distribution of the Kullback-Leibler divergence we can apply a cumu-
lative generating function method where
h(s) = log
∫
dLpesD(p;q)fr(p|nk,q) (21)
= −λ log(1− s
nk
) (22)
This is the cumulative generating function of a gamma random variable with λ = (L− 1)/2
and scale = 1
nk
. The the distribution of the Kullback-Leibler divergence is given by
fD(D|nk) = n
λ
k
Γ(λ)
Dλ−1e−nkD (23)
Using the above derivations we can compare group distributions of the CDR3 length. We
will be testing to see if the population parameter q is identical in all groups. Thus, our null
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hypothesis is that the distribution of CDR3 lengths is identical in all groups.
Let pijk represent the relative frequency counts of CDR3 length i = 1, ..., L, where j =
1, ..., G represents the group and k = 1, ..., nij the k
th subject of the jth group for CDR3
length i. Then the mean of group j for CDR3 length i is defined as
p¯ij. =
1
ni
nj∑
k=1
pijk (24)
where ni is the number of counts of CDR3 length i and nj is the number of subjects in group
j. If G is the number of groups then the grand sample mean is
p¯i.. =
1
n.
G∑
j=1
nipij. (25)
where n. is the total number of subjects.
If we denote pjk as the vector that has components pijk we can partition the total diver-
gence as
Dtot =
∑
j
∑
k
D(pjk; q) (26)
=
∑
j
∑
k
[D(pjk; p¯k.) +D(p¯k.; p¯..) +D(p¯..; q)] (27)
Under the null hypothesis that q is the same in all groups the expected values of the
partitioned divergences are
E[D(pjk; p¯k.)] =
L− 1
nk
(1− G− 1
n.
) (28)
E[D(p¯k.; p¯..)] =
L− 1
nkn.
(1− 1
G
) (29)
E[D(p¯..; q)] =
L− 1
n.nk
(30)
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Finally, because the divergences are distributed Gamma, the following statistic is asymptot-
ically distributed as Fisher’s F with (L-1)(G-1) numerator and (L-1)(n.-G+1) denominator
degrees of freedom under the null hypothesis.
F =
(n.−G+ 1)ΣkD(p¯k.; p¯..)
(G− 1)ΣjkD(pjk; p¯k.) (31)
Notice that the numerator is a between group divergence and the denominator is within
group divergence. This is analogous to the typical ANOVA test. This statistic can be used
to compare different groups of subjects that have TCR data collected for them at each VDJ
combination, f .
1.6.5 Non-parametric Method
Bolkhovskaya et al. [2014] described a non-parametric method for assessing the TCR length
distribution. To incorporate statistical uncertainty, a non-parametric kernel distribution
estimator is constructed for the cumulative frequency distribution, Ff (p
∗) ≡ Prob(p ≥ p∗)
Fˆf (p) =
1
L
L∑
i=1
Φ(p− pi), (32)
where L is the number of TCR lengths, pi is the frequency of each TCR CDR3 length, p is
a pre-chosen frequency value and Φ(·) is the cumulative normal distribution with mean zero
and standard deviation
σpi =
[
S∑
s=1
σ2pi,s
] 1
2
(33)
where σ2pi,s is the standard deviation present at each of S steps of repertoire profiling. Three
steps (S) during the sampling process that add to statistical error are sampling T-cells,
PCR and sequencing. Each of these steps introduce variation to the final TCR frequency.
Bolkhovskaya et al. [2014] assume the sampling process at each step takes on a binomial
distribution so
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σ2pi,s =
√
pi(1− pi)
Ns
(34)
where Ns is the total number of samples at step s. However, this variation can only be
measured at the sequencing stage so S = 1. From here the probability density distribution
can be estimated by
Wˆ (p) = − d
dp
= Fˆf (p). (35)
Finally, the upper 95% confidence interval can be computed using
p0 = 1− (1− 0.95)z, z =
S∑
s=1
1
Ns
. (36)
Bolkhovskaya et al. [2014] applied this method to patient data and found that Ff (p) follows
a power law decay
Ff (p) ∝ pαi . (37)
The power law represents a relationship between two variables where one variable varies as
the power of another. It can be seen in scenarios where a few values dominate. Many times
a TCR CDR3 length distribution is dominated by one or two lengths. Thus, the power may
be an appropriate way to compare TCR CDR3 length distributions between groups. This
can be done by calculating and comparing α values between groups.
1.6.6 Proportion Logit Transformation
The proportion of shared sequences between donor and recipient can be considered as a
measure of how closely the donor and recipient are matched. The question posed is if
there is a difference in the proportion of shared sequences between donor and recipient
between patients with GVHD and no GVHD. Hence, we can match recipient and donor
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TCR sequencing data by amino acid sequence and calculate the proportion of unique and
shared TCR sequences. Proportions do not follow a Gaussian distribution. However, by
applying a logit transformation to the proportions, they can be transformed into a value
that follows a Gaussian distribution. If we let pi be the proportion of shared sequences, the
logit transformation is defined as:
logit(pikf ) = log(
pikf
1− pikf ) (38)
where pikf is the proportion of shared sequences for subject k within VDJ family, f . Once
pikf is logit transformed, t-tests can be applied to test for group mean differences. Since each
VDJ combination is to be tested a multiple comparisons correction is needed. A discussion
of multiple comparisons can be found in section 1.6.8.
1.6.7 Tabular Summary of Statistical Methods for CDR3 data
Table 1 shows a summary of the methods described and test that is being performed.
Table 1: Table of Methods for Analyzing TCR Sequencing Data
Method Summaries Alternative Hypothesis
Perturbation using
Matched Donor
Each VDJ combination Group pertrubations are different
Perturbation using
Mean Distribution
Each VDJ combination Group pertrubations are different
Oligoscores Each CDR3 length
within a VDJ combination
N/A
Simpson’s Diversity Index Each VDJ combination Group diversity measures are different
Kullback-Leibler Divergence Each VDJ combination Group distributions are different
Non-parametric Method Each VDJ combination Group α values are different
Proportion Logit Transformation Each VDJ combination Group proportions are different
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1.6.8 Multiple Comparisons
Testing many independent hypotheses runs the danger of identifying significant differences
that are the result of random chance. Methods such as the Bonferroni correction aim to
control the probability of making a Type I error. This means that these methods also control
the simultaneous correctness of all rejections [Benjamini and Hochberg, 2000]. However, the
Bonferroni method is conservative and results in a substantial loss in power for individual
tests. For high-throughput technologies it is more important to find all possible differences
at the cost of getting a few hypotheses wrong.
The false discovery rate is defined as the expected ratio of erroneous rejections to the
number of rejected hypotheses. Benjamini and Hochberg [1995] showed that this procedure
has a substantial increase in power over classic α controlling methods. The procedure was
shown to control the FDR at a lower level than desired so the adaptive procedure was
created [Benjamini and Hochberg, 2000].
Let m represent the total hypotheses that we wish to test and m0 represent those that are
true. Let R define the total number of hypotheses rejected and V denote the number of those
hypotheses that were rejected incorrectly. Note that V is an unobservable variable. Using
these definitions the effective error rate is E[ V
m0
] and the type I error rate is P (V ≥ 1). By
testing each hypothesis at level α we guarantee E[ V
m0
] ≤ α but not P (V ≥ 1) ≤ α. Using a
procedure such as the Bonferroni by testing each hypothesis at α
m
guarantees P (V ≥ 1) ≤ α.
However, in the FDR procedure the error of falsely rejecting a null hypothesis is captured
by the random variable Q = V
R
, the proportion of false-positives [Benjamini and Hochberg,
1995]. Thus,
FDR = E(Q) = E
(
V
R
)
.
Benjamini and Hochberg [2000] showed that when m0 < m the FDR is smaller than or
equal to the Type I error rate. Thus any procedure that controls the Type I error rate also
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controls the FDR. But if you are only controlling the FDR then an improvement in power
is expected. The following procedure is shown to control the FDR at level q and improve
power:
1. Let P(1) ≤ ... ≤ P(i) ≤ ... ≤ P(m) be the ordered p-values.
2. Let k be the largest i for which P(i) ≤ imq.
3. Reject all k ordered hypotheses.
The proof that this procedure controls the FDR is based on the lemma that says for
m1 = m−m0 false null hypotheses the test procedure satisfies the inequality [Benjamini and
Hochberg, 2000]
E(Q|Pm0+1 = p1, ...., pm = pm1) ≤
m0
m
q
Thus, when some of the null hypotheses are rejected the FDR is controlled at a level less
than q. So there is once again room to improve power in this procedure. If m0 was known
then E(V ) = m0α and r(α) = v + s where s is the number of null hypotheses rejected
correctly. So the new estimate of the FDR can be [Benjamini and Hochberg, 2000]
Qˆe(α) =
vˆ(α)
r(α)
=
mˆ0α
r(α)
.
Then to control the FDR at level q we can follow the following procedure
1. Let k be the largest i for which P(i) ≤ imˆ0 q.
2. Reject all k ordered hypotheses.
The final problem is how to estimate m0. A graphical method can be used. If you consider
the p-values to be independent, under the null hypothesis they should follow a uniform[0,1]
distribution. Thus, a quantile plot of the pi’s should have a linear relationship through the
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origin and slope of S = 1
m+1
. When there are false null hypotheses they tend to stack at the
lower end. However, the upper end should continue with a linear relationship. Thus, we can
use the slope of the higher p-values to solve for m0. Benjamini and Hochberg [2000] suggest
the estimate of m0 to be calculated as follows.
1. Calculate slopes Si =
1−pi
m+1−i and continue as long as Si ≥ Si−1
2. Stop once Sj < Sj−1.
3. Then mˆ0 = min(
1
Sj
+ 1,m).
1.7 Discussion
In this chapter we discussed T-cell biology and the ImmunoSEQ platform used to analyze
the T-cell repertoire. Further, different methodologies were described to analyze the high-
throughput sequencing data generated by the ImmunoSEQ assay. In the next chapter, we will
apply these methodologies to a hematopoietic stem cell transplantation data set. In Chapter
3, we will discuss how high-throughput sequencing data can be considered compositional
data and the analytical challenges that can present. Finally, the same HSCT data from
chapter 2 will be analyzed as compositional data.
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2 Applications to TCR sequencing data
2.1 Introduction
In this chapter, HSCT data (described in section 2.3) were analyzed using the methodologies
described in chapter 1. To determine what pre-processing steps other researchers used,
previously published data were reanalyzed. Finally, the differences in the methods were
discussed.
2.2 Reanalysis of Published TCR data
We acquired the data from Dr. Harlan Robins’ lab that were analyzed in the 2012 paper
titled “Ultra-sensitive detection of rare T-cell clones” [Robins et al., 2012]. This article
describes the Adaptive Technologies ImmunoSEQ technology and it’s ability to detect T-
cell clones. Thus, it was useful to reanalyze the data to determine the exact process used to
perform the analysis. Specifically, we acquired replicate data for one patient but were unable
to obtain the spike-in data used in the experiments. The data that we acquired included
samples DNA A, DNA B, PCR A1, PCR A2, SeqA1b and SeqA1a.
We performed a similar analysis and compared our results to that reported by Robins
et al. [2012]. In the publication, the authors were not specific about their data processing
procedures so several different attempts were made to replicate their results. The first step
required deciding whether to use all the sequences or a subset. The sequences are flagged
by Adaptive Biotechnologies software as productive (usable proteins) or non-productive and
through trial and error we discovered both productive and non-productive sequences were
used for the analysis performed by Robins et al. [2012]. Next, in order to compare counts
between replicates the files needed to be merged. The CDR3 sequences can be merged either
by amino acid or nucleotide sequence and through trial and error we discovered Robins et al.
[2012] merged by nucleotide sequence.
Comparing Figure 6 to Figure 2 reported in the Robins et al. [2012] paper, we see that the
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log-log plots are almost identical. Thus we established in our reanalysis the specific process
the authors undertook. We noted a small difference between the total number of shared
sequences between samples SeqA1a and SeqA1b. The authors identified 150,612 sequences
but our analysis identified 150,567.
Figure 6: Reproducibility Plots The plots show frequencies of unique sequences from
different samples.
2.3 Data
Thirteen patients with hematological disorders who underwent HSCT were included in this
study. This was a randomized phase II trial conducted at Virginia Commonwealth University
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of a reduced intensity condition regimen for patients undergoing HSCT [Meier et al., 2013].
Human leukocyte antigen (HLA) matching was done and only patients with 7 of 8 or 8 of
8 matches were eligible for transplantation. HLA is a protein found on most cells in the
body and there are 8 major types. The best transplant outcomes happen when patient and
donor HLA’s are closely matched. Note that the TCR’s present are also determined by
the protein they recognize along with the HLA’s present. Thus, the sample data could be
skewed despite the close HLA matching. Peripheral blood stem cells were collected from the
donor and recipient whole blood samples were collected post-HSCT. The goal of this analysis
was to identify differences at the molecular level between T-cell repertoires of patients who
suffered from GVHD and those that did not. Eight patients suffered from GVHD and five
did not. T-cell sequencing data was generated using the ImmunoSEQ technology described
in section 1.2. The methods described in section 1.6 were applied to the data and the results
are described in the following sections.
All data analyses were performed using the R programming environment version 3.1.1 [R
Core Team, 2014]. Only sequences that could result in usable proteins (productive sequences)
were used in the analyses. Further, reads per million (RPM) were calculated for each sample
and used in the analyses. RPM were calculated by dividing each CDR3 frequency by the
total number of CDR3 sequences and multiplying by one million. VDJ combinations were
filtered out to keep only combinations that had counts for at least 7 patients, leaving 947
VDJ combinations for analysis. CDR3 length summaries were obtained by summing all the
CDR3 RPM’s of the same length within each VDJ combination. Further data management
applied to a specific method will be described in the following sections.
2.4 Permutation Tests
Because of the low sample size (13 patients) permutation tests were used to compare groups.
In this case, there are two samples that have been drawn from two distributions that may
or many not be the same. That is the no GVHD group is drawn from a distribution, F ,
32
independent of the GVHD group from a distribution, G. Thus, the null hypothesis to test is
that the two distributions are equal and the alternative is that they are not equal. That is
H0 : F = G
Ha : F 6= G
Under the null hypothesis, any of the 13 observations could have come from either distribu-
tion F or G. All 13 observations were considered as a single set of values. A sample of size
five was drawn without replacement from this set of values to represent the no GVHD group.
The remaining eight observations represent the GVHD group. 1000 random samples were
drawn in this manner. The absolute difference between group means, |µˆ∗|, was calculated
for each permutation. The p-value is then calculated as follows
p-value =
#(|µˆ∗| ≥ |µˆ|)
1000
(39)
where |µˆ| is the absolute difference in means using the original sample. Thus, this is the
probability that the statistic was greater than that which was observed using the original
sample [Efron and Tibshirani, 1994]. P-values were calculated for all 947 VDJ combinations
considered for analysis. The p-values were then corrected for multiple comparisons using an
FDR threshold of 0.05. All permutation tests and FDR corrections were implemented in the
R programming environment.
2.5 CDR3 Distribution Perturbation Results
The CDR3 Distribution Perturbation method described in section 1.6.1 was adapted for
TCR sequencing data and applied to the study data. Each possible VDJ combination, f ,
was examined individually. There were 947 perturbations calculated for each sample after
filtering. The perturbations were calculated both as a perturbation from each donor’s T-cell
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distribution, Dfkd, and as a perturbation from an average donor T-cell distribution, D
f
ka. D
f
kd
measures the perturbation from each donor and can be considered as a measure of how similar
the recipient is to the donor. Dfka measures the perturbation from a control distribution and
can be considered to measure how different the samples are from each other. Depending
on which calculation is used the interpretation of the difference between the GVHD and no
GVHD groups is slightly different. Permutation tests described in section 2.4 were used to
test for differences between the recipient GVHD and no GVHD groups.
The probability of each CDR3 length, i, was calculated using equation 8. The RPM were
summed for each unique CDR3 length and then divided by the total RPM present within
the VDJ combination of interest to calculate the CDR3 length probability, Ai. First, the
perturbation for each recipient was calculated as a perturbation from their matched donor.
The donor CDR3 length probabilities were calculated in the manner described above. The
perturbations were also calculated as a perturbation from a mean distribution of the 13
donors. The mean distribution was calculated by averaging the probability of each CDR3
length across all 13 donors. The perturbations were calculated using equation 10, where k is
each sample and c is the control distribution. The control distribution is either an average
donor distribution or the matched donor distribution.
Then statistics were calculated using each matched donor for each VDJ combination and
tested for differences between the GVHD and no GVHD groups. After adjusting for multiple
comparisons using the Benjamini and Hochberg FDR method described in section 1.6.8, there
were two significant differences (FDR <0.001). The distribution of the statistic for the two
signifcantly different VDJ combinations can be seen in Figure 7. The figure shows boxplots
where the median, 25th and 75th percentiles make up the box. The whiskers extend to 1.5
times the interquartile range (IQR) and if there are outliers they are represented by dots
outside the whiskers. Table 2 shows the median perturbations and observed FDR for the
two VDJ combinations. It was of interest to determine why the differences are in opposite
directions. Looking at Figures 9 and 10 it appears as though the VDJ combination TRBJ2-
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6 TRBV9 TRBD1-2 is not present in a large number of the samples. Figure 9 shows the
CDR3 length distributions in the donors for VDJ combination TRBJ2-6 TRBV9 TRBD1-2
and Figure 10 shows the CDR3 length distributions in the recipients for VDJ combination
TRBJ2-6 TRBV9 TRBD1-2. Matched donors and recipients are in the same positions in
the 2 figures. The low prevalence of this VDJ combination in the sample population could
be causing the results of the test to be skewed.
Second the statistics were calculated using a mean donor distribution as a control for
each VDJ combination. After adjusting for multiple comparisons using the Benjamini and
Hochberg FDR method, there were three significant differences (FDR <0.001). The distri-
bution of the statistic for the three significantly different VDJ combinations can be seen in
Figure 8. This is a measure of how different the No GVHD and GVHD groups are from
each other. Table 3 shows the median perturbations and observed FDR for the three VDJ
combinations. Note that the two analyses have no VDJ combinations in common.
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Figure 7: Distribution of perturbation from matched donor statistic for the 2 significantly
different VDJ combinations.
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Figure 8: Distribution of perturbation from mean donor statistic for the 3 significantly
different VDJ combinations.
Table 2: Median Perturbation Using Matched Donor Control
Median Median Observed
JGene VGene DGene No GVHD GVHD FDR< 0.05
Perturbation Perturbation
TRBJ2-3 TRBV7-9 TRBD1-1 37.946 22.513 <0.001
TRBJ2-6 TRBV9 TRBD1-2 50.000 60.310 <0.001
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Table 3: Median Perturbation Using Mean Control
Median Median Observed
JGene VGene DGene No GVHD GVHD FDR< 0.05
Perturbation Perturbation
TRBJ2-7 TRBV7-9 TRBD1-1 47.001 14.364 <0.001
TRBJ1-1 TRBV9 TRBD1-1 51.051 33.529 <0.001
TRBJ2-1 TRBV7-7 TRBD1-2 46.154 23.571 <0.001
Figure 9: Distributions of CDR3 lengths from VDJ combination TRBJ2-6 TRBV9 TRBD1-2
donors.
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Figure 10: Distributions of CDR3 lengths from VDJ combination TRBJ2-6 TRBV9 TRBD1-
2 recipients.
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2.6 Oligoscores Results
The Oligoscore method described in section 1.6.2 was adapted for TCR sequencing data and
applied to the study data. Each possible VDJ combination, f , was examined individually.
An Oligoscore was calculated for each CDR3 length, i, within each VDJ combination using
equation 13. The RPM were summed for each unique CDR3 length and then divided by the
total RPM present within the VDJ combination of interest to calculate the CDR3 length
probability. Further, the scores were calculated for both groups, GVHD and no GVHD,
individually. Each CDR3 length, i, was considered that ranged from 1 to nk, the number
of peaks for sample k. Because this is a measure to rank interesting peaks, the maximum
Oligoscore from each group was examined graphically. Looking at Figure 11 we see that
CDR3 length 39 shows up as a major peak in every patient with GVHD but only 2 of the
No GVHD patients. Similarly, looking at Figure 12 we see that CDR3 length 33 shows up in
4 out of 5 patients with no GVHD and 3 out of 8 with GVHD. Further, Fisher’s exact test
was calculated to test for a difference in number of subjects that had the two peaks as major
peaks. Calculating the Fisher’s exact test of the peak with the highest oligoscore in the
GVHD group showed a significant difference between the two groups (p=0.035). Calculating
the Fisher’s exact test of the peak with the highest Oligoscore in the no GVHD group showed
a non-significant difference between the two groups (p=0.266).
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Figure 11: Distribution of CDR3 length for highest Oligoscore in GVHD group.
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Figure 12: Distribution of CDR3 length for highest Oligoscore in No GVHD group.
2.7 Simpson’s Diversity Index Results
The Simpson’s diversity index method described in section 1.6.3 was adapted for TCR se-
quencing data and applied to the study data. Each possible VDJ combination, f , was
examined individually. There were 947 diversity indexes calculated for each sample using
equation 14. Each CDR3 length, i, was considered that ranged from 1 to L. L could vary
for each VDJ combination, nkf was the total RPM for each sample within a VDJ combina-
tion and nikf was the RPM for the i
th CDR3 length in the kth sample of VDJ combination,
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f . Permutation tests described in section 2.4 were used to test for differences in Diversity
between the GVHD and no GVHD groups.
Simpson’s diversity indices were calculated for every VDJ combination in each sample.
After adjusting for multiple comparisons using the Benjamini and Hochberg FDR method,
there were five significant differences (FDR < 0.001). The distribution of the statistic for
the five significanlty different VDJ combinations can be seen in Figure 13. Table 4 shows
the median diversity and observed FDR for the five VDJ combinations.
Figure 13: Distribution of Simpson’s Diversity Index statistic for the 5 significantly different
VDJ combinations.
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Table 4: Median Simpson’s Diversity
Median Median Observed
JGene VGene DGene No GVHD GVHD FDR< 0.05
Diversity Diversity
TRBJ2-2 TRBV11-1 TRBD1-1 0.458 0.544 <0.001
TRBJ2-6 TRBV5-5 TRBD1-1 0.470 0.034 <0.001
TRBJ2-4 TRBV5-5 TRBD1-2 0.715 0.000 <0.001
TRBJ1-3 TRBV5-6 TRBD1-2 0.649 0.155 <0.001
TRBJ2-6 TRBV7-6 TRBD1-2 1.088 0.619 <0.001
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For comparison Shannon’s diversity indices (see section 1.5.2) were also calculated for
every VDJ combination in each sample. After adjusting for multiple comparisons using
the Benjamini and Hochberg FDR method, there were no significant differences (FDR >
0.453). However, there were 34 p-values before adjusting below the α = 0.05 threshold. For
illustrative purposes, we examined the 6 VDJ combinations with the smallest p-values for
differences between the diversity index statistic. The distribution of the statistic can be seen
in Figure 14. Table 5 shows the median diversity and p-values for the 6 VDJ combinations
having the smallest p-values.
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Figure 14: Distribution of Shannon’s Diversity Index statistic for the 6 VDJ combinations
having the smallest p-values.
Table 5: Median Shannon Diversity
Median Median
JGene VGene DGene No GVHD GVHD p-value
Diversity Diversity
TRBJ2-4 TRBV20-1 TRBD1-2 -6722.642 -2237.406 0.005
TRBJ2-1 TRBV16 TRBD1-1 >-0.001 -52.182 0.007
TRBJ1-6 TRBV20-1 TRBD1-2 -3413.701 -699.385 0.012
TRBJ1-1 TRBV10-3 TRBD1-2 -4.448 -562.484 0.013
TRBJ2-5 TRBV10-1 TRBD1-2 -100.164 -2.094 0.014
TRBJ2-5 TRBV5-1 TRBD1-1 -33045.878 -9146.991 0.015
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2.8 Kullback-Leibler Divergence Results
The Kullback-Leibler (KL) Divergence method described in section 1.6.4 was adapted for
TCR sequencing data and applied to the study data. Each possible VDJ combination, f ,
was examined individually. There were 947 F-statistics calculated using equation 31 and the
K-L divergence was calculated using equation 20. Each CDR3 length, i, was considered that
ranged from 1 to L. L could vary for each VDJ combination. For the equation, n. = 13
was the total number of subjects and G = 2 represents the GVHD and no GVHD groups.
Further, ΣkD(p¯k.; p¯..) is the within group divergence and ΣjkD(pjk; p¯k.) is the between
group divergence. The K-L divergence was calculated using equation 20 and pi is the overall
relative abundance of CDR3 length i. Group differences were tested using equation 31. After
adjusting for multiple comparisons using the Benjamini and Hochberg FDR method, there
were 947 significant differences. This is all possible differences so only the lowest p-values
were looked at graphically. As Figures 15 and 16 show, there is considerable variability
within a group in the CDR3 length distribution. Thus, an average distribution would not
be very informative in this particular data set.
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Figure 15: CDR3 length distribution for each patient of VDJ combination: TRBJ2-1,
TRBV18, TRBD1-1.
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Figure 16: CDR3 length distribution for each patient of VDJ combination: TRBJ1-2,
TRBV3-1, TRBD1-1.
2.9 Non-parametric Method Results
The non-parametric method described in section 1.6.5 was adapted for TCR sequencing
data and applied to the study data. Each possible VDJ combination, f , was examined
individually. There were 947 α values calculated for each subject, k. Each CDR3 length,
i, was considered that ranged from 1 to L. L could vary for each VDJ combination. First,
standard deviation was calculated for each CDR3 length, i, using equation 33, where the
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probability of each CDR3 length was calculated by summing the RPM for each unique CDR3
length and then dividing by the total RPM present within the VDJ combination of interest.
Only one step of variation was considered, the final TCR sampling step, so S = 1 and
equation 34 was used to calculate the standard deviation. This standard deviation was then
used to estimate the complementary cumulative frequency distribution from equation 32. An
α was then calculated using equation 37 by setting p = (0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9)
and taking the log of both sides to estimate a slope. Permutation tests described in section 2.4
were used to test for differences between the α values of the GVHD and no GVHD groups.
The α values were calculated for every VDJ combination in each sample. After adjusting
for multiple comparisons using the Benjamini and Hochberg FDR method, there was one
significant difference (FDR < 0.001). The distribution of the statistic for the significantly
different VDJ combination can be seen in Figure 17. Table 6 shows the median α values for
the VDJ combination and the observed FDR.
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Figure 17: Distribution of the non-parametric α statistic for the significantly different VDJ
combination.
Table 6: Median Alpha Value
Median Median Observed
JGene VGene DGene No GVHD GVHD FDR< 0.05
Alpha Alpha
TRBJ2-2 TRBV25-1 TRBD1-1 -0.032 -0.074 <0.001
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2.10 Proportion Logit Transformation
The procedure described in section 1.6.6 was applied to the study data. Recipient data was
matched to donor data by amino acid sequences. Proportions for shared sequences were
then calculated for each VDJ combination and logit transformed. Because logit transformed
proportions are assumed to follow a Gaussian distribution, Student’s t-tests were applied
to each VDJ combination to test for difference between the GVHD and no GVHD groups.
After adjusting for multiple comparisons using the Benjamini and Hochberg FDR method,
there were no significant differences found (FDR > 0.659). However, there were 2 p-values
before adjusting below the α = 0.05 threshold. For illustrative purposes, we looked at the 2
VDJ combinations with the smallest p-values for differences between the proportions. The
distribution of the logit transformed proportions can be seen in Figure 18. Table 7 shows the
median logit transformed proportion values for each group and the corresponding p-values.
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Figure 18: Distribution of the logit transformed proportion of shared sequences for the 2
VDJ combinations having the smallest p-values.
Table 7: Median of the logit transformed proportion of shared sequences
Median Median
JGene VGene DGene No GVHD GVHD p-value
Proportion Proportion
TRBJ2-6 TRBV19 TRBD1-1 5.496 0.271 0.033
TRBJ2-1 TRBV30 TRBD1-1 68.000 2.748 0.037
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2.11 Discussion
This chapter looked at several different methods to analyze TCR data. Permutation tests
were then used to compare GVHD and no GVHD groups. Four methods identified several
significantly different VDJ combinations after adjusting for multiple comparisons. None of
the these methods found the same significant VDJ combinations. This could be because the
methods attempt to quantify different aspects of the T-cell repertoire. The CDR3 perturba-
tion method measures either how different the recipient distributions are from the donor or
from a control distribution. On the other hand, the diversity measure simply describes how
diverse the recipient’s repertoire is at that point in time. Oligoscores simply look for major
peaks within groups. The Kullback-Leibler divergence measures difference in distributions
but assumes an underlying distribution so appears to be more sensitive to changes than the
perturbation method. The non-parametric method assumes the distribution follows a power
law and can be interpreted as a measure of diversity. Finally, the proportion method com-
pares patient and donor similarity. Some of these methods measure similar aspects of the
repertoire while some measure very different aspects. So the method that bests corresponds
to the research question should be chosen. For this data set, Simpson’s diversity index would
be an appropriate choice since T-cell diversity has been shown to be a good measure of T-cell
repertoire health.
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3 Compositional Data in Bioscience
In the previous chapters several different methods were applied to high-throughput sequenc-
ing data. However, none of these methods consider the unit sum constraint on the data.
This constraint can have large effects on data analysis and data of this type is called com-
positional. This chapter will describe what effects compositional data can have on analysis
and how to analyze compositional data.
3.1 Introduction
To motivate what compositional data are and how they can affect data analyses consider
two scenarios that Pawlowsky-Glahn and Buccianti [2011] described in their textbook on
compositional data analysis. The first scenario pertains to counting the number of different
messenger RNAs (mRNA) that emerge from the nucleus of a cell in a given time interval.
The production of one type of mRNA does not necessarily affect the production of another
mRNA. This means each mRNA can be considered independent of another mRNA and
traditional analytical approaches are appropriate. The second scenario pertains to counting
total mRNA within a cell that has reached its maximum capacity of mRNA. If one type
of mRNA increases within the cell then another mRNA must decrease by some mechanism
such as degradation. This is the sum-constrained property of compositional data that can
have large effects on both the information gleaned and the interpretation of results.
There are quite a large amount of compositional data being generated in using “omics”
technologies (genomics, transcriptomics, etc.) but little awareness to the fact that these
are compositional data and should be treated as such. A lot of ground has been gained in
the geosciences in dealing with compositional data [Pawlowsky-Glahn and Buccianti, 2011].
However, there are some big differences between the subject matters, the main one being that
sequencing data produces compositions with hundreds-of-thousands of components whereas
geoscience data usually produces tens to hundreds of components. This lower dimensionality
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makes the data much easier to work with. For example, we can look at TCR sequencing
data which appears to provide the absolute abundance of different TCR transcripts but, in
reality, TCR sequencing provides only relative information for the specific sample. Note that
depending on when and how the sample is prepared the sequencing can be dominated by
several specific transcripts. This can be seen in experiments performed by van Heijst et al.
[2013] in monitoring T-cell repertoire recovery after HSCT over time. In this case, one patient
had a large spike in a TCR related to Epstein-Barr virus at day 145 which was undetectable
at days 138 and 194. Furthermore, low frequency transcripts can be highly affected by
changes in high frequency transcripts because only a limited number of transcripts can be
sequenced. Even worse, if an experiment is repeated, the subset of low frequency transcripts
detected can change with each run [Robins et al., 2009]. During TCR sequencing, a fixed
amount of sample is procured and then a fixed amount of that sample is sequenced. The
data are then “standardized”(ie reads per million) which results in a relative abundance.
This constraint has not always been taken into account in current analytical practices. In
the following sections, we will define compositional data and propose that compositional
methods are more appropriate to apply to sequencing data, specifically TCR sequencing.
3.2 Definition of Compositional Data
Compositional data are defined as data where the elements of the composition are non-
negative and sum to unity. This data structure often arises from non-negative data, such
as counts, that has been scaled by the total of the components [Pawlowsky-Glahn and
Buccianti, 2011]. Compositional data anlysis was most recently defined by Egozcue [2009].
The formulation he proposes is separated into a definition and three principles for a total of
four parts.
Definition A compositional vector, or simply a composition, of D parts is a positive real
vector of D components, describing quantitatively the parts of some whole, which carry
exclusively relative information between the parts.
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Principle A Scale Invariance: The information in a composition does not depend on the
particular units in which the composition is expressed. Proportional positive vectors
represent the same composition. Any sensible characteristic of a composition should
be invariant under scale.
Principle B Permutation Invariance: Permutation of components of a composition does not
alter information conveyed by the compositional vector.
Principle C Subcompositional Coherence: Information conveyed by a composition of D
parts should not be in contradiction with that coming from a sub-composition con-
taining d parts, d ≤ D .
3.3 Representations of a Composition
To represent a composition so that the representation follows the principles in section 3.2,
Aitchison [1986] proposed that all compositions be treated on a log transformed scale. This
allows for most classical multivariate methods to be applied to compositional data. Log
contrasts are scale invariant log ratios generically defined as
D∑
i=1
αi log(xi), whereΣ
D
i=1αi = 0 (40)
where αi is a transformation coefficient, xi is the compositional data and D is the size of
the simplex. The condition on the coefficients guarantees scale invariance. Three different
transformations are proposed [Pawlowsky-Glahn and Buccianti, 2011] for use depending on
the hypothesis to be tested. The first is called the additive-log-ratio transformation (alr). If
x is a composition in the D-part simplex SD,
alr(x) = log
(
x1
xD
,
x2
xD
, ...,
xD−1
xD
)
(41)
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where the natural logarithm is applied componentwise. The transformation is easily inverted
to get the composition back. However, it is not invariant under permutation of components
which may cause problems with some statistical tests. To remedy this problem, Aitchison
[1986] proposed another transformation called the centered log-ratio transformation (clr)
that is defined as
clr(x) = log
(
x1
gm(x)
,
x2
gm(x)
, ...,
xD
gm(x)
)
, gm(x) =
(
D∏
i=1
xi
) 1
D
(42)
where gm is the geometric mean. However, in this case the components change when working
with a subcomposition (defined in section 3.2) which is a violation of principle C. The
components of a subcomposition using the clr transformation change because the geometric
mean changes. Because of the sum-constrained property of compositional data, a D-part
composition can only be represented with D-1 coefficients but the clr transformation tries
to do this using D coefficients. The clr representation can be used as a measure of distance,
called the Aitchison distance, that is discussed in more detail in section 3.4. The final
representation is called the isometric log-ratio transformation (ilr) [Egozcue et al., 2003].
The major differences between the clr and ilr transformation are that the ilr transformation
results in D-1 components and there are procedures that allow for this transformation to be
easily interpretable. Simply, for the ilr transformation we are looking for an orthonormal
basis of SD using a set of compositions, e1, e2, ...eD−1 such that 〈ei, ej〉a = 0 for i 6= j,
and ‖ei‖a = 1. Where 〈·, ·〉a and ‖ · ‖a are the Aitchison inner product and norm. Where
〈x,y〉a = 〈clr(x), clr(y)〉 and ‖x‖a = ‖clr(x)‖ and ‖ · ‖ and 〈·, ·〉 are the Euclidean norm and
inner product respectively. Note, a full discussion of the Aitchison metric is presented in
Section 3.5. Using this terminology the ilr transformation is defined as
ilr(x) = (〈x, e1〉a, 〈x, e2〉a), ..., 〈x, eD−1〉a). (43)
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3.4 Statistical Modelling
Compositional data do not lend themselves well to traditional statistical approaches. Is-
sues such as spurious correlations can affect analytical results. For this reason some kind
of transformation is necessary prior to performing statistical analysis. Further, composi-
tional data are not part of the natural sample space and do not follow Euclidean geometry.
The observations can be moved to a new sample space or represented using an orthonormal
basis [Pawlowsky-Glahn and Buccianti, 2011]. The “move method” is the log-ratio transfor-
mation method and the “stay method” includes the alr, clr and ilr transformations that were
mentioned in section 3.3. These transformations place the compositional data in terms of
its basis and corresponding coordinates. These coordinates, based on linear algebra theory,
are part of the real space and standard multivariate techniques can be applied to them.
The simplex can be defined as follows: Let x = (x1, x2, ..., xD) denote a D-part composi-
tion, then
SD =
(
x = (x1, x2, ..., xD) : xi > 0 (i = 1, 2, ..., D),
D∑
i=1
xi = κ
)
(44)
where κ is a positive constant that is typically 1 or 100 depending on how the composition
is designed. The simplex has two basic operations called perturbation and powering as its
internal and external operations.
x⊕ x∗ = C(x1x∗1, ..., xDx∗D), (45)
α x = C(xα1 , ..., xαD), (46)
where C denotes the closure operation that normalises any vector to a constant sum. Fur-
thermore, we can define an inner product, norm and distance to define a (D-1) Euclidean
vector space structure on the simplex;
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〈x,x∗〉a = 1
D
∑
i<j
log
xi
xj
log
x∗i
x∗j
; (47)
‖ x ‖a =
√√√√ 1
D
∑
i<j
(
log
xi
xj
)2
; (48)
da(x,x
∗) =
√√√√ 1
D
∑
i<j
(
log
xi
xj
− log x
∗
i
x∗j
)2
(49)
Note that these equations are applied to the original simplex and are called the Aitchison
geometry, hence the a subscript.
An appropriate basis for the simplex needs to be determined. Because compositions are
a subset of the real space they can be expressed in terms of the canonical basis. However,
this does not follow Euclidean space rules. Egozcue et al. [2003] suggested one orthonormal
basis {e1, e2, ..., eD−1} ;
ei = C
(
exp
(
1√
i(i+ 1)
)
, ..., exp
(
1√
i(i+ 1)
)
, exp
(
−
√
i
i+ 1
)
, 1, .....1
)
(50)
and coordinates
x = (y1  e1)⊕ (y2  e2)⊕ ...⊕ (yD−1  eD−1), (51)
with
yi =
1√
i(i+ 1)
log
[
x1x2...xi
(xi+1)i
]
, i = 1, 2, ..., D − 1. (52)
Once the basis is selected typical multivariate methods can be applied such as Principal
Component Analysis.
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3.5 Current Practices and Their Pitfalls
TCRβ sequencing data are multivariate. Most methods applied to sequence data are univari-
ate, such as the t-tests (moderated), with extra procedures that adjust for multiple-testing.
However, the effect of the sum constraint on univariate analysis results is questionable. Con-
sider a simple thought exercise and imagine how the sum constraint can affect univariate
statistics. Specifically, for a simple two-part composition, x = (x1, x2) derived from a basis
w = (w1, w2) through its closure:
x = C(w) = (
w1
w1 + w2
,
w2
w1 + w2
).
Consider two different scenarios that have the same result. First, consider what is necessary
for w2 to double x2 if w1 is fixed,
w′ = (w1, w′2)
x′ = (x′1, x
′
2) = (x
′
1, 2x2)
∴ w
′
2
w1 + w′2
= 2 · w2
w1 + w2
w′2 = 2w2 ·
w1
w1 − w2
≈ 2w2, if w1 >> w2
Next, consider what is necessary for w1 if we fixed w2 to double x2.
w′ = (w′1, w2)
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x′ = (x′1, x
′
2) = (x
′
1, 2x2)
∴ w
′
2
w′1 + w2
= 2 · w2
w1 + w2
w′1 =
1
2
(w1 − w2)
≈ 1
2
w1, if w1 >> w2
This example demonstrates that there are two different mechanisms that can result in a
doubling of x2, but we can not determine from the data alone which mechanism produced
such a doubling. When working with a composition that consists of more than two parts,
such as TCRβ sequencing, x1 can be considered as an aggregation of everything except x2.
In this scenario, “x2 → kx2” implies w2 → kw2” only if certain conditions apply:
1. x2 is a relatively small component
2. the rest of the basis stays the same
3. log k is small
These three conditions are what, in practice, occur in ‘spike-in’ experiments but not neces-
sarily in sequencing experiments. ‘Spike-in’ experiments are when a known concentration is
added to an unknown mixture usually to assess assay sensitivity. x2 represents the ‘spike-in’
portion of the sample and is usually small compared to the rest of the sample. The known
mixtures are tested while the rest of the sample stays unchanged. In this case, it is safe to
use univariate statistics since the compositions are not changing dramatically and follow the
three conditions above. It can be assumed that samples in sequencing experiments are much
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more variable than in controlled ‘spike-in’ experiments. Thus, using these kinds of experi-
ments as proof of concept to be applied to more variable data, such as TCRβ sequencing,
can be misleading.
Multivariate methods are commonly applied in the analysis of high-throughput data.
Specifically, clustering methods are applied to identify homogeneous groups. Clustering
methods require that a distance measure be calculated between samples. Lovell et al.
[2010] described four different distance metrics that can be used as measures of distance for
multivariate methods: the Aitchison distance, Euclidean distance, the Euclidean distance
between log values, and the Kullback-Leibler divergence. Knowing how these metrics behave
can help select the appropriate metric for analysis.
Consider two compositions, x and y, with positive components xi and yi, where i = 1, ...D
and D is the number of components of the composition. For TCRβ sequencing the D
components are the unique nucleotide sequences, unique amino acid sequences or unique
CDR3 lengths. The analysis will depend on the research question and can be done for the
overall components or separated by VDJ family. Their perturbation difference, z = x 	 y,
is defined by
z = C(x1
y1
,
x2
y2
, ....,
xD
yD
)
where C is the closure.
The Aitchinson distance can be written as
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da(x,y) =
√
‖ clr(x)− clr(y) ‖ (53)
=
√
‖ clr(z) ‖ (54)
=
√∑
i
(log
xi
gm(x)
− log yi
gm(y)
)2 (55)
=
√∑
i
(log
zi
gm(z)
)2 (56)
where gm is the geometric mean. By writing the Aitchinson distance in terms of z, it can
be seen that the Aitchinson distance is a measure of relative distances. In comparison, the
Euclidean distance between x and y is written as
de(x,y) =
√∑
i
(xi − yi)2 (57)
=
√∑
i
(
xi
yi
− 1)2y2i (58)
Notice that this distance depends not only on the ratio of the two compositions but on one of
the compositions itself. Also, the Euclidean distance is bounded by
√
2 whereas the Aitchison
distance has no upper limit. The Aitchison distance would do a much more appropriate job
because it is not constrained by an upper limit and can give more information about relative
differences. Further, the Aitchinson distance is not constrained to lie on a simplex and does
not have a sum-constraint.
High-throughput genomic data are frequently log2 transformed. For illustrative pur-
poses Pawlowsky-Glahn and Buccianti [2011] showed how the Aitchison distance compares
to the Euclidean distance between logged values. The Euclidean distance between log trans-
formed values is
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de(log(x), log2(y)) =
√∑
i
(log(xi)− log(yi))2 (59)
=
√√√√∑
i
(
log(
xi
gm(x)
)− log( yi
gm(y)
) + log(
gm(x)
gm(y)
)
)2
(60)
=
√
d2a(x,y) +D log
2
(
gm(x)
gm(x)
)
(61)
≥
√
d2a(x,y) (62)
This is very similar to Aitchinson’s distance with an extra component, D log2
(
gm(x)
gm(x)
)
.
Because high throughput sequencing data are typically log2 transformed, similar results
should be observed when comparing analyses performed using Aitchison’s distance and the
log2 transformed Euclidean distance [Lovell et al., 2010].
Finally, the Kullback-Leibler (K-L) divergence, which is not specifically a distance mea-
sure [Lovell et al., 2010], is typically used to measure the difference between two probability
distributions. Distributions are similar to compositions in the sense that they sum to 1.
Therefore, the K-L divergence is another method that can be used when comparing compo-
sitions. The K-L divergence between compositions depends on the ratios of the composition
components, their absolute values of components, and the dimensionality of the compositions.
Recall that the K-L divergence (see Section 1.6.4) between discrete probability distribution
P and probability distribtution Q, both indexed by i = 1 to D where D is the size of the
simplex, is
DKL(P |Q) =
∑
i
P (i) log
P (i)
Q(i)
(63)
The effect that compositional data has on estimates of covariance and correlation should
be used to guide the decision of which metric to use. Lovell et al. [2010] showed the
relationship between the log of two components in a composition. Consider two basis vectors
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and their closures
w = (w1, w2)
W = (W1,W2)
x = C(w)
X = C(W).
The following result will also be used
cov(A+ C,B + C) = cov(A,B) + cov(A,C) + cov(B,C) + var(C).
Applying this result to the log of the compositions and the log of the basis we get
cov(log x1, log x2) = cov(log(
w1
t
), log(
w2
t
))
= cov(logw1 − log t, logw2 − log t)
= cov(logw1, logw2)− cov(logw1, log t)− cov(logw2, log t) + var(log t)
where t is the size of the basis. Thus, the covariance of the log of two components of interest
in a composition is equal to the covariance between the log of those components in the
basis plus or minus some terms related to the size of the basis. If the terms related to the
size of the basis are large, the covariance estimates could become very different between
using the components and the basis. Similarly, since correlations are functions of variance
and covariance they can also be very different between compositional data and those in the
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basis. By definition the correlation is defined as
corr(A+ C,B + C) =
cov(A+ C,B + C)√
var(A+ C)
√
var(B + C)
Unfortunately, there is no nice representation of correlation to show how the components
and the basis are related.
3.6 Treatment of Zeros in Compositional Data
As previously described, compositional data analysis is performed using a log ratio scale.
Therefore, consideration must be given with respect to how to appropriately handle observed
zeros. Aitchison et al. [2003] identified three processes that may give rise to observed zero
values. The process that gave rise to the zero values should guide the analyst as to how
to deal with the zero values. First, a zero value may truly represent a zero in the data.
This is known as a structural zero or essential zero. Second, a zero might occur because of
an underlying discrete process such as space on a sequencing chip. For example, in TCR
sequencing data, CDR3 sequences with low counts may not be sequenced because clonotypes
with high frequency used up all the space on the chip. Third, zeroes can occur because values
fall below the limit of detection.
Rounded zeros are zeros when very small values are rounded to zero because of rounding
error or the value falls below the limit of detection. In compositional data, these zeros fall
under the category of not missing at random (NMAR) and require special models. Gener-
ally, methods for working with rounded zeroes can be classified into either non-parametric
or parametric techniques. The non-parametric methods are based on different imputation
methods. On the other hand, the parametric methods rely on parametric models such as
the normal distribution on the simplex.
Counts are values that occur when the number of times an event occurs is measured. In
the case of TCR sequencing data the number of times a particular CDR3 sequence occurs is
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being counted. Since TCR sequencing data are transformed into RPM (reads per million),
a measure of relative abundance, they should be considered in the compostional framework.
Pierotti et al. [2009] suggest a Bayesian-multiplicative approach.
The multiplicative part of the approach is based on an imputation strategy for rounded
zeros [Mart´ın-Ferna´ndez et al., 2003]. This strategy involves replacing the zeros with an
appropriately small value δj and then modifying the non-zeros in a multiplicative way, where
j = 1, ..., n the number of observations. The specific modification is based on the sum
constraint for imputation data. Let us consider a D-composition, x ∈ SD that has rounded
zeros. This composition is replaced by a new composition r ∈ SD according to the formula
rj =

δj if xj = 0
xj
(
1−
∑
k|xk=0
δk
c
)
if xj > 0
(64)
where c is the constant for the sum constraint and δj is a chosen value below the limit of
detection. This method mixed with a Bayesian approach can be used to impute zero values
in count data.
Now let x be a count vector with D categories in data set X. Let N be the total count
in x and θ be its vector of probabilities from a multinomial distribution. Then the prior
distribution for θ is a Dirichlet iid parameter vector α where αk = stk, where k = 1....D.
The vector t is the prior expectation for θ and s is known as the strength of that prior.
The parameter s can be chosen to be between 0 and 1. From Bayes theorem the posterior
estimation for θ is
θˆ =
xk + stk
N + s
(65)
There are several different proposed priors but all come from the Dirichlet distribution.
Then the chosen prior can be used to apply the multiplicative part of the method to actually
impute zero values using a modification of the rounded zeros formula
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rj =

αj
N+s
if xj = 0
xj
1− ∑
k|xk=0
αj
N + s
 if xj > 0 (66)
In this way we are able to preserve the ratios of the non-zero values while having a data
set that contains no zeros. This new data set also preserves the unit constraint.
3.7 Application of Compositional Methods to TCR data
The data described in section 2.3 were treated as compositional data. All compositional
calculations were done using the coin package in the R programming environment [Zeileis
et al., 2008]. First each VDJ combination was treated as one part of a 947 part composition.
The top 10 % most variable VDJ combinations were considered for clustering. Clustering was
then done using the Aitchison distance and Ward’s minimum variance method. Figure 19
shows the results of the clustering. Notice that other than the 2 No GVHD patients there
seems to be no obvious grouping pattern.
Next, the CDR3 length distribution within each VDJ combination was considered as an
L-part compositions. To compare groups linear models of the following form were run
Yi = a⊕Xi  b + i (67)
ilr(Yi) = ilr(a) +Xiilr(b) + ilr(i) (68)
where a and b are compositional constants, Yi is a random composition, Xi is the group in-
dicator and i is a compositional random variable with compositional expectation (1, ..., 1)/L
and constant variance [Zeileis et al., 2008]. There were 947 models run to compare groups
at each VDJ combination using this model. Zero values were replaced by a below limit of
detection value of 1e− 6. After adjusting for multiple comparisons using the Benjamini and
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Hochberg FDR method, there were no significant differences found (FDR > 0.534). However,
there were 20 p-values before adjusting below the α = 0.05 threshold. Table 8 shows the 20
p-values.
Table 8: Compositional Linear Model p-values
JGene VGene DGene p-value
TRBJ2-3 TRBV10-2 TRBD1-1 0.001
TRBJ2-4 TRBV5-6 TRBD1-1 0.001
TRBJ2-4 TRBV28 TRBD1-1 0.002
TRBJ2-7 TRBV11-1 TRBD1-2 0.005
TRBJ2-5 TRBV6-1 TRBD1-2 0.005
TRBJ2-3 TRBV4-2 TRBD1-2 0.006
TRBJ2-4 TRBV7-6 TRBD1-1 0.010
TRBJ2-5 TRBV27 TRBD1-2 0.014
TRBJ2-6 TRBV11-2 TRBD1-2 0.015
TRBJ2-3 TRBV28 TRBD1-2 0.019
TRBJ2-5 TRBV4-3 TRBD1-1 0.022
TRBJ2-7 TRBV27 TRBD1-2 0.022
TRBJ2-7 TRBV7-3 TRBD1-2 0.027
TRBJ2-5 TRBV13 TRBD1-1 0.029
TRBJ2-1 TRBV5-5 TRBD1-1 0.032
TRBJ2-7 TRBV14 TRBD1-1 0.033
TRBJ2-5 TRBV9 TRBD1-1 0.034
TRBJ2-5 TRBV27 TRBD1-1 0.035
TRBJ2-1 TRBV16 TRBD1-1 0.037
TRBJ2-5 TRBV28 TRBD1-1 0.049
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Figure 19: Cluster Dendrogram of the 13 HSCT patients.
3.8 Discussion
In this chapter we discussed what compositional data are and why sequencing data falls in
that category. The compositional methodology was then applied to the TCR sequencing data
described in section 2.3. The compositional models identified different VDJ combinations
compared to all the methods applied in chapter 2. This shows that choosing the appropriate
analysis strategy can have large effects on results. The research question of interest in this
study was to identify VDJ combinations that differ between the GVHD and no GVHD
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groups. This seems to best be addressed by Simpson’s Diversity measure since it has a
biological interpretation that more diversity is correlated with a healthier TCR repertoire.
On the other hand, tests such as the Kullback-Leibler divergance method test for the equality
of individual peak distributions which is not really the research question. It was of further
interest to determine if the different methods identified similar V or J genes individually
instead of specific VDJ combinations. Table 9 shows a summary of V or J genes that were
identified by multiple methods.
Table 9: Common V or J Gene Using Different Analyses
Individual Mean Simpson’s Compositional Alpha
Gene Perturbation Perturbation Diversity Analysis Value
TRBJ2-6 X X X
TRBJ1-1 X X
TRBJ2-1 X X
TRBJ2-2 X X X
TRBJ1-3 X X
TRBV7-9 X X
TRBV9 X X
TRBV7-7 X X
TRBV7-6 X X
TRBV25-1 X X
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4 Generalized monotone incremental forward stagewise
method for modeling count data: Application pre-
dicting micronuclei frequency
This chapter considers count data that are left as counts and not transformed like sequencing
data. Specifically, this chapter looks at a method to use high-throughput data to predict
a count response. Because many methodologies cannot be applied to scenarios where there
is a larger number of predictors than samples, a generalized monotone forward stagewise
(GMIFS) method is considered.
4.1 Introduction
Micronuclei (MN) are small nuclear bodies that are formed in cells that are in the process of
division but are not part of the nucleus. Therefore MN can only be found in cells that have
undergone nuclear division at least once and appear as small extranuclear bodies. When
two daughter nuclei are formed during cell division, these bodies are placed into a smaller
nucleus not part of the main nuclei, hence the term micronuclei [Kirsch-Volders et al., 2011].
Once the micronuclei are formed the cell has several different response options. MN can stay
within the cell, if it has functional DNA, as its own entity or be reabsorbed into the main
nucleus. If the DNA is non-functional the MN may be expelled from the cell or the whole
cell may be destroyed through apoptosis. Since MN can be expelled from the cell, they can
be used as a mechanism to remove extra chromosomes from the cell [Kirsch-Volders et al.,
2011].
Micronuclei can form spontaneously or they can be induced by mutagens. Some spon-
taneous MN are actually beneficial to the organism. An example is in the mouse cerebral
cortex where MN formation adds diversity to the nervous system [Kirsch-Volders et al., 2011].
However, the large majority of MN are caused by mutagens and may play a role in carcino-
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genesis. Depending on the fate of the MN, the end result could be a variety of different
DNA and chromosome cell contents. This variety could result in an accumulation of DNA
changes and instability that could result in cancer [Kirsch-Volders et al., 2011]. Several
studies have shown that higher MN counts result in a higher risk of cancer in the future
[Kirsch-Volders et al., 2011]. Thus, using the cytokinesis-block micronucleus (CBMN) assay
as a risk assessment for cancer has potential clinical benefits. Further, combining CBMN
with other high-throughput technologies such as gene expression and methylation analyses
may help identify factors related to micronucleation.
Quantifying MN in patient samples has been shown to be a good measure of genetic
damage. MN scoring, counting the number of MN present in a sample, is a popular tool
for testing genotoxicity mostly because of its simplicity, accuracy, applicability to different
cell types and ease of automation. Cancer cells show a loss of genetic control which can be
caused by DNA damage so they are a good candidate for MN testing. The CBMN assay has
successfully been used and validated to score MN. The CBMN assay uses Cytochalasin-B
which stops cells from performing cytokinesis but does not stop nuclear division giving rise to
cells that are binucleated [Fenech, 1993, Fenech et al., 1999]. Furthermore, the Organisation
for Economic Co-operation and Development (OECD) has developed a set of guidelines for
running the CBMN assay to have the most consistent and reliable results [Kirsch-Volders
et al., 2011].
Guidelines for the process of scoring MN have been presented by the HUman Micron-
Nucleus (HUMN) project. This is an international collaborative project aimed at improving
the application of the CBMN assay. One of the HUMN projects main goals is to identify
methodological variables in the scoring of the assay to minimise confounding effects [Fenech
et al., 2003]. The HUMN project compiled 6583 subjects from 25 laboratories from 16 coun-
tries and looked at background MN frequency using the CBMN assay. The goal of the study
was to identify variables that affect the background MN frequency. Scoring criteria was
found to account for 47% of the observed variability thus standardized scoring criterion were
74
developed and described by Fenech et al. [2003]. The guideline includes scoring 2000 cells
in order to accurately estimate MN frequency.
Because these guidelines were developed for assay performance they do not address how
to statistically analyze the data generated by the assay. This has led to the application
of various statistical methods that may render different interpretations and conclusions. In
a review article examing analytical methods, Ceppi et al. [2010] reviewed 63 studies that
statistically analyzed MN data and developed recommendations for selecting an appropriate
analytical method. The review included studies that applied both parametric and non-
parametric tests. The non-parametric tests included Kruskall-Wallis, Friedman, Wilcoxon
and Mann-Whitney U-tests. Although these tests do not require an underlying distributional
assumption, they are unable to adjust for confounding factors. There were a variety of para-
metric tests performed that assume normality such as ANOVA, ANCOVA, and multivariable
linear models which can adjust for confounding factors. Other methods such as correlations
and Student’s t-test were also used. However, applying these methods to MN data, which
are rarely normally distributed, could result in inappropriate inferences. Although the data
could be transformed to better adhere to a Gaussian distribution prior to applying such para-
metric tests, few studies applied any type of transformation. Further, Student’s t-tests and
Pearson’s correlation cannot adjust for confounding variables. The common non-Gaussian
models used were log-linear, Poisson, negative binomial and logistic regression. The logistic
and log-linear models account for categories whereas Poisson and negative binomial directly
model count data. For this reason Ceppi et al. [2010] recommend using negative binomial
or Poisson models for MN data analysis. Another advantage of these count models is that
they can adjust for confounding variables such as age, gender and smoking status. Finally,
Ceppi et al. [2010] recommended 2000 or more cells be scored for best model performance. If
less than 2000 cells are scored, a zero-inflated Poisson model is recommended [Ceppi et al.,
2010].
When trying to identify molecular features related to MN frequency, high-throughput
75
genomic assays can be used. However, the previously described methods cannot be applied
in settings where there are more predictor variables than samples. Therefore, in this section
we extended the generalized monotone forward stagewise (GMIFS) method to the Poisson
regression setting and apply it to a breast cancer study where we were interested in predicting
MN frequency using features from the Illumina HumanMethylation 450K assay and to a cord
blood data set where we were interested in predicting MN frequency using features from the
Agilent 4x44k human oligonucleotide microarray.
4.1.1 Cytokinesis-block Micronucleus Assay
Micronuclei assays can only be effective if dividing cells can be identified. This is because MN
only occur in cells that have undergone at least one nuclear division after DNA damage has
occurred. Cytokinesis is the step in the cell division process that involves the splitting of the
cytoplasm to form two cells. Cytochalasin-B stops cells from performing cytokinesis but does
not stop nuclear division giving rise to cells that are binucleated [Fenech, 1993, Fenech et al.,
1999]. However, only cells in the sample that are going to divide will take on a binucleated
appearance. The sample is heterogeneous with cells that tried to divide and those that
did not. Thus, there will be a mixture of mononucleated cells along with binucleated cells.
Mononucleated cells in the CBMN assay can arise from several possibilities. There could
be cells that never divide, cells which replicate DNA but escape nuclear division, cells that
escape the cytochalasin B block or cells that are in an early stage of apoptosis or necrosis
[Kirsch-Volders and Fenech, 2001]. Thus it can be considered that mononucleated cells
indicate chromosome damage in vivo, present prior to the assay being done, and binucleated
cells indicate DNA damage present before culture as well as damage expressed in vitro
during culture. Thus, what is scored is dependent on the protocol followed and what type
of hypothesis is being tested.
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4.2 Methods
4.2.1 Statistical Methods
There are many available methods that can model count data. However, these methods
require independence of explanatory variables (p) and that the number of samples (n) does
not exceed the number of explanatory variables. The incremental forward stagewise re-
gression method for linear regression and the Generalized Monotone Incremental Forward
Stagewise (GMIFS) for a logistic regression model have been previously described [Hastie
et al., 2007]. The GMIFS method for modeling ordinal response data has also been de-
scribed [Archer et al., 2014]. To motivate our extension to the Poisson regression setting,
we first review Poisson regression. We subsequently describe our GMIFS method for fitting
Poisson regression models when n < p.
4.2.2 Poisson Regression
Poisson regression is commonly used to model count data. Let i = 1, ..., n be the number of
observations and yi represent a Poisson distributed random variable. Let the expected value
of yi be written as
E(yi) = λi.
Then the conditional probability is given by
P (yi|λi) = e
−λiλyii
yi!
for each observation i. The likelihood is represented by
L(λ|y) =
n∏
i=1
e−λiλyii
yi!
.
Mathematically it is easier to maximize the log-likelihood which is given by
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`(λ|y) =
n∑
i=1
(yi log λi − λi − log(yi!)).
Thus, we are looking for the value of λ that maximizes the log-likelihood above. Further, an
offset is used if the response variable can be considered a rate. For example, MN frequency
is scored from a larger number of total cells. So if the total number of cells examined varies
by subject an offset is appropriate. In this case the expected value is
E(yi) = tiλi
where ti is the offset value. The conditional probability is then given by
P (yi|λi) = e
−tiλi(tiλi)yi
yi!
for each observation i. The likelihood is represented by
L(λ|y) =
n∏
i=1
e−tiλi(tiλi)yi
yi!
.
Again, mathematically it is easier to maximize the log-likelihood which is given by
`(λ|y) =
n∑
i=1
(yi log(tiλi)− tiλi − log(yi!)).
Once again we are looking for the λ value that maximizes the log-likelihood. These log-
likelihoods are used to model predictor variables. In Poisson regression the model assumes
that the expected value can be modeled by a linear combination of predictors. In this case
the natural log of ti is entered as an offset in the model estimation. The natural log of the
expected value is
log(E(yi|xi)) = log(ti) + θ′xi
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where xi is a vector of predictor variables and θ is a vector of coefficients. The estimated
coefficients can be exponentiated to determine how the response changes with the predictor.
By using the estimated linear combination of coefficient estimates and taking the exponent
we can calculate the estimated response of that particular subject.
4.2.3 Generalized Monotone Incremental Forward Stagewise Poisson Model
The GMIFS method was previously described for the logistic regression scenario by Hastie
et al. 2007 and here we adapted it to a Poisson regression model. For the proposed method we
consider three types of parameters that θ from section 4.2.2 can be separated into along with
an offset (ti). The parameters are the intercept (α), those corresponding to an unpenalized
subset of predictors (γ), and those corresponding to a set of penalized predictors (β). The
design matrix, x, consists of two parts, xj and xk, where j = 1, ..., J is the set of unpenalized
predictors, k = 1, ..., K is the set of penalized predictors and J +K = P is the total number
of predictors. The unpenalized predictors are those that we wish to force into the model, such
as gender, age and smoking status which researchers consider important predictors of MN
frequency [Ceppi et al., 2010] and their values are in the xij design matrix for subject i. The
penalized variables (thousands of features from a high-throughput genomic experiment) are
those that the model will choose for us and are considered to be the investigative predictors
and their values are in the xik design matrix for subject i.
The algorithm proceeds in an iterative fashion and updates one of the penalized covariates
by a small incremental amount at each step. To determine which penalized covariate is to
be updated next the largest negative gradient is used. Thus we need to calculate the first
derivative of the log-likelihood corresponding to each penalized predictor. The log-likelihood
written in terms of α, β and γ is
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`(α,β,γ|y,xj,xk) =
n∑
i=1
(yi(α + log(ti) + γxij + βxik)
− exp(α + log(ti) + γxij + βxik)− log(yi!))
and the first derivative written in terms of α, β and γ in matrix notation is
∂`
∂β
= x′(y − exp(α + log(ti) + γxj + βxk)).
Once we know which covariate to update, we need to determine in what direction to update
the covariate. In order to know the direction of the update the second derivative would need
to be calculated which is a cumbersome process. Hastie et al. 2007 showed that to avoid
having to calculate the second derivative an expanded covariate space can be used. Using the
notation mention previously where xj are the unpenalized variables and xk are the penalized
subset, the expanded covariate space is x˜ = [xj : xk : −xk]. For example, let β1, ..., βp be
the positive coefficient estimates and βp+1, ..., β2p be the coefficient estimates of the negative
version of xk. Then β is calculated by subtracting the pairs, β1 − βp+1, ..., βp − β2p. Our
proposed GMIFS algorithm using the expanded covariate set is
1. Initialize the components of βˆ
(s)
= 0 at step s = 0.
2. Initialize the intercept α and the unpenalized coefficients γj where j = 1, ..., J using a
maximization algorithm of the log-likelihood.
3. Considering α and γ fixed, find the predictor xm where m = argmin
2K
(
− ∂`
∂βk
)
at the
current estimate βˆ = βˆ
(s)
.
4. Update the corresponding coefficient βˆ
(s+1)
m = βˆ
(s)
m + to yield a new vector of parameter
estimates.
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5. Update α and the unpenalized coefficients, γj, by maximum likelihood considering the
βˆ
s+1
from step 4 as fixed.
6. Repeat steps 3-5 until the difference between successive log-likelihoods is less than a
pre-specified tolerance, τ . The defaults for the GMIFS algorithm are  = 0.001 and
τ = 0.00001.
4.2.4 Comparative Method: Penalized Linear Regression
A penalized linear regression model can be fit by adding a penalty term to the sums of
squares. Specifically, the glmpath algorithm uses a linear combination of the L1 and L2
norm penalizations. The glmpath algorithm is based on a previous algorithm called LASSO.
LASSO minimizes the typical sum of squares with an added constraint. Specifically for linear
regression LASSO minimizes [Tibshirani, 2011]
N∑
i=1
(yi −
∑
j
xijβj)
2 + λ
p∑
j=1
|βj|
where xij are the standardized predictors and yi is the set of centered responses for i = 1, ..., N
and j = 1, ..., p. Because of the form of the constraint, LASSO does both variable selection
and shrinkage. The glmpath algorithm modifies this slightly by first considering the typical
generalized linear model formula
βˆ = argmax
β
L(y;β)
where L denotes the appropriate likelihood function. The glmpath algorithm then adds an
analagous LASSO penalty term to help with variable selection when p > n
βˆ(λ) = argmin
β
{− logL(y;β) + λ||β||1}
where λ > 0 is the regularization parameter. The glmpath algorithm computes coefficient
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estimates as λ varies. The algorithm starts with the largest λ that makes βˆ(λ) nonzero with
each step using a smaller λ. Each optimization consists of three parts: determining the step
size in λ, predicting the corresponding change in the coefficients, and correcting the error in
the previous prediction [Park and Hastie, 2007]. The algorithm continues finding the next
largest λ that will change the coefficient estimates until no further predictors can be found.
However, when the predictors are strongly correlated the coefficient estimates become highly
unstable using the L1 norm penalization [Hastie et al., 2007]. Thus, the glmpath algorithm
adds a quadratic penalty term and computes the solution to
βˆ(λ1) = argmin
β
{− logL(y;β) + λ1||β||1 + λ2
2
||β||22}
where λ1 ∈ (0,∞) and λ2 is a fixed, small, positive constant. By adding this quadratic
penalty, the effects of the strong correlations do not affect the stability of the fit. Further,
when the correlations are not strong, the effects of the quadratic penalty are neglible [Hastie
et al., 2007]. Thus, the glmpath algorithm uses both the L1 and L2 penalties as its default
method.
The glmpath algorithm uses a default binomial distribution with a logit link and λ2 =
.00001. The algorithm also allows for a Poisson distribution with a log link and Gaussian
distribution with an identity link. The algorithm then computes the regularization path for
generalized linear models with L1 penalty.
4.2.5 Simulations
Simulations are a useful technique to test how well a new methodology performs. In this
case, we wished to quantify how accurately the GMIFS method estimated true non-zero
coefficients and predicted count data. Furthermore, we wished to determine how the GMIFS
method compared to the glmpath method in predicting the count outcome and simulations
provide a good platform to accomplish this comparison. Several general steps must be
considered in the simulation process; how to simulate the response, how to simulate the
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predictors associated with the response and how to simulate the predictors not associated
with the response. Furthermore, we wished to examine how the methods perform under ideal
situations and non-ideal situations such as when distributional assumptions are met and are
not met respectively. Note that all simulations were performed using the R programming
environment (version 3.1.1) [R Core Team, 2014].
First, we considered the situation where the response is Poisson distributed and the
user fits a Poisson regression model. Then we generated the response to follow a Poisson
distribution where an offset (a) was and (b) was not used. The uniform distribution was used
to generate the predictors. The steps involved in simulating the data under these conditions
were as follows:
1. Randomly generate P variables, xi1, xi2, ..., xiP where i = 1 to n, using the uniform
distribution on the [0,1] interval.
2. Choose P1 of the P variables to be associated with the response.
3. Assign the P1 β values associated with the response and the intercept value, α. If
the offset is to vary, then a uniform distribution was used with maximum 2200 and
minimum 1800 and rounded to the nearest integer. This range was selected because it
is recommended to score MN using 2000 cells.
4. Generate the λ values for the Poisson distribution using the following formula:
λi = exp(α + log(offseti) +
P1∑
k=1
βkxik).
5. Randomly generate Yi ∼ Poisson(λi).
6. Fit a Poisson GMIFS model and fit a glmpath model.
7. Repeat steps 1-6 r times.
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This simulation method was adjusted in several places. In this case we chose n = 30 and
n = 80 which are roughly the sample sizes of our cord blood and breast cancer datasets,
respectively. We studied the models letting P = 100 predictor variables, P1 = 5 predictor
variables associated with the response, and r = 100 simulations were used. The intercept
(α) and the five predictor variables associated with the response (β1, β2, β3, β4, β5) were set
to -5, 0.3, 0.2, -0.7, 0.5 and 0.1 respectively for data simulated using no offset. For data
simulated using an offset, α was set to -7. This was done to keep lambda values low so the
Gaussian approximation for the Poisson distribution is not appropriate. To compare the two
different statistical models, the following three outcomes were examined:
A. The number of true predictors that have a non-zero coefficient;
B. The number of false predictors that have a non-zero coefficient;
C. Accuracy of count predictions from the model (sum of squared residuals) when applied
to an independent test set.
The methods were compared with and without the use of an offset during the simulation
process. Furthermore, the glmpath method allows for the use of Gaussian and Poisson
distributions. Thus, those options were also used to see what effects user error had on the
results. Thus, a total of three models were compared when the true distribution was Poisson:
1. Poisson GMIFS model;
2. glmpath using “poisson” family option and lambda2=0 which fits a LASSO model;
and
3. glmpath using “gaussian” family option and lambda2=0 which fits a LASSO model.
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4.3 Results
4.3.1 Simulations
Simulations were performed as described in section 4.2.5 and Figures 20- 22 show the results
of the simulations. Figure 20 shows the distribution of the number of predictors correctly
identified as non-zero over 100 simulations and the types of models used. The data were
generated using both n = 30 and n = 80 observations. The median number of correctly
identified non-zero coefficients with no offset using GMIFS is 1 (range=0, 3) for n = 30 and
2 (range=0, 4) for n = 80. Similarly, the median number of correctly identified non-zero
coefficients with no offset using glmpath with Poisson family is 1 (range=0, 5) for n = 30
and 2 (range=0, 4) for n = 80. This number increases slightly when using the glmpath with
Gaussian family to a median of 2 (range=0, 5) for n = 30 and 4 (range=2, 5) for n = 80.
All the numbers are similar when an offset is used to generate the data. The median correct
using GMIFS is 0 (range=0, 3) for n = 30 and 1 (range=0, 4) for n = 80. The median
correct using glmpath with Poisson family is 0 (range=0, 3) for n = 30 and 1 (range=0, 4)
for n = 80. Once again the median values increase when using the glmpath with Gaussian
family to 2 (range=0, 5) for n = 30 and 4 (range=2, 5) for n = 80.
Figure 21 shows the distribution of the number of predictors incorrectly identified as
non-zero over 100 simulations and the types of models used. The data were generated using
both n = 30 and n = 80 observations. The median number of incorrectly identified non-zero
coefficients with no offset using GMIFS is 3 (range=0, 15) for n = 30 and 7 (range=0, 28)
for n = 80. Similarly, the median number of incorrectly identified non-zero coefficients with
no offset using glmpath with Poisson family is 3 (range=0, 17) for n = 30 and 7 (range=0,
41) for n = 80. This number increases when using the glmpath with Gaussian family to a
median of 26 (range=23, 28) for n = 30 and 74 (range=73, 76) for n = 80. All results are
similar when an offset is used to generate the data. The median incorrect using GMIFS is
2 (range=0, 14) for n = 30 and 5 (range=0, 26) for n = 80. The median incorrect using
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glmpath with Poisson family is 2 (range=0, 24) for n = 30 and 4.5 (range=0, 31) for n = 80.
Once again the median values increase when using the glmpath with Gaussian family to 26
(range=23, 28) for n = 30 and 74 (range=72, 76) for n = 80.
Figure 22 shows the distribution of the sum of residuals squared as a measure of the model
prediction accuracy. The data were generated using both n = 30 and n = 80 observations.
For both sample sizes a learning data set was used to estimate coefficients and then the
model was applied to an independent test data set. The median accuracy with no offset
using GMIFS is 133 (range=68, 240) for n = 30 and 325 (range=188, 699) for n = 80.
Similarly, the median accuracy with no offset using glmpath with Poisson family is 142
(range=55, 254) for n = 30 and 333 (range=185, 1666) for n = 80. The median accuracy
with no offset using glmpath with Gaussian family is 206 (range=90, 383) for n = 30 and
1,503 (range=535, 3772) for n = 80. The numbers are different when an offset is used to
generate the data. The median accuracy using GMIFS is 80 (range=30, 185) for n = 30 and
205 (range=137, 367) for n = 80. The median accuracy using glmpath with Poisson family
is 80 (range=33, 805) for n = 30 and 206 (range=126, 339) for n = 80. The median accuracy
with an offset using glmpath with Gaussian family for both sample sizes is above 50,000.
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Figure 20: Number of Predictors Correctly Identified as Non-zero: This figure shows the
distribution of the number of predictors correctly identified as non-zero over 100 simulations.
There were 5 predictors had non-zero coefficients. Boxplots are separated by the type of
distribution used to generate the data and number of observations.
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Figure 21: Number of Predictors Incorrectly Identified as Non-zero: This figure shows the
distribution of the number of predictors incorrectly identified as non-zero over 100 simula-
tions. There were 95 predictors that had coefficients set to zero. Boxplots are separated by
the type of distribution used to generate the data and number of observations.
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Figure 22: Accuracy of Count Predictions: This figure shows the distribution of the sum
of residuals squared over 100 simulations using a learning data set and an independent test
data set. Boxplots are separated by the type of distribution used to generate the data and
number of observations. The results for glmpath with Gaussian family using an offset are
not displayed because both values are above 50,000.
4.3.2 Gene Expression Analysis
The cord blood data were collected as part of the Norwegian Mother and Child Cohort Study
(Moba) [Magnus et al., 2006]. The target population of Moba is all women who give birth
in Norway. The overall goal of this study was to collect data on pregnant women and their
children to estimate the association between exposures and diseases. Specifically, the data
are part of a subcohort called BraMat, which translates to “good food” in English. This
subcohort concentrates on what effect a pregnant woman’s diet has on her child. Umbilical
cord blood samples were collected immediately after birth from 200 babies. After quality
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control and other exclusions, 111 samples were hybridized to Agilent 4x44k human oligonu-
cleotide microarrays to measure gene expression. Of the 111 subjects, 29 also had MN data
collected. The MN were scored using the procedure described by Decordier et al. [2009].
Further, demographics such as gender were collected for all subjects. Data were downloaded
from Gene Expression Omnibus (GSE31836). Sample processing, image analysis, normal-
ization, background correction and filtering are described in Hochstenbach et al. [2012]. For
this analysis the data were further filtered to only include genes that had no missing values,
leaving 8497 genes for statistical modeling.
Both GMIFS and glmpath models were applied to the cord blood gene expression data
set described above. For glmpath, the Poisson family option was used and the lambda2
option was set to zero. For GMIFS, the default options were chosen. The response in the
model was MN counts and the predictors were the gene expression intensities. Gender was
included in the model as part of the unpenalized subset. Based on Figure 23, a Poisson
distribution was assumed for both models since the data appear skewed. The final model
parameters were chosen using the minimum AIC. The GMIFS model identified 17 non-zero
gene expression coefficients as associated with MN count and glmpath with Poisson family
identified 23. Out of the genes that were identified, 10 were common to both models. Figures
24 (Sum of squared residuals = 101.7) and 25 (Sum of squared residuals = 1.8) show that
both models seem to predict MN relatively well. Because simulations showed that glmpath
seems to overfit, glmpath’s ability to predict MN frequency was looked at using only 17
non-zero coefficients . Figure 26 (Sum of squared residuals = 80.0) shows that when the
same number of coefficients are used both GMIFS and glmpath predict MN frequency with
similar accuracy. Table 10 shows the genes that both models identified as being associated
with MN count and the types of cancer with which they are linked. Nine out of the ten
genes are linked to some type of cancer.
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Table 10: Genes Identified as Associated with MN Count by both GMIFS and glmpath
Probe ID Gene Symbol Gene Name Associated with Cancer GMIFS glmpath
A-23-P100196 USP10 ubiquitin specific peptidase 10 Glioblastoma multiforme [Grunda et al., 2006] X X
A-23-P138967 SDHD succinate dehydrogenase complex Tumor Suppressor [King et al., 2006] X X
A-23-P42331 HMGA1 high mobility group AT-hook 1 Pancreatic Adenocarcinoma [Liau et al., 2008] X X
A-23-P9293 TJP2 tight junction protein 2 Breast [Martin et al., 2004] X X
A-24-P19410 CBX7 chromobox homolog 7 Carcinomas [Federico et al., 2009] X X
A-24-P214858 TREML2 triggering receptor expressed on myeloid cells-like 2 Pancreatic [Loos et al., 2009] X X
A-24-P2463 WHSC1 Wolf-Hirschhorn syndrome candidate 1 Carcinogenesis [Toyokawa et al., 2011] X X
A-24-P397584 TBCC tubulin folding cofactor C None Found X X
A-24-P398064 KIAA0258 KIAA0258 Colorectal [Sasaki et al., 2008] X X
A-32-P18547 C21ORF57 chromosome 21 open reading frame 57 Breast [Smeets et al., 2011] X X
A-23-P103824 FAU Finkel-Biskis-Reilly murine sarcoma virus
(FBR-MuSV) ubiquitously expressed
None Found X
A-23-P209394 CFLAR CASP8 and FADD-like apoptosis regulator Human cancers [Fulda, 2013] X
A-23-P79911 PSMF1 proteasome (prosome, macropain)
inhibitor subunit 1 (PI31)
Breast Kuznetsova et al. [2006] X
A-24-P202567 ITPKC inositol 1,4,5-trisphosphate 3-kinase C Cervical [Yang et al., 2012] X
A-24-P31235 EIF5A eukaryotic translation initiation factor 5A Chronic myeloid leukemia [Balabanov et al., 2007] X
A-24-P405054 C1ORF144 chromosome 1 open reading frame 144 Mantle cell lymphoma [Schraders et al., 2008] X
A-32-P156549 C1ORF144 X
A-23-P118313 GABARAPL2 GABA(A) receptor-associated protein-like 2 Lung [Borczuk et al., 2003] X
A-23-P143817 MYLK myosin, light polypeptide kinase Gastric [Chen et al., 2012] X
A-23-P156809 LOC642880 similar to FKSG62 None Found X
A-23-P394304 PDZK1IP1 PDZK1 interacting protein 1 Thyroid [Di Maro et al., 2014] X
A-23-P39665 SLC11A1 solute carrier family 11, member 1 Esophageal [Zaahl et al., 2005] X
A-23-P67529 KCNN4 potassium intermediate/small conductance
calcium-activated channel, subfamily N, member 4
Colorectal [Lai et al., 2011] X
A-24-P594683 LOC645592 similar to peptidylprolyl isomerase A isoform 1 X
A-24-P708161 X
A-24-P98086 GNA12 guanine nucleotide binding protein
(G protein) alpha 12
Oral [Gan et al., 2011] X
A-32-P10067 X
A-32-P137849 X
A-32-P169754 LOC145221 EST X
A-32-P208078 MTHFR 5,10-methylenetetrahydrofolate reductase (NADPH) Breast [Chen et al., 2005] X
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Figure 23: Histogram of MN Counts for cord blood data set.
Figure 24: Plot of actual MN counts versus predicted MN counts using GMIFS.
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Figure 25: Plot of actual MN counts versus predicted MN counts using glmpath.
Figure 26: Plot of actual MN counts versus predicted MN counts using glmpath using 17
non-zero coefficients.
4.3.3 Methylation Analysis
The breast cancer data were collected as part of an ongoing prospective study titled, Epi-
genetics and psychoneurologic symptoms in women with breast cancer (R01NR012667) and
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includes 70 women diagnosed with breast cancer having both MN frequencies and methyla-
tion profiles collected at baseline. MN frequency was typically scored from among 2000 cells
with some variation in the total number of cells scored. Specifically, the cells were scored in
four sets of 500 cells and mononucleated, binucleated and trinucleated cells were considered
in the total. The subjects also all have methylation data available that can be paired with
the MN data to test for associations. For each subject MN frequency was calculated as the
number of binucleated cells containing one or more nuclei. Further, demographic variables
such as age and smoking status were collected for all subjects.
Epigenetics is the “study of heritable changes in gene expression that occur independent
of changes in the primary DNA sequence” [Sharma et al., 2010]. The epigenetic gene ex-
pression profile is affected by modifications such as DNA methylation, histone modifications,
nucleosome positioning and microRNA. Cancer cells undergo drastic changes in the epige-
nomic landscape compared to normal cells [Sharma et al., 2010]. Alterations in epigenetic
mechanisms can lead to silencing of tumor suppresor genes, activation of oncogenes and ge-
netic instability. The first epigenetic alterations identified in cancer were DNA methylation
changes. A typical cancer epigenome shows overall global hypomethylation and in contrast
hypermethylation of CpG islands [Sharma et al., 2010].
There are several mechanisms that are used to upregulate or downregulate gene expres-
sion, one of which is DNA methylation. Essentially this process involves adding a methyl
group to a CpG site. A CpG site is a cystine followed by a guanine connected by a phosphate
backbone (hence CpG) on a single strand of DNA. There are two important features of CpG
sites to consider. The first is rarity; a CpG combination occurs only about one fifth of the
expected frequency. The second feature is methylation; CpG sites can be methylated and
this accounts for most, if not all, of the methylcytosine in the vertebrate genome [Bird, 1985].
CpG sites can be part of CpG islands, a section of DNA that is rich in CpG sites and are
generally present near gene promoters. The methylation status of adjacent CpG sites has
been shown to be highly correlated [Bibikova et al., 2011]. This implies that CpG islands are
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often methylated or unmethylated as a group. This large scale methylation of CpG islands
near promoters has been shown to inhibit transcription of genes. CpG islands are found in
approximately 60% of gene promoters [Dedeurwaerder et al., 2011].
Hypomethylation and hypermethylation of specific DNA regions work together to pro-
mote tumor growth. Hypomethylation of the genome at repetitive elements, retrotrans-
posons, introns and gene deserts results in the increase of genomic instability. By opening
these regions to modification, such as chromosomal rearrangement and transposon translo-
cation, hypomethylation promotes genomic instability which is implicated in many cancers
such as thymic lymphomas [Howard et al., 2007]. Similarly, hypomethylation of CpG poor
promoters can result in activation of growth promoting genes, such as R-Ras and MAPSIN
in gastric cancer [Sharma et al., 2010]. By activating these types of genes, hypomethyla-
tion promotes cancer development and progression. On the other hand, hypermethylation
downregulates tumor suppressor genes such as Rb, a gene associated with retinoblastoma
[Sharma et al., 2010]. Many other genes have been shown to be suppressed by hyperme-
thylation that control functions such as DNA repair, cell cycle, cell adhesion, apoptosis and
angiogenesis. All of these mechanisms have been shown to affect cancer development and
progression. Thus, studying the epigenomic changes in cancer such as DNA methylation
is of great interest. Having a better understanding of these changes can result in possible
targets for cancer therapies.
The downregulation of genes with methylated CpG islands can be seen in studies per-
formed on the inactive X chromosome. Females have two X chromosomes and only one needs
to be transcriptionally active. Studies have found that many genes on the X chromosome,
such as HPRT and G6PD, are made inactive by the methylation of CpG islands [Bird, 1985].
One way to study DNA methylation profiles is to use the Illumina HumanMethylation
450K assay. This assay uses bisulfite conversion followed by hybridization of the sample to an
array that interrogates specific CpG sites. Bisulfite treatment of DNA converts unmethylated
cytosines into uracils but leaves methylated cytosines unchanged. Since uracil binds to
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adenine and cytosine binds to guanine, the bisulfite converted DNA can be differentiated
between methylated and unmethylated loci. This can be done by using probes for specific
CpG sites and using amplification with marked amino acids to measure whether an adenine
or guanine was added. The Illumina 450K methylation assay consists of a chip that contains
probes for 482,421 CpG sites [Bibikova et al., 2011]. It is worth mentioning that bisulfite
treatment is a harsh process but has been shown to have good reproducibility and precision
[Ogino et al., 2006]
The Illumina 450K chip covers 98.9 % of UCSC RefGenes with an average of 17.2 probes
per gene. Similarly, the probes target a high proportion of CpG islands. Using in vitro
created standards, Bibikova et al. [2011] were able to show that β values (intensity of methy-
lated allele/(intensity of methylated allele + intensity of unmethylated allele + 100) ) cluster
around the expected value. Bibikova et al. [2011] also tested reproducibility and correlation
with whole-genome bisulfite sequencing (WGBS). The 450K assay showed high reproducibil-
ity between technical replicates with an R2 of 0.992. Similarly, there was a high correlation
between whole genome bisulfite sequencing (WGBS) and the 450K array. In normal lung cells
the correlation was 0.95 and in tumor lung cells the correlation was 0.96 [Bibikova et al.,
2011]. This shows that 450K methylation assay provides an accurate and cost-effective
method to measure large scale DNA methylation levels.
The numerical summaries per beadtype are β values which can be interpreted as the
proportion methylation for that CpG site. Given that there are over 480,000 CpG sites
interrogated, it is often necessary to filter the dataset prior to analysis. For example, CpG
sites for which all samples have β < 20% are considered completely unmethylated and CpG
sites for which all samples have β > 80% are considered completely methylated and both
can be filtered from downstream analysis [Zou et al., 2014].
We intended to model MN frequency in the breast cancer data set, however when look-
ing at Figure 27 the MN counts appear to be normally distributed. Thus, we modeled bud
frequency, which appear Poisson distributed (Figure 28). Specifically, we were interested in
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identifying a multivariable model where methylation levels served as predictor and bud fre-
quency of binucleated cells was the outcome. Buds are similar to MN but do not completely
separate from the main nucleus. Buds were calculated in the breast cancer data set as num-
ber of cells containing at least one bud. Age and smoking status were included in the model
as part of the unpenalized subset. The default options were chosen for GMIFS. The total
number of binucleated cells scored was included in the model as an offset. Prior to model-
ing, methylation sites that were all above 80% methylated and below 20% methylated were
filtered out. Further, univariate Poisson models were run on each CpG site where bud fre-
quency was the outcome to further retain only those that were significantly related to buds.
CpG sites that had a p-value≤ 0.05 were included in the GMIFS model, leaving 10,860 CpG
sites. The final model parameters were chosen using the minimum AIC. The final GMIFS
model included 25 non-zero methylation loci coefficients. The model predicts that these 25
loci and subsequently the genes they are associated with Bud formation. Table 11 shows
the 25 loci and the genes with which they are associated. Looking at Figure 29, the GMIFS
model seems to predict bud frequency relatively well. When glmpath was applied to the
data, a fatal error occured and the model would not run.
Figure 27: Histogram of MN Counts for breast cancer data set.
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Figure 28: Histogram of bud frquencies in the breast cancer data set.
Figure 29: Plot of actual MN counts versus predicted MN counts using GMIFS for breast
cancer data.
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Table 11: Methylation Loci Identified as Associated with Bud Formation
Methylation Loci Associated Gene Gene Name Associated with Cancer
cg21271015
cg23791325
cg18598029 HCG27 HLA Complex Group 27
cg06213635
cg02402208
cg06558765 ZFY Zinc Finger Protein, Y-Linked
cg21605248
cg12099459
cg17594670
cg13819787 SP9 Sp9 Transcription Factor
cg26443646
cg05988603 NCRNA00171 ZNRD1 Antisense RNA 1 Stomach [Hong et al., 2004]
cg10511429
cg26952662 CTHRC1 Collagen Triple Helix Repeat Containing 1 Solid Cancers [Tang et al., 2006]
cg14140673
cg15357934 TSPAN31 Tetraspanin 31 Colorectal [Kuhn et al., 2007]
cg15744240 FGF14 Fibroblast Growth Factor 14 Many [Turner and Grose, 2010]
cg12281446 SNAP23 Synaptosomal-Associated Protein
cg12788108 C17orf64 Chromosome 17 Open Reading Frame 64 Breast [Natrajan et al., 2009]
cg05190096 SHC2 SHC Transforming Protein 2 Breast [Dankort et al., 2001]
cg07054927
cg21100328 DKFZp434J0226 Uncharacterized LOC93429
cg23343875 OR10H4 Olfactory Receptor, Family 10, Subfamily H, Member 4
cg07219314 ZDHHC8P Zinc Finger, DHHC-Type Containing 8 Pseudogene 1
cg09692492 ZDHHC8P Zinc Finger, DHHC-Type Containing 8 Pseudogene 1
4.4 Discussion
We described the generalized monotone incremental forward stagewise method for model-
ing a count response when we want to (1) coerce some variables into the model and (2)
perform automatic variable selection and model estimation by penalizing predictors. High-
throughput data contains more predictors than there are samples so traditional methods
are not appropriate in this setting. The GMIFS method was compared to glmpath, a pop-
ular penalization algorithm. Simulations showed that both methods performed similarly
when identifying predictors known to be non-zero. GMIFS appeared to slightly outperform
glmpath in the sense that GMIFS included fewer predictors that are truly unimportant in
the model. This implies glmpath tends to overfit. Similarly, when applied to an independent
data set GMIFS appeared to have higher predictive accuracy. Also, glmpath seems to be
unstable and crashed on all attempts to run on our breast cancer data set. Thus, it appears
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that GMIFS is more generalizable than glmpath to independent data sets.
Both methods were applied to a cord blood gene expression data set. Gene expression
profiles were used to predict MN frequency. Both models identified a similar number of
genes as related to MN frequency. Further, ten of those genes were common to both models.
Nine out of the ten genes have been shown to be associated with different types of cancers.
Since MN count is a measure of DNA damage, genes associated with MN frequency would
be expected to be linked to cancer. Similarly, both methods were applied breast cancer
methylation data set. Both models identified a similar number of methylation sites and 51
of those sites were common to both models.
Both models appear to identify genes linked to cancer. As in the simulations, glmpath
identified more genes as non-zero compared to GMIFS. In the simulations, this was because
glmpath was including more predictors incorrectly. However, there is no way to know if this
is also the case in the cord blood data set given that these data are observational and no
further confirmatory studies can be performed on the samples.
When the models were applied to a breast cancer data set, GMIFS found 25 methylation
loci associated with bud formation. Because bud formation is a measure of DNA damage
it is a reasonable assumption that these loci are related to genes that are involved in DNA
stability. glmpath, on the other hand, crashed when the model was run.
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5 Conclusions and Future Work
5.1 TCR Analysis Conclusions and Future Work
The first part of this thesis proposed several methods to analyze TCR repertoire data. Specif-
ically, methods to differentiate between patients with and without GVHD after HSCT. The
study data consisted of 13 patients that had undergone HSCT. Five patients suffered for
GVHD and eight were GVHD-free. Six methods were described and applied that attempted
to differentiate the two groups at the VDJ combination level. Three of these methods (CDR3
Distribution Perturbation, Simpson’s Diversity Index and Non-parametric Method) calcu-
lated different measures for each VDJ combination of the recipients and then permutation
tests were used to test for differences. The CDR3 perturbation method calculated using
a mean reference and individual reference found three and two significant differences after
adjusting for multiple comparisons, respectively. Simpson’s diversity index found five signifi-
cant differences after adjusting for multiple comparisons. The non-parametric method found
one significant difference after adjusting for multiple comparisons. The Kullback-Leibler
Divergence method was used to compare the difference between CDR3 length distribution
at each VDJ combination. This method found almost all VDJ combinations to be statis-
tically different between groups. However, looking at histograms it is difficult to tell what
is causing those differences. The proportion logit method used both donor and recipient
data to calculate the proportion of shared sequences between donor and recipient at each
VDJ combination. Student’s T-tests were then used to test for differences. Once again no
differences were found between the groups after adjusting for multiple comparison. There
were two VDJ combinations that were significant before multiple comparison adjustment.
Finally, the Oligoscore method calculated a score for each CDR3 length within a VDJ com-
bination for each group. This method identified several peaks that seem to differ between
groups when looked at graphically. These methods were all applied to data collected shortly
after the HSCT procedure when the immune systems is not very well reconstituted. Future
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work should be done to test for differences in later time points after treatment and prior to
treatment. The measures can also be modified to analyze nucleotide or amino acid sequences
rather than CDR3 lengths. The HSCT data were also treated as compositional data. No
significant differences were found after adjusting for multiple comparisons. All these meth-
ods measure different aspects of the T-cell repertoire. Researchers should choose the best
measure for the research question they wish to answer. Further, these methodologies should
be tried on larger sample sizes to see how they perform in more ideal circumstances.
5.2 Generalized Monotone Incremental Foreward Stagewise Method
Conclusions and Future Work
The GMIFS method was extended to analyze count data using the Poisson distribution.
Chapter 4 described our GMIFS method and how it performed compared to a popular al-
ternative, glmpath. Specifically, analyses related to gene expression and methylation were
considered. In both cases, it is important to take into account the cell composition of the
sample being tested [Jaffe and Irizarry, 2014]. This is because different cell types have dif-
ferent gene expression and methylation profiles. Houseman et al. [2012] describe a statistical
method using methylation data to estimate cell composition. Accounting for varying cell
compositions is important because differences between groups could be due to the difference
in sample cell composition rather than true biological differences. Not all count data follows
a Poisson distribution and GMIFS can be extended to the negative binomial distribution
as well. Finally, both the Poisson and negative binomial GMIFS should be extended to the
longitudinal setting as well.
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6 R Code
6.1 T-cell Receptor Code
1 ###################################################
2 # Reading in the TSV files
3 ###################################################
4
5 #Change file directory to where TSV files are located
6 setwd("C:/Users/makowski/Desktop/Dissertation/TCRdata")
7 #locate TSV files in directory
8 files <- dir(pattern="tsv$")
9 #Function to pull out on sequences marked as productive
10 #and put recipient and donor in one list
11 fileread <- function(name1, name2, file1, file2) {
12 name1<-subset(read.delim(files[file1]),sequenceStatus=="Productive")
13 name2<-subset(read.delim(files[file2]),sequenceStatus=="Productive")
14 list(name1,name2)
15 }
16 #Run the function for each patient
17 pt11<-fileread(name1=ptlld, name2=pt11r3, file1=1, file2=2)
18 pt12<-fileread(name1=ptl2d, name2=pt12r2, file1=3, file2=4)
19 pt13<-fileread(name1=ptl3d, name2=pt13r2, file1=5, file2=6)
20 pt14<-fileread(name1=ptl4d, name2=pt14r3, file1=7, file2=8)
21 pt16<-fileread(name1=ptl6d, name2=pt16r2, file1=9, file2=10)
22 pt24<-fileread(name1=pt24d, name2=pt24r3, file1=11, file2=12)
23 pt3<-fileread(name1=pt3d, name2=pt3r2, file1=13, file2=14)
24 pt4<-fileread(name1=pt4d, name2=pt4r2, file1=15, file2=16)
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25 pt5<-fileread(name1=pt5d, name2=pt5r2, file1=17, file2=18)
26 pt6<-fileread(name1=pt6d, name2=pt6r3, file1=19, file2=20)
27 pt7<-fileread(name1=pt7d, name2=pt7r3, file1=21, file2=22)
28 pt8<-fileread(name1=pt8d, name2=pt8r3, file1=23, file2=24)
29 pt9<-fileread(name1=pt9d, name2=pt9r3, file1=25, file2=26)
30
31 #function to calculate rpm for both patient and donor
32 rpm<-function(patient){
33 norm<-patient[[1]][,6]
34 depth<-sum(norm)
35 RPM<-(norm/depth)*1e6
36 donor<-cbind(patient[[1]],RPM)
37
38 norm<-patient[[2]][,6]
39 depth<-sum(norm)
40 RPM<-(norm/depth)*1e6
41 recipient<-cbind(patient[[2]],RPM)
42
43 list(donor,recipient)
44 }
45
46 #use function to calculate rpm for donor and recipient
47 pt11rpm<-rpm(pt11)
48 rm(pt11)
49 pt12rpm<-rpm(pt12)
50 rm(pt12)
51 pt13rpm<-rpm(pt13)
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52 rm(pt13)
53 pt14rpm<-rpm(pt14)
54 rm(pt14)
55 pt16rpm<-rpm(pt16)
56 rm(pt16)
57 pt24rpm<-rpm(pt24)
58 rm(pt24)
59 pt3rpm<-rpm(pt3)
60 rm(pt3)
61 pt4rpm<-rpm(pt4)
62 rm(pt4)
63 pt5rpm<-rpm(pt5)
64 rm(pt5)
65 pt6rpm<-rpm(pt6)
66 rm(pt6)
67 pt7rpm<-rpm(pt7)
68 rm(pt7)
69 pt8rpm<-rpm(pt8)
70 rm(pt8)
71 pt9rpm<-rpm(pt9)
72 rm(pt9)
73
74 #possible V,D and J genes
75 #Note not all patients have all VDJ combinations interrogated
76 #by Immunoseq technology so this finds all of them
77 #I use both Dg and d later and eaier to make both than change more code
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78 J<-unique(c(levels(pt11rpm[[1]]$JGeneName),levels(pt12rpm[[1]]$JGeneName),
levels(pt13rpm[[1]]$JGeneName),levels(pt14rpm[[1]]$JGeneName),levels(
pt16rpm[[1]]$JGeneName),levels(pt24rpm[[1]]$JGeneName),levels(pt3rpm
[[1]]$JGeneName),levels(pt4rpm[[1]]$JGeneName),levels(pt5rpm[[1]]$
JGeneName),levels(pt6rpm[[1]]$JGeneName),levels(pt7rpm[[1]]$JGeneName),
levels(pt8rpm[[1]]$JGeneName),levels(pt9rpm[[1]]$JGeneName)))
79 V<-unique(c(levels(pt11rpm[[1]]$VGeneName),levels(pt12rpm[[1]]$VGeneName),
levels(pt13rpm[[1]]$VGeneName),levels(pt14rpm[[1]]$VGeneName),levels(
pt16rpm[[1]]$VGeneName),levels(pt24rpm[[1]]$VGeneName),levels(pt3rpm
[[1]]$VGeneName),levels(pt4rpm[[1]]$VGeneName),levels(pt5rpm[[1]]$
VGeneName),levels(pt6rpm[[1]]$VGeneName),levels(pt7rpm[[1]]$VGeneName),
levels(pt8rpm[[1]]$VGeneName),levels(pt9rpm[[1]]$VGeneName)))
80 Dg<-unique(c(levels(pt11rpm[[1]]$DGeneName),levels(pt12rpm[[1]]$DGeneName),
levels(pt13rpm[[1]]$DGeneName),levels(pt14rpm[[1]]$DGeneName),levels(
pt16rpm[[1]]$DGeneName),levels(pt24rpm[[1]]$DGeneName),levels(pt3rpm
[[1]]$DGeneName),levels(pt4rpm[[1]]$DGeneName),levels(pt5rpm[[1]]$
DGeneName),levels(pt6rpm[[1]]$DGeneName),levels(pt7rpm[[1]]$DGeneName),
levels(pt8rpm[[1]]$DGeneName),levels(pt9rpm[[1]]$DGeneName)))
81 #remove undefined values
82 V<-V[-1]
83 d<-Dg[-1]
84
85 #save file for later use
86 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
87 save.image("TcellRPM.RData")
88
89
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90 ##############################################
91 #Determine VDJ combinations present in each sample
92 ##############################################
93
94 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
95 load("TcellRPM.RData")
96
97 #Sum all VDJ combinations
98 location<-expand.grid(J,V,d)
99 VDJcomp<-matrix(ncol=1248,nrow=13)
100 for (i in 1:1248){
101 y<-2
102 x<-which(J==location[i,1])
103 w<-which(V==location[i,2])
104 z<-which(d==location[i,3])
105 VDJcomp[,i]<-c(sum(pt11rpm[[y]]$RPM[which(pt11rpm[[y]]$JGeneName==J[x] &
pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName==d[z])]),
106 sum(pt12rpm[[y]]$RPM[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z])
]),
107 sum(pt13rpm[[y]]$RPM[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z])
]),
108 sum(pt14rpm[[y]]$RPM[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z])
]),
120
109 sum(pt16rpm[[y]]$RPM[which(pt16rpm[[y]]$JGeneName==J[x] &
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z])
]),
110 sum(pt24rpm[[y]]$RPM[which(pt24rpm[[y]]$JGeneName==J[x] &
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z])
]),
111 sum(pt3rpm[[y]]$RPM[which(pt3rpm[[y]]$JGeneName==J[x] & pt3rpm
[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z])]),
112 sum(pt4rpm[[y]]$RPM[which(pt4rpm[[y]]$JGeneName==J[x] & pt4rpm
[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z])]),
113 sum(pt5rpm[[y]]$RPM[which(pt5rpm[[y]]$JGeneName==J[x] & pt5rpm
[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z])]),
114 sum(pt6rpm[[y]]$RPM[which(pt6rpm[[y]]$JGeneName==J[x] & pt6rpm
[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z])]),
115 sum(pt7rpm[[y]]$RPM[which(pt7rpm[[y]]$JGeneName==J[x] & pt7rpm
[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z])]),
116 sum(pt8rpm[[y]]$RPM[which(pt8rpm[[y]]$JGeneName==J[x] & pt8rpm
[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z])]),
117 sum(pt9rpm[[y]]$RPM[which(pt9rpm[[y]]$JGeneName==J[x] & pt9rpm
[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z])]))
118 }
119
120 #check to see where 0’s are
121 Diversity.check<-matrix(rep(0,(1248*13)),ncol=1248,nrow=13)
122 for (i in 1:13){
123 for (j in 1:1248){
124
121
125 if (VDJcomp[i,j]=="0"){
126 Diversity.check[i,j]<-1
127 }
128 else {
129 Diversity.check[i,j]<-0
130 }
131 }
132 }
133
134 #keep only VDJ combinations that 7 or more of the sample contain
135 NAs<-c(which(apply(Diversity.check,2,sum)==13),which(apply(Diversity.check
,2,sum)==12),which(apply(Diversity.check,2,sum)==11),which(apply(
Diversity.check,2,sum)==10),which(apply(Diversity.check,2,sum)==9),which
(apply(Diversity.check,2,sum)==8),which(apply(Diversity.check,2,sum)==7)
,which(apply(Diversity.check,2,sum)==6))
136
137 save(NAs,file="VDJNAs.RData")
138
139 ####################################
140 #CDR3 Perturbation Test using mean
141 ####################################
142 #loaded the needed file
143 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
144 load("TcellRPM.RData")
145
146 #Function that does the perturbation test for the VDJ families; x is the J
gene, w is V gene and z is d gene and y=1 is donor and y=2 is recipient
122
147 Perttest<-function(x,w,z,y){
148 #this part calculates the number of unique CDR3 lengths
149 L=length(unique(c(unique(pt11rpm[[y]]$cdr3Length[which(pt11rpm[[y]]$
JGeneName==J[x] & pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName
==d[z])]),
150 unique(pt12rpm[[y]]$cdr3Length[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z])]),
151 unique(pt13rpm[[y]]$cdr3Length[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z])]),
152 unique(pt14rpm[[y]]$cdr3Length[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z])]),
153 unique(pt16rpm[[y]]$cdr3Length[which(pt16rpm[[y]]$JGeneName==J[x]&
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z])]),
154 unique(pt24rpm[[y]]$cdr3Length[which(pt24rpm[[y]]$JGeneName==J[x]&
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z])]),
155 unique(pt3rpm[[y]]$cdr3Length[which(pt3rpm[[y]]$JGeneName==J[x] &
pt3rpm[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z])]),
156 unique(pt4rpm[[y]]$cdr3Length[which(pt4rpm[[y]]$JGeneName==J[x] &
pt4rpm[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z])]),
157 unique(pt5rpm[[y]]$cdr3Length[which(pt5rpm[[y]]$JGeneName==J[x] &
pt5rpm[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z])]),
158 unique(pt6rpm[[y]]$cdr3Length[which(pt6rpm[[y]]$JGeneName==J[x] &
pt6rpm[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z])]),
159 unique(pt7rpm[[y]]$cdr3Length[which(pt7rpm[[y]]$JGeneName==J[x] &
pt7rpm[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z])]),
160 unique(pt8rpm[[y]]$cdr3Length[which(pt8rpm[[y]]$JGeneName==J[x] &
pt8rpm[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z])]),
123
161 unique(pt9rpm[[y]]$cdr3Length[which(pt9rpm[[y]]$JGeneName==J[x] &
pt9rpm[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z])]))))
162 #print(L)
163
164 #this sets the perturbation statistic to zero if the VDJ combination is not
present
165 if (L==0){
166 AbsoluteDeviancei<-rep(0,13)
167 AbsoluteDeviancei
168 }
169
170 else {
171 #This list the peak lengths
172 Peaks=unique(c(unique(pt11rpm[[y]]$cdr3Length[which(pt11rpm[[y]]$JGeneName
==J[x] & pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName==d[z])])
,
173 unique(pt12rpm[[y]]$cdr3Length[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z])]),
174 unique(pt13rpm[[y]]$cdr3Length[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z])]),
175 unique(pt14rpm[[y]]$cdr3Length[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z])]),
176 unique(pt16rpm[[y]]$cdr3Length[which(pt16rpm[[y]]$JGeneName==J[x]&
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z])]),
177 unique(pt24rpm[[y]]$cdr3Length[which(pt24rpm[[y]]$JGeneName==J[x]&
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z])]),
124
178 unique(pt3rpm[[y]]$cdr3Length[which(pt3rpm[[y]]$JGeneName==J[x] &
pt3rpm[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z])]),
179 unique(pt4rpm[[y]]$cdr3Length[which(pt4rpm[[y]]$JGeneName==J[x] &
pt4rpm[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z])]),
180 unique(pt5rpm[[y]]$cdr3Length[which(pt5rpm[[y]]$JGeneName==J[x] &
pt5rpm[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z])]),
181 unique(pt6rpm[[y]]$cdr3Length[which(pt6rpm[[y]]$JGeneName==J[x] &
pt6rpm[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z])]),
182 unique(pt7rpm[[y]]$cdr3Length[which(pt7rpm[[y]]$JGeneName==J[x] &
pt7rpm[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z])]),
183 unique(pt8rpm[[y]]$cdr3Length[which(pt8rpm[[y]]$JGeneName==J[x] &
pt8rpm[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z])]),
184 unique(pt9rpm[[y]]$cdr3Length[which(pt9rpm[[y]]$JGeneName==J[x] &
pt9rpm[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z])])))
185 #print(Peaks)
186 #this calculates the total rpm in each peack
187 Peaksi<-matrix(ncol=13,nrow=L)
188 for (i in 1:L){
189 Peaksi[i,]<-c(sum(pt11rpm[[y]]$RPM[which(pt11rpm[[y]]$JGeneName==J[x] &
pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName==d[z] & pt11rpm[[y
]]$cdr3Length==Peaks[i])]),
190 sum(pt12rpm[[y]]$RPM[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z]
& pt12rpm[[y]]$cdr3Length==Peaks[i])]),
191 sum(pt13rpm[[y]]$RPM[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z]
& pt13rpm[[y]]$cdr3Length==Peaks[i])]),
125
192 sum(pt14rpm[[y]]$RPM[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z]
& pt14rpm[[y]]$cdr3Length==Peaks[i])]),
193 sum(pt16rpm[[y]]$RPM[which(pt16rpm[[y]]$JGeneName==J[x] &
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z]
& pt16rpm[[y]]$cdr3Length==Peaks[i])]),
194 sum(pt24rpm[[y]]$RPM[which(pt24rpm[[y]]$JGeneName==J[x] &
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z]
& pt24rpm[[y]]$cdr3Length==Peaks[i])]),
195 sum(pt3rpm[[y]]$RPM[which(pt3rpm[[y]]$JGeneName==J[x] & pt3rpm
[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z] & pt3rpm
[[y]]$cdr3Length==Peaks[i])]),
196 sum(pt4rpm[[y]]$RPM[which(pt4rpm[[y]]$JGeneName==J[x] & pt4rpm
[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z] & pt4rpm
[[y]]$cdr3Length==Peaks[i])]),
197 sum(pt5rpm[[y]]$RPM[which(pt5rpm[[y]]$JGeneName==J[x] & pt5rpm
[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z] & pt5rpm
[[y]]$cdr3Length==Peaks[i])]),
198 sum(pt6rpm[[y]]$RPM[which(pt6rpm[[y]]$JGeneName==J[x] & pt6rpm
[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z] & pt6rpm
[[y]]$cdr3Length==Peaks[i])]),
199 sum(pt7rpm[[y]]$RPM[which(pt7rpm[[y]]$JGeneName==J[x] & pt7rpm
[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z] & pt7rpm
[[y]]$cdr3Length==Peaks[i])]),
200 sum(pt8rpm[[y]]$RPM[which(pt8rpm[[y]]$JGeneName==J[x] & pt8rpm
[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z] & pt8rpm
[[y]]$cdr3Length==Peaks[i])]),
126
201 sum(pt9rpm[[y]]$RPM[which(pt9rpm[[y]]$JGeneName==J[x] & pt9rpm
[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z] & pt9rpm
[[y]]$cdr3Length==Peaks[i])]))
202 }
203 #print(Peaksi)
204 #total rpm per patient
205 Peakssum<-apply(Peaksi,2,sum)
206
207 #print(Peakssum)
208 #calculates the probability of each peak
209 Probabilityi<-matrix(ncol=13,nrow=L)
210 for (j in 1:L) {
211 Probabilityi[j,]<-Peaksi[j,]/Peakssum
212 }
213
214 #print(Probabilityi)
215 #calculates total rpm in each donor peak
216 controlPeaksi<-matrix(ncol=13,nrow=L)
217 for (k in 1:L){
218 controlPeaksi[k,]<-c(sum(pt11rpm[[1]]$RPM[which(pt11rpm[[1]]$JGeneName==J[x]
& pt11rpm[[1]]$VGeneName==V[w] & pt11rpm[[1]]$DGeneName==d[z] & pt11rpm
[[1]]$cdr3Length==Peaks[k])]),
219 sum(pt12rpm[[1]]$RPM[which(pt12rpm[[1]]$JGeneName==J[x] &
pt12rpm[[1]]$VGeneName==V[w] & pt12rpm[[1]]$DGeneName==d[z]
& pt12rpm[[1]]$cdr3Length==Peaks[k])]),
220 sum(pt13rpm[[1]]$RPM[which(pt13rpm[[1]]$JGeneName==J[x] &
pt13rpm[[1]]$VGeneName==V[w] & pt13rpm[[1]]$DGeneName==d[z]
127
& pt13rpm[[1]]$cdr3Length==Peaks[k])]),
221 sum(pt14rpm[[1]]$RPM[which(pt14rpm[[1]]$JGeneName==J[x] &
pt14rpm[[1]]$VGeneName==V[w] & pt14rpm[[1]]$DGeneName==d[z]
& pt14rpm[[1]]$cdr3Length==Peaks[k])]),
222 sum(pt16rpm[[1]]$RPM[which(pt16rpm[[1]]$JGeneName==J[x] &
pt16rpm[[1]]$VGeneName==V[w] & pt16rpm[[1]]$DGeneName==d[z]
& pt16rpm[[1]]$cdr3Length==Peaks[k])]),
223 sum(pt24rpm[[1]]$RPM[which(pt24rpm[[1]]$JGeneName==J[x] &
pt24rpm[[1]]$VGeneName==V[w] & pt24rpm[[1]]$DGeneName==d[z]
& pt24rpm[[1]]$cdr3Length==Peaks[k])]),
224 sum(pt3rpm[[1]]$RPM[which(pt3rpm[[1]]$JGeneName==J[x] & pt3rpm
[[1]]$VGeneName==V[w] & pt3rpm[[1]]$DGeneName==d[z] & pt3rpm
[[1]]$cdr3Length==Peaks[k])]),
225 sum(pt4rpm[[1]]$RPM[which(pt4rpm[[1]]$JGeneName==J[x] & pt4rpm
[[1]]$VGeneName==V[w] & pt4rpm[[1]]$DGeneName==d[z] & pt4rpm
[[1]]$cdr3Length==Peaks[k])]),
226 sum(pt5rpm[[1]]$RPM[which(pt5rpm[[1]]$JGeneName==J[x] & pt5rpm
[[1]]$VGeneName==V[w] & pt5rpm[[1]]$DGeneName==d[z] & pt5rpm
[[1]]$cdr3Length==Peaks[k])]),
227 sum(pt6rpm[[1]]$RPM[which(pt6rpm[[1]]$JGeneName==J[x] & pt6rpm
[[1]]$VGeneName==V[w] & pt6rpm[[1]]$DGeneName==d[z] & pt6rpm
[[1]]$cdr3Length==Peaks[k])]),
228 sum(pt7rpm[[1]]$RPM[which(pt7rpm[[1]]$JGeneName==J[x] & pt7rpm
[[1]]$VGeneName==V[w] & pt7rpm[[1]]$DGeneName==d[z] & pt7rpm
[[1]]$cdr3Length==Peaks[k])]),
229 sum(pt8rpm[[1]]$RPM[which(pt8rpm[[1]]$JGeneName==J[x] & pt8rpm
[[1]]$VGeneName==V[w] & pt8rpm[[1]]$DGeneName==d[z] & pt8rpm
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[[1]]$cdr3Length==Peaks[k])]),
230 sum(pt9rpm[[1]]$RPM[which(pt9rpm[[1]]$JGeneName==J[x] & pt9rpm
[[1]]$VGeneName==V[w] & pt9rpm[[1]]$DGeneName==d[z] & pt9rpm
[[1]]$cdr3Length==Peaks[k])]))
231 }
232 #print(controlPeaksi)
233 #calculates total rpm for each donor
234 controlPeakssum<-apply(controlPeaksi,2,sum)
235
236 #print(controlPeakssum)
237 #calculates probability of each donor peak
238 controlProbabilityi<-matrix(ncol=13,nrow=L)
239 for (l in 1:L) {
240 controlProbabilityi[l,]<-controlPeaksi[l,]/controlPeakssum
241 }
242
243 #print(controlProbabilityi)
244 #sets division by zero calculations to zero instead of NaN
245 for (m in 1:L){
246 Probabilityi[m,which(Probabilityi[m,]=="NaN")]<-0
247 controlProbabilityi[m,which(controlProbabilityi[m,]=="NaN")]<-0
248 }
249 #calculates the deviance for mean donor or individual donor
250 Deviancei<-Probabilityi-apply(controlProbabilityi,1,mean)
251 #Change this line to make it a perturbation from each donor instead of mean
252 #Deviancei<-Probabilityi-controlProbabilityi
253 #calculates total deviance per subject
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254 AbsoluteDeviancei<-matrix(nrow=1,ncol=13)
255 for (o in 1:13){
256 AbsoluteDeviancei[o]<-100*sum(abs(Deviancei[,o])/2)
257 }
258 #print(AbsoluteDeviancei)
259
260 AbsoluteDeviancei
261 }
262 }
263 #lists all possible VDJ combinations
264 location<-expand.grid(J,V,d)
265
266 # a is VDJ combination from location object
267 #function calculates perturbation statistic for each VDJ combination
268 AbsoluteDeviance<-matrix(nrow=(length(J)*length(V)*length(d)),ncol=13)
269 for (a in 1:1248){
270 AbsoluteDeviance[a,]<-Perttest(which(J==location[a,1]),which(V==location[a
,2]),which(d==location[a,3]),2)
271 print(a)
272 }
273
274 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
275 save(AbsoluteDeviance,location,file="Perturbationtestmean.RData")
276
277
278
279
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280 #############################################
281 #Run the permutation tests for perturbation test using mean
282 #############################################
283
284 #set the two groups
285 GroupGVT<-c(2,5,7,8,11)
286 GroupGVHD<-c(1,3,4,6,9,10,12,13)
287 #GVT is 0 and GVHD is 1
288 Group<-c(1,0,1,1,0,1,0,0,1,1,0,1,1)
289
290 #for referencing which VDJ combination
291 rownames(AbsoluteDeviance)<-c(1:1248)
292
293 #load NA values for tests
294 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
295 load("VDJNAs.RData")
296
297 AbsoluteDeviance.NA<-AbsoluteDeviance[-NAs,]
298 #run the permutation test
299 set.seed(123)
300 B <- 1000
301 test.stat<-pval<-numeric()
302 test.stat.b<-matrix(nrow=dim(AbsoluteDeviance.NA)[1], ncol=B)
303 for (i in 1:dim(AbsoluteDeviance.NA)[1]) {
304
305 test.stat[i]<-mean(AbsoluteDeviance.NA[i,Group==1]) - mean(
AbsoluteDeviance.NA[i,Group==0])
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306 for (j in 1:B) {
307
308 sample<-sample(Group, replace=FALSE)
309 test.stat.b[i,j]<-mean(AbsoluteDeviance.NA[i,sample==1]) -
mean(AbsoluteDeviance.NA[i,sample==0])
310 }
311 pval[i]<-sum(abs(test.stat.b[i,]>abs(test.stat[i])))/B
312 }
313
314 fdr<-cbind(p.adjust(pval, method="BH"),c(1:dim(AbsoluteDeviance.NA)[1]))
315 sum(fdr<0.05)
316 fdr.order<-fdr[order(pval),]
317 location.NA<-location[-NAs,]
318 groupnames<-factor(Group,levels=c(0,1),labels=c("No GVHD","GVHD"))
319 #make some plots
320
321 png(file = "perttestmean.png", width = 1200, height = 1000, units = "px")
322 par(mfrow=c(2,2),mar=c(5.1,4.5,4.1,2.1))
323 plot(groupnames,AbsoluteDeviance.NA[fdr.order[1,2],],main=paste(location.NA[
fdr.order[1,2],1],location.NA[fdr.order[1,2],2],location.NA[fdr.order
[1,2],3]),cex.lab=2,cex.main=2,cex.axis=2,ylab="Perturbation")
324 plot(groupnames,AbsoluteDeviance.NA[fdr.order[2,2],],main=paste(location.NA[
fdr.order[2,2],1],location.NA[fdr.order[2,2],2],location.NA[fdr.order
[2,2],3]),cex.lab=2,cex.main=2,cex.axis=2,ylab="Perturbation")
325 plot(groupnames,AbsoluteDeviance.NA[fdr.order[3,2],],main=paste(location.NA[
fdr.order[3,2],1],location.NA[fdr.order[3,2],2],location.NA[fdr.order
[3,2],3]),cex.lab=2,cex.main=2,cex.axis=2,ylab="Perturbation")
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326 dev.off()
327
328
329 library(xtable)
330 apply(t(AbsoluteDeviance[fdr.order[c(1:4),2],GroupGVT]),2,FUN=median)
331 perttest.table<-cbind(location.NA[fdr.order[c(1:3),2],],apply(t(
AbsoluteDeviance.NA[fdr.order[c(1:3),2],GroupGVT]),2,FUN=median),apply(t
(AbsoluteDeviance.NA[fdr.order[c(1:3),2],GroupGVHD]),2,FUN=median),fdr.
order[c(1:3),1])
332 colnames(perttest.table)<-c("JGene","VGene","DGene", "Median No GVHD
Perturbation", "Median GVHD Perturbation", "FDR")
333 xtable(perttest.table,digits=3)
334
335
336
337
338
339 ###################################################
340 #CDR3 Perturbation Test using individual control
341 ###################################################
342 #loaded the needed file
343 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
344 load("TcellRPM.RData")
345
346 #Function that does the perturbation test for the VDJ families; x is the J
gene, w is V gene and z is d gene and y=1 is donor and y=2 is recipient
347 Perttest<-function(x,w,z,y){
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348 #this part calculates the number of unique CDR3 lengths
349 L=length(unique(c(unique(pt11rpm[[y]]$cdr3Length[which(pt11rpm[[y]]$
JGeneName==J[x] & pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName
==d[z])]),
350 unique(pt12rpm[[y]]$cdr3Length[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z])]),
351 unique(pt13rpm[[y]]$cdr3Length[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z])]),
352 unique(pt14rpm[[y]]$cdr3Length[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z])]),
353 unique(pt16rpm[[y]]$cdr3Length[which(pt16rpm[[y]]$JGeneName==J[x]&
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z])]),
354 unique(pt24rpm[[y]]$cdr3Length[which(pt24rpm[[y]]$JGeneName==J[x]&
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z])]),
355 unique(pt3rpm[[y]]$cdr3Length[which(pt3rpm[[y]]$JGeneName==J[x] &
pt3rpm[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z])]),
356 unique(pt4rpm[[y]]$cdr3Length[which(pt4rpm[[y]]$JGeneName==J[x] &
pt4rpm[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z])]),
357 unique(pt5rpm[[y]]$cdr3Length[which(pt5rpm[[y]]$JGeneName==J[x] &
pt5rpm[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z])]),
358 unique(pt6rpm[[y]]$cdr3Length[which(pt6rpm[[y]]$JGeneName==J[x] &
pt6rpm[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z])]),
359 unique(pt7rpm[[y]]$cdr3Length[which(pt7rpm[[y]]$JGeneName==J[x] &
pt7rpm[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z])]),
360 unique(pt8rpm[[y]]$cdr3Length[which(pt8rpm[[y]]$JGeneName==J[x] &
pt8rpm[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z])]),
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361 unique(pt9rpm[[y]]$cdr3Length[which(pt9rpm[[y]]$JGeneName==J[x] &
pt9rpm[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z])]))))
362 #print(L)
363
364 #this sets the perturbation statistic to zero if the VDJ combination is not
present
365 if (L==0){
366 AbsoluteDeviancei<-rep(0,13)
367 AbsoluteDeviancei
368 }
369
370 else {
371 #This list the peak lengths
372 Peaks=unique(c(unique(pt11rpm[[y]]$cdr3Length[which(pt11rpm[[y]]$JGeneName
==J[x] & pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName==d[z])])
,
373 unique(pt12rpm[[y]]$cdr3Length[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z])]),
374 unique(pt13rpm[[y]]$cdr3Length[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z])]),
375 unique(pt14rpm[[y]]$cdr3Length[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z])]),
376 unique(pt16rpm[[y]]$cdr3Length[which(pt16rpm[[y]]$JGeneName==J[x]&
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z])]),
377 unique(pt24rpm[[y]]$cdr3Length[which(pt24rpm[[y]]$JGeneName==J[x]&
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z])]),
135
378 unique(pt3rpm[[y]]$cdr3Length[which(pt3rpm[[y]]$JGeneName==J[x] &
pt3rpm[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z])]),
379 unique(pt4rpm[[y]]$cdr3Length[which(pt4rpm[[y]]$JGeneName==J[x] &
pt4rpm[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z])]),
380 unique(pt5rpm[[y]]$cdr3Length[which(pt5rpm[[y]]$JGeneName==J[x] &
pt5rpm[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z])]),
381 unique(pt6rpm[[y]]$cdr3Length[which(pt6rpm[[y]]$JGeneName==J[x] &
pt6rpm[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z])]),
382 unique(pt7rpm[[y]]$cdr3Length[which(pt7rpm[[y]]$JGeneName==J[x] &
pt7rpm[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z])]),
383 unique(pt8rpm[[y]]$cdr3Length[which(pt8rpm[[y]]$JGeneName==J[x] &
pt8rpm[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z])]),
384 unique(pt9rpm[[y]]$cdr3Length[which(pt9rpm[[y]]$JGeneName==J[x] &
pt9rpm[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z])])))
385 #print(Peaks)
386 #this calculates the total rpm in each peack
387 Peaksi<-matrix(ncol=13,nrow=L)
388 for (i in 1:L){
389 Peaksi[i,]<-c(sum(pt11rpm[[y]]$RPM[which(pt11rpm[[y]]$JGeneName==J[x] &
pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName==d[z] & pt11rpm[[y
]]$cdr3Length==Peaks[i])]),
390 sum(pt12rpm[[y]]$RPM[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z]
& pt12rpm[[y]]$cdr3Length==Peaks[i])]),
391 sum(pt13rpm[[y]]$RPM[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z]
& pt13rpm[[y]]$cdr3Length==Peaks[i])]),
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392 sum(pt14rpm[[y]]$RPM[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z]
& pt14rpm[[y]]$cdr3Length==Peaks[i])]),
393 sum(pt16rpm[[y]]$RPM[which(pt16rpm[[y]]$JGeneName==J[x] &
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z]
& pt16rpm[[y]]$cdr3Length==Peaks[i])]),
394 sum(pt24rpm[[y]]$RPM[which(pt24rpm[[y]]$JGeneName==J[x] &
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z]
& pt24rpm[[y]]$cdr3Length==Peaks[i])]),
395 sum(pt3rpm[[y]]$RPM[which(pt3rpm[[y]]$JGeneName==J[x] & pt3rpm
[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z] & pt3rpm
[[y]]$cdr3Length==Peaks[i])]),
396 sum(pt4rpm[[y]]$RPM[which(pt4rpm[[y]]$JGeneName==J[x] & pt4rpm
[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z] & pt4rpm
[[y]]$cdr3Length==Peaks[i])]),
397 sum(pt5rpm[[y]]$RPM[which(pt5rpm[[y]]$JGeneName==J[x] & pt5rpm
[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z] & pt5rpm
[[y]]$cdr3Length==Peaks[i])]),
398 sum(pt6rpm[[y]]$RPM[which(pt6rpm[[y]]$JGeneName==J[x] & pt6rpm
[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z] & pt6rpm
[[y]]$cdr3Length==Peaks[i])]),
399 sum(pt7rpm[[y]]$RPM[which(pt7rpm[[y]]$JGeneName==J[x] & pt7rpm
[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z] & pt7rpm
[[y]]$cdr3Length==Peaks[i])]),
400 sum(pt8rpm[[y]]$RPM[which(pt8rpm[[y]]$JGeneName==J[x] & pt8rpm
[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z] & pt8rpm
[[y]]$cdr3Length==Peaks[i])]),
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401 sum(pt9rpm[[y]]$RPM[which(pt9rpm[[y]]$JGeneName==J[x] & pt9rpm
[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z] & pt9rpm
[[y]]$cdr3Length==Peaks[i])]))
402 }
403 #print(Peaksi)
404 #total rpm per patient
405 Peakssum<-apply(Peaksi,2,sum)
406
407 #print(Peakssum)
408 #calculates the probability of each peak
409 Probabilityi<-matrix(ncol=13,nrow=L)
410 for (j in 1:L) {
411 Probabilityi[j,]<-Peaksi[j,]/Peakssum
412 }
413
414 #print(Probabilityi)
415 #calculates total rpm in each donor peak
416 controlPeaksi<-matrix(ncol=13,nrow=L)
417 for (k in 1:L){
418 controlPeaksi[k,]<-c(sum(pt11rpm[[1]]$RPM[which(pt11rpm[[1]]$JGeneName==J[x]
& pt11rpm[[1]]$VGeneName==V[w] & pt11rpm[[1]]$DGeneName==d[z] & pt11rpm
[[1]]$cdr3Length==Peaks[k])]),
419 sum(pt12rpm[[1]]$RPM[which(pt12rpm[[1]]$JGeneName==J[x] &
pt12rpm[[1]]$VGeneName==V[w] & pt12rpm[[1]]$DGeneName==d[z]
& pt12rpm[[1]]$cdr3Length==Peaks[k])]),
420 sum(pt13rpm[[1]]$RPM[which(pt13rpm[[1]]$JGeneName==J[x] &
pt13rpm[[1]]$VGeneName==V[w] & pt13rpm[[1]]$DGeneName==d[z]
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& pt13rpm[[1]]$cdr3Length==Peaks[k])]),
421 sum(pt14rpm[[1]]$RPM[which(pt14rpm[[1]]$JGeneName==J[x] &
pt14rpm[[1]]$VGeneName==V[w] & pt14rpm[[1]]$DGeneName==d[z]
& pt14rpm[[1]]$cdr3Length==Peaks[k])]),
422 sum(pt16rpm[[1]]$RPM[which(pt16rpm[[1]]$JGeneName==J[x] &
pt16rpm[[1]]$VGeneName==V[w] & pt16rpm[[1]]$DGeneName==d[z]
& pt16rpm[[1]]$cdr3Length==Peaks[k])]),
423 sum(pt24rpm[[1]]$RPM[which(pt24rpm[[1]]$JGeneName==J[x] &
pt24rpm[[1]]$VGeneName==V[w] & pt24rpm[[1]]$DGeneName==d[z]
& pt24rpm[[1]]$cdr3Length==Peaks[k])]),
424 sum(pt3rpm[[1]]$RPM[which(pt3rpm[[1]]$JGeneName==J[x] & pt3rpm
[[1]]$VGeneName==V[w] & pt3rpm[[1]]$DGeneName==d[z] & pt3rpm
[[1]]$cdr3Length==Peaks[k])]),
425 sum(pt4rpm[[1]]$RPM[which(pt4rpm[[1]]$JGeneName==J[x] & pt4rpm
[[1]]$VGeneName==V[w] & pt4rpm[[1]]$DGeneName==d[z] & pt4rpm
[[1]]$cdr3Length==Peaks[k])]),
426 sum(pt5rpm[[1]]$RPM[which(pt5rpm[[1]]$JGeneName==J[x] & pt5rpm
[[1]]$VGeneName==V[w] & pt5rpm[[1]]$DGeneName==d[z] & pt5rpm
[[1]]$cdr3Length==Peaks[k])]),
427 sum(pt6rpm[[1]]$RPM[which(pt6rpm[[1]]$JGeneName==J[x] & pt6rpm
[[1]]$VGeneName==V[w] & pt6rpm[[1]]$DGeneName==d[z] & pt6rpm
[[1]]$cdr3Length==Peaks[k])]),
428 sum(pt7rpm[[1]]$RPM[which(pt7rpm[[1]]$JGeneName==J[x] & pt7rpm
[[1]]$VGeneName==V[w] & pt7rpm[[1]]$DGeneName==d[z] & pt7rpm
[[1]]$cdr3Length==Peaks[k])]),
429 sum(pt8rpm[[1]]$RPM[which(pt8rpm[[1]]$JGeneName==J[x] & pt8rpm
[[1]]$VGeneName==V[w] & pt8rpm[[1]]$DGeneName==d[z] & pt8rpm
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[[1]]$cdr3Length==Peaks[k])]),
430 sum(pt9rpm[[1]]$RPM[which(pt9rpm[[1]]$JGeneName==J[x] & pt9rpm
[[1]]$VGeneName==V[w] & pt9rpm[[1]]$DGeneName==d[z] & pt9rpm
[[1]]$cdr3Length==Peaks[k])]))
431 }
432 #print(controlPeaksi)
433 #calculates total rpm for each donor
434 controlPeakssum<-apply(controlPeaksi,2,sum)
435
436 #print(controlPeakssum)
437 #calculates probability of each donor peak
438 controlProbabilityi<-matrix(ncol=13,nrow=L)
439 for (l in 1:L) {
440 controlProbabilityi[l,]<-controlPeaksi[l,]/controlPeakssum
441 }
442
443 #print(controlProbabilityi)
444 #sets division by zero calculations to zero instead of NaN
445 for (m in 1:L){
446 Probabilityi[m,which(Probabilityi[m,]=="NaN")]<-0
447 controlProbabilityi[m,which(controlProbabilityi[m,]=="NaN")]<-0
448 }
449 #calculates the deviance for mean donor or individual donor
450 #Deviancei<-Probabilityi-apply(controlProbabilityi,1,mean)
451 #Change this line to make it a perturbation from each donor instead of mean
452 Deviancei<-Probabilityi-controlProbabilityi
453 #calculates total deviance per subject
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454 AbsoluteDeviancei<-matrix(nrow=1,ncol=13)
455 for (o in 1:13){
456 AbsoluteDeviancei[o]<-100*sum(abs(Deviancei[,o])/2)
457 }
458 #print(AbsoluteDeviancei)
459
460 AbsoluteDeviancei
461 }
462 }
463 #lists all possible VDJ combinations
464 location<-expand.grid(J,V,d)
465
466 # a is VDJ combination from location object
467 #function calculates perturbation statistic for each VDJ combination
468 AbsoluteDeviance<-matrix(nrow=(length(J)*length(V)*length(d)),ncol=13)
469 for (a in 1:1248){
470 AbsoluteDeviance[a,]<-Perttest(which(J==location[a,1]),which(V==location[a
,2]),which(d==location[a,3]),2)
471 print(a)
472 }
473
474 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
475 save(AbsoluteDeviance,location,file="Perturbationtestdonor.RData")
476
477
478
479
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480 #############################################
481 #Run the permutation tests for perturbation test using individual control
482 #############################################
483
484
485 #set the two groups
486 GroupGVT<-c(2,5,7,8,11)
487 GroupGVHD<-c(1,3,4,6,9,10,12,13)
488 #GVT is 0 and GVHD is 1
489 Group<-c(1,0,1,1,0,1,0,0,1,1,0,1,1)
490
491 #for referencing which VDJ combination
492 rownames(AbsoluteDeviance)<-c(1:1248)
493 #load NA values for tests
494 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
495 load("VDJNAs.RData")
496
497 AbsoluteDeviance.NA<-AbsoluteDeviance[-NAs,]
498 #run the permutation test
499 set.seed(123)
500 B <- 1000
501 test.stat<-pval<-numeric()
502 test.stat.b<-matrix(nrow=dim(AbsoluteDeviance.NA)[1], ncol=B)
503 for (i in 1:dim(AbsoluteDeviance.NA)[1]) {
504
505 test.stat[i]<-mean(AbsoluteDeviance.NA[i,Group==1]) - mean(
AbsoluteDeviance.NA[i,Group==0])
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506 for (j in 1:B) {
507
508 sample<-sample(Group, replace=FALSE)
509 test.stat.b[i,j]<-mean(AbsoluteDeviance.NA[i,sample==1]) -
mean(AbsoluteDeviance.NA[i,sample==0])
510 }
511 pval[i]<-sum(abs(test.stat.b[i,]>abs(test.stat[i])))/B
512 }
513
514 fdr<-cbind(p.adjust(pval, method="BH"),c(1:dim(AbsoluteDeviance.NA)[1]))
515 sum(fdr<0.05)
516 fdr.order<-fdr[order(pval),]
517 location.NA<-location[-NAs,]
518 groupnames<-factor(Group,levels=c(0,1),labels=c("No GVHD","GVHD"))
519 #make some plots
520
521 png(file = "perttestindiv.png", width = 1200, height = 1000, units = "px")
522 par(mfrow=c(1,2),mar=c(5.1,4.5,4.1,2.1))
523 plot(groupnames,AbsoluteDeviance.NA[fdr.order[1,2],],main=paste(location.NA[
fdr.order[1,2],1],location.NA[fdr.order[1,2],2],location.NA[fdr.order
[1,2],3]),cex.lab=2,cex.main=2,cex.axis=2,ylab="Perturbation")
524 plot(groupnames,AbsoluteDeviance.NA[fdr.order[2,2],],main=paste(location.NA[
fdr.order[2,2],1],location.NA[fdr.order[2,2],2],location.NA[fdr.order
[2,2],3]),cex.lab=2,cex.main=2,cex.axis=2,ylab="Perturbation")
525 dev.off()
526
527
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528 library(xtable)
529 apply(t(AbsoluteDeviance.NA[fdr.order[c(1:2),2],GroupGVT]),2,FUN=median)
530 perttest.table<-cbind(location.NA[fdr.order[c(1:2),2],],apply(t(
AbsoluteDeviance.NA[fdr.order[c(1:2),2],GroupGVT]),2,FUN=median),apply(t
(AbsoluteDeviance.NA[fdr.order[c(1:2),2],GroupGVHD]),2,FUN=median),fdr.
order[c(1:2),1])
531 colnames(perttest.table)<-c("JGene","VGene","DGene", "Median No GVHD
Perturbation", "Median GVHD Perturbation", "FDR")
532 xtable(perttest.table,digits=3)
533
534
535 ##########################################
536 #Calculation of Oligoscores
537 ##########################################
538
539 #loaded the needed file
540 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
541 load("TcellRPM.RData")
542
543 GroupGVT<-c(2,5,7,8,11)
544 GroupGVHD<-c(1,3,4,6,9,10,12,13)
545
546 #Function that does the oliogoscore test for the VDJ families x is the J
gene, w is V gene and z is d gene and y=1 is donor and y=2 is recipient
547 oligotest<-function(x,w,z,y){
548 #this part calculates the number of unique CDR3 lengths
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549 L=length(unique(c(unique(pt11rpm[[y]]$cdr3Length[which(pt11rpm[[y]]$
JGeneName==J[x] & pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName
==d[z])]),
550 unique(pt12rpm[[y]]$cdr3Length[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z])]),
551 unique(pt13rpm[[y]]$cdr3Length[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z])]),
552 unique(pt14rpm[[y]]$cdr3Length[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z])]),
553 unique(pt16rpm[[y]]$cdr3Length[which(pt16rpm[[y]]$JGeneName==J[x]&
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z])]),
554 unique(pt24rpm[[y]]$cdr3Length[which(pt24rpm[[y]]$JGeneName==J[x]&
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z])]),
555 unique(pt3rpm[[y]]$cdr3Length[which(pt3rpm[[y]]$JGeneName==J[x] &
pt3rpm[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z])]),
556 unique(pt4rpm[[y]]$cdr3Length[which(pt4rpm[[y]]$JGeneName==J[x] &
pt4rpm[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z])]),
557 unique(pt5rpm[[y]]$cdr3Length[which(pt5rpm[[y]]$JGeneName==J[x] &
pt5rpm[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z])]),
558 unique(pt6rpm[[y]]$cdr3Length[which(pt6rpm[[y]]$JGeneName==J[x] &
pt6rpm[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z])]),
559 unique(pt7rpm[[y]]$cdr3Length[which(pt7rpm[[y]]$JGeneName==J[x] &
pt7rpm[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z])]),
560 unique(pt8rpm[[y]]$cdr3Length[which(pt8rpm[[y]]$JGeneName==J[x] &
pt8rpm[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z])]),
561 unique(pt9rpm[[y]]$cdr3Length[which(pt9rpm[[y]]$JGeneName==J[x] &
pt9rpm[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z])]))))
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562 #print(L)
563 #if VDJ combination not present set to zero
564 if (L==0){
565 Peaks<-0
566 OligoscoreiGVT<-0
567 OligoscoreiGVHD<-0
568 cbind(Peaks,OligoscoreiGVT,OligoscoreiGVHD)
569 }
570 #this calculates the number of peaks for each subject
571 else {
572 nk=c(length(unique(pt11rpm[[y]]$cdr3Length[which(pt11rpm[[y]]$JGeneName==J[x
] & pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName==d[z])])),
573 length(unique(pt12rpm[[y]]$cdr3Length[which(pt12rpm[[y]]$JGeneName==J[x
] & pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z])])),
574 length(unique(pt13rpm[[y]]$cdr3Length[which(pt13rpm[[y]]$JGeneName==J[x
] & pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z])])),
575 length(unique(pt14rpm[[y]]$cdr3Length[which(pt14rpm[[y]]$JGeneName==J[x
] & pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z])])),
576 length(unique(pt16rpm[[y]]$cdr3Length[which(pt16rpm[[y]]$JGeneName==J[x
]& pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z])])),
577 length(unique(pt24rpm[[y]]$cdr3Length[which(pt24rpm[[y]]$JGeneName==J[x
]& pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z])])),
578 length(unique(pt3rpm[[y]]$cdr3Length[which(pt3rpm[[y]]$JGeneName==J[x]
& pt3rpm[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z])])),
579 length(unique(pt4rpm[[y]]$cdr3Length[which(pt4rpm[[y]]$JGeneName==J[x]
& pt4rpm[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z])])),
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580 length(unique(pt5rpm[[y]]$cdr3Length[which(pt5rpm[[y]]$JGeneName==J[x]
& pt5rpm[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z])])),
581 length(unique(pt6rpm[[y]]$cdr3Length[which(pt6rpm[[y]]$JGeneName==J[x]
& pt6rpm[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z])])),
582 length(unique(pt7rpm[[y]]$cdr3Length[which(pt7rpm[[y]]$JGeneName==J[x]
& pt7rpm[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z])])),
583 length(unique(pt8rpm[[y]]$cdr3Length[which(pt8rpm[[y]]$JGeneName==J[x]
& pt8rpm[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z])])),
584 length(unique(pt9rpm[[y]]$cdr3Length[which(pt9rpm[[y]]$JGeneName==J[x]
& pt9rpm[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z])])))
585 #print(nk)
586
587 #This list the peak lengths
588 Peaks=unique(c(unique(pt11rpm[[y]]$cdr3Length[which(pt11rpm[[y]]$JGeneName
==J[x] & pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName==d[z])])
,
589 unique(pt12rpm[[y]]$cdr3Length[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z])]),
590 unique(pt13rpm[[y]]$cdr3Length[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z])]),
591 unique(pt14rpm[[y]]$cdr3Length[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z])]),
592 unique(pt16rpm[[y]]$cdr3Length[which(pt16rpm[[y]]$JGeneName==J[x]&
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z])]),
593 unique(pt24rpm[[y]]$cdr3Length[which(pt24rpm[[y]]$JGeneName==J[x]&
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z])]),
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594 unique(pt3rpm[[y]]$cdr3Length[which(pt3rpm[[y]]$JGeneName==J[x] &
pt3rpm[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z])]),
595 unique(pt4rpm[[y]]$cdr3Length[which(pt4rpm[[y]]$JGeneName==J[x] &
pt4rpm[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z])]),
596 unique(pt5rpm[[y]]$cdr3Length[which(pt5rpm[[y]]$JGeneName==J[x] &
pt5rpm[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z])]),
597 unique(pt6rpm[[y]]$cdr3Length[which(pt6rpm[[y]]$JGeneName==J[x] &
pt6rpm[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z])]),
598 unique(pt7rpm[[y]]$cdr3Length[which(pt7rpm[[y]]$JGeneName==J[x] &
pt7rpm[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z])]),
599 unique(pt8rpm[[y]]$cdr3Length[which(pt8rpm[[y]]$JGeneName==J[x] &
pt8rpm[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z])]),
600 unique(pt9rpm[[y]]$cdr3Length[which(pt9rpm[[y]]$JGeneName==J[x] &
pt9rpm[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z])])))
601 #print(Peaks)
602 #this calculates the total rpm in each peak
603 Peaksi<-matrix(ncol=13,nrow=L)
604 for (i in 1:L){
605 Peaksi[i,]<-c(sum(pt11rpm[[y]]$RPM[which(pt11rpm[[y]]$JGeneName==J[x] &
pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName==d[z] & pt11rpm[[y
]]$cdr3Length==Peaks[i])]),
606 sum(pt12rpm[[y]]$RPM[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z]
& pt12rpm[[y]]$cdr3Length==Peaks[i])]),
607 sum(pt13rpm[[y]]$RPM[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z]
& pt13rpm[[y]]$cdr3Length==Peaks[i])]),
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608 sum(pt14rpm[[y]]$RPM[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z]
& pt14rpm[[y]]$cdr3Length==Peaks[i])]),
609 sum(pt16rpm[[y]]$RPM[which(pt16rpm[[y]]$JGeneName==J[x] &
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z]
& pt16rpm[[y]]$cdr3Length==Peaks[i])]),
610 sum(pt24rpm[[y]]$RPM[which(pt24rpm[[y]]$JGeneName==J[x] &
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z]
& pt24rpm[[y]]$cdr3Length==Peaks[i])]),
611 sum(pt3rpm[[y]]$RPM[which(pt3rpm[[y]]$JGeneName==J[x] & pt3rpm
[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z] & pt3rpm
[[y]]$cdr3Length==Peaks[i])]),
612 sum(pt4rpm[[y]]$RPM[which(pt4rpm[[y]]$JGeneName==J[x] & pt4rpm
[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z] & pt4rpm
[[y]]$cdr3Length==Peaks[i])]),
613 sum(pt5rpm[[y]]$RPM[which(pt5rpm[[y]]$JGeneName==J[x] & pt5rpm
[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z] & pt5rpm
[[y]]$cdr3Length==Peaks[i])]),
614 sum(pt6rpm[[y]]$RPM[which(pt6rpm[[y]]$JGeneName==J[x] & pt6rpm
[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z] & pt6rpm
[[y]]$cdr3Length==Peaks[i])]),
615 sum(pt7rpm[[y]]$RPM[which(pt7rpm[[y]]$JGeneName==J[x] & pt7rpm
[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z] & pt7rpm
[[y]]$cdr3Length==Peaks[i])]),
616 sum(pt8rpm[[y]]$RPM[which(pt8rpm[[y]]$JGeneName==J[x] & pt8rpm
[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z] & pt8rpm
[[y]]$cdr3Length==Peaks[i])]),
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617 sum(pt9rpm[[y]]$RPM[which(pt9rpm[[y]]$JGeneName==J[x] & pt9rpm
[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z] & pt9rpm
[[y]]$cdr3Length==Peaks[i])]))
618 }
619 #print(Peaksi)
620 #total rpm per patient
621 Peakssum<-apply(Peaksi,2,sum)
622
623 #print(Peakssum)
624 #calculates the probability of each peak
625 Probabilityi<-matrix(ncol=13,nrow=L)
626 for (j in 1:L) {
627 Probabilityi[j,]<-Peaksi[j,]/Peakssum
628 }
629 #sets 0 values and NaN values to a low detection threshold as recommended
630 for (m in 1:L){
631 Probabilityi[m,which(Probabilityi[m,]=="NaN")]<-1e-6
632 Probabilityi[m,which(Probabilityi[m,]==0)]<-1e-6
633 }
634
635 #print(Probabilityi)
636 #calculate oligoscore for GVT group
637 OligoscoreiGVT<-matrix(nrow=L,ncol=1)
638 for (k in 1:L){
639 OligoscoreiGVT[k]<-exp(1)*((prod(Probabilityi[k,GroupGVT]*exp(-nk[GroupGVT])
))^(1/length(GroupGVT)))
640 }
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641 #print(OligoscoreiGVT)
642 #calculate Oligoscore for GVHD group
643 OligoscoreiGVHD<-matrix(nrow=L,ncol=1)
644 for (l in 1:L){
645 OligoscoreiGVHD[l]<-exp(1)*((prod(Probabilityi[l,GroupGVHD]*exp(-nk[
GroupGVHD])))^(1/length(GroupGVHD)))
646 }
647 #print(OligoscoreiGVHD)
648
649 cbind(Peaks,OligoscoreiGVT,OligoscoreiGVHD)
650 }
651 }
652
653 #make list of VDJ combos
654 location<-expand.grid(J,V,d)
655 #calculate oligoscore for each vdj combination
656 Oligoscores<-matrix(0,ncol=6)
657 colnames(Oligoscores)<-c("JGeneName","VGeneName","DGeneName","CDR3Length","
GVT","GVHD")
658 #a is vdj combination
659 for (a in 1:1248){
660 Oligoscoresa<-cbind(location[a,],oligotest(which(J==location[a,1]),which(V==
location[a,2]),which(d==location[a,3]),2))
661 colnames(Oligoscoresa)<-c("JGeneName","VGeneName","DGeneName","CDR3Length","
GVT","GVHD")
662 Oligoscores<-rbind(Oligoscores,Oligoscoresa)
663 print(a)
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664 }
665
666 Oligoscores<-Oligoscores[-1,]
667
668
669 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
670 save(Oligoscores,location,file="Oligoscores.RData")
671
672 #run Fisher’s exact test
673 GVHDmatrix<-matrix(c(8,0,2,3),nrow=2,ncol=2)
674 fisher.test(GVHDmatrix) #p-value = 0.03497
675 NoGVHDmatrix<-matrix(c(3,5,4,1),nrow=2,ncol=2)
676 fisher.test(NoGVHDmatrix) #p-value = 0.2657
677
678
679 ########################################################
680 #This section calculated Simpson’s Diversity Index
681 ########################################################
682
683
684 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
685 load("TcellRPM.RData")
686
687 #Function that does the Diversity test for the VDJ families x is the J gene,
w is V gene and z is d gene and y=1 is donor and y=2 is recipient
688 diversitytest<-function(x,w,z,y){
689 #this part calculates the number of unique CDR3 lengths
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690 L=length(unique(c(unique(pt11rpm[[y]]$cdr3Length[which(pt11rpm[[y]]$
JGeneName==J[x] & pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName
==d[z])]),
691 unique(pt12rpm[[y]]$cdr3Length[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z])]),
692 unique(pt13rpm[[y]]$cdr3Length[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z])]),
693 unique(pt14rpm[[y]]$cdr3Length[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z])]),
694 unique(pt16rpm[[y]]$cdr3Length[which(pt16rpm[[y]]$JGeneName==J[x]&
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z])]),
695 unique(pt24rpm[[y]]$cdr3Length[which(pt24rpm[[y]]$JGeneName==J[x]&
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z])]),
696 unique(pt3rpm[[y]]$cdr3Length[which(pt3rpm[[y]]$JGeneName==J[x] &
pt3rpm[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z])]),
697 unique(pt4rpm[[y]]$cdr3Length[which(pt4rpm[[y]]$JGeneName==J[x] &
pt4rpm[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z])]),
698 unique(pt5rpm[[y]]$cdr3Length[which(pt5rpm[[y]]$JGeneName==J[x] &
pt5rpm[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z])]),
699 unique(pt6rpm[[y]]$cdr3Length[which(pt6rpm[[y]]$JGeneName==J[x] &
pt6rpm[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z])]),
700 unique(pt7rpm[[y]]$cdr3Length[which(pt7rpm[[y]]$JGeneName==J[x] &
pt7rpm[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z])]),
701 unique(pt8rpm[[y]]$cdr3Length[which(pt8rpm[[y]]$JGeneName==J[x] &
pt8rpm[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z])]),
702 unique(pt9rpm[[y]]$cdr3Length[which(pt9rpm[[y]]$JGeneName==J[x] &
pt9rpm[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z])]))))
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703 #print(L)
704 #this sets the perturbation statistic to zero if the VDJ combination is not
present
705 if (L==0){
706 Diversity<-rep(0,13)
707 Diversity
708 }
709
710 else {
711 #This list the peak lengths
712 Peaks=unique(c(unique(pt11rpm[[y]]$cdr3Length[which(pt11rpm[[y]]$JGeneName
==J[x] & pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName==d[z])])
,
713 unique(pt12rpm[[y]]$cdr3Length[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z])]),
714 unique(pt13rpm[[y]]$cdr3Length[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z])]),
715 unique(pt14rpm[[y]]$cdr3Length[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z])]),
716 unique(pt16rpm[[y]]$cdr3Length[which(pt16rpm[[y]]$JGeneName==J[x]&
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z])]),
717 unique(pt24rpm[[y]]$cdr3Length[which(pt24rpm[[y]]$JGeneName==J[x]&
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z])]),
718 unique(pt3rpm[[y]]$cdr3Length[which(pt3rpm[[y]]$JGeneName==J[x] &
pt3rpm[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z])]),
719 unique(pt4rpm[[y]]$cdr3Length[which(pt4rpm[[y]]$JGeneName==J[x] &
pt4rpm[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z])]),
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720 unique(pt5rpm[[y]]$cdr3Length[which(pt5rpm[[y]]$JGeneName==J[x] &
pt5rpm[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z])]),
721 unique(pt6rpm[[y]]$cdr3Length[which(pt6rpm[[y]]$JGeneName==J[x] &
pt6rpm[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z])]),
722 unique(pt7rpm[[y]]$cdr3Length[which(pt7rpm[[y]]$JGeneName==J[x] &
pt7rpm[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z])]),
723 unique(pt8rpm[[y]]$cdr3Length[which(pt8rpm[[y]]$JGeneName==J[x] &
pt8rpm[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z])]),
724 unique(pt9rpm[[y]]$cdr3Length[which(pt9rpm[[y]]$JGeneName==J[x] &
pt9rpm[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z])])))
725 #print(Peaks)
726 #this calculates the total rpm in each peak
727 Peaksi<-matrix(ncol=13,nrow=L)
728 for (i in 1:L){
729 Peaksi[i,]<-c(sum(pt11rpm[[y]]$RPM[which(pt11rpm[[y]]$JGeneName==J[x] &
pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName==d[z] & pt11rpm[[y
]]$cdr3Length==Peaks[i])]),
730 sum(pt12rpm[[y]]$RPM[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z]
& pt12rpm[[y]]$cdr3Length==Peaks[i])]),
731 sum(pt13rpm[[y]]$RPM[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z]
& pt13rpm[[y]]$cdr3Length==Peaks[i])]),
732 sum(pt14rpm[[y]]$RPM[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z]
& pt14rpm[[y]]$cdr3Length==Peaks[i])]),
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733 sum(pt16rpm[[y]]$RPM[which(pt16rpm[[y]]$JGeneName==J[x] &
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z]
& pt16rpm[[y]]$cdr3Length==Peaks[i])]),
734 sum(pt24rpm[[y]]$RPM[which(pt24rpm[[y]]$JGeneName==J[x] &
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z]
& pt24rpm[[y]]$cdr3Length==Peaks[i])]),
735 sum(pt3rpm[[y]]$RPM[which(pt3rpm[[y]]$JGeneName==J[x] & pt3rpm
[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z] & pt3rpm
[[y]]$cdr3Length==Peaks[i])]),
736 sum(pt4rpm[[y]]$RPM[which(pt4rpm[[y]]$JGeneName==J[x] & pt4rpm
[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z] & pt4rpm
[[y]]$cdr3Length==Peaks[i])]),
737 sum(pt5rpm[[y]]$RPM[which(pt5rpm[[y]]$JGeneName==J[x] & pt5rpm
[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z] & pt5rpm
[[y]]$cdr3Length==Peaks[i])]),
738 sum(pt6rpm[[y]]$RPM[which(pt6rpm[[y]]$JGeneName==J[x] & pt6rpm
[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z] & pt6rpm
[[y]]$cdr3Length==Peaks[i])]),
739 sum(pt7rpm[[y]]$RPM[which(pt7rpm[[y]]$JGeneName==J[x] & pt7rpm
[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z] & pt7rpm
[[y]]$cdr3Length==Peaks[i])]),
740 sum(pt8rpm[[y]]$RPM[which(pt8rpm[[y]]$JGeneName==J[x] & pt8rpm
[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z] & pt8rpm
[[y]]$cdr3Length==Peaks[i])]),
741 sum(pt9rpm[[y]]$RPM[which(pt9rpm[[y]]$JGeneName==J[x] & pt9rpm
[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z] & pt9rpm
[[y]]$cdr3Length==Peaks[i])]))
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742 }
743 #print(Peaksi)
744 #total rpm per patient
745 Peakssum<-apply(Peaksi,2,sum)
746 #print(Peakssum)
747 #calculates the diversity statistic
748 Diversity<-matrix(nrow=1,ncol=13)
749 for (j in 1:13) {
750 Diversity[j]<-1-sum((Peaksi[,j]*(Peaksi[,j]-1))/(Peakssum[j]*(Peakssum[j]-1)
))
751 }
752 #print(Diversity)
753
754 Diversity
755 }
756 }
757 #list of VDJ combinations
758 location<-expand.grid(J,V,d)
759 #calculates diversity statistic for each VDJ combination
760 #a is VDJ combination
761 Diversity<-matrix(nrow=(length(J)*length(V)*length(d)),ncol=13)
762 for (a in 1:1248){
763 Diversity[a,]<-diversitytest(which(J==location[a,1]),which(V==location[a,2])
,which(d==location[a,3]),2)
764 print(a)
765 }
766
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767 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
768 save(Diversity,location,file="Diversity.RData")
769
770 #############################################
771 #Run the permutation tests for the Diversity index
772 #############################################
773
774
775 GroupGVT<-c(2,5,7,8,11)
776 GroupGVHD<-c(1,3,4,6,9,10,12,13)
777
778 #GVT is 0 and GVHD is 1
779 Group<-c(1,0,1,1,0,1,0,0,1,1,0,1,1)
780
781 #for referencing which VDJ combination
782 rownames(Diversity)<-c(1:1248)
783 #load NA values for tests
784 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
785 load("VDJNAs.RData")
786
787 Diversity.NA<-Diversity[-NAs,]
788 #replace NaN with NA
789 for (i in 1:13){
790 for (j in 1:dim(Diversity.NA)[1]){
791
792 if (Diversity.NA[j,i]=="NaN"){
793 Diversity.NA[j,i]<-NA
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794 }
795 }
796 } }
797
798 set.seed(123)
799 B <- 1000
800 test.stat<-pval<-numeric()
801 test.stat.b<-matrix(nrow=dim(Diversity.NA)[1], ncol=B)
802 for (i in 1:dim(Diversity.NA)[1]) {
803
804 test.stat[i]<-mean(Diversity.NA[i,Group==1],na.rm=TRUE) - mean(
Diversity.NA[i,Group==0],na.rm=TRUE)
805 for (j in 1:B) {
806
807 sample<-sample(Group, replace=FALSE)
808 test.stat.b[i,j]<-mean(Diversity.NA[i,sample==1],na.rm=TRUE)
- mean(Diversity.NA[i,sample==0],na.rm=TRUE)
809 }
810 pval[i]<-sum(abs(test.stat.b[i,]>abs(test.stat[i])))/B
811 }
812
813 fdr<-cbind(p.adjust(pval, method="BH"),c(1:dim(Diversity.NA)[1]))
814 length(which(fdr[,1]<0.05))
815 fdr.order<-fdr[order(pval),]
816 location.NA<-location[-NAs,]
817 groupnames<-factor(Group,levels=c(0,1),labels=c("No GVHD","GVHD"))
818 #make some plots
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819 png(file = "Diversitytest.png", width = 1200, height = 1000, units = "px")
820 par(mfrow=c(3,2),mar=c(5.1,4.5,4.1,2.1))
821 plot(groupnames,Diversity.NA[fdr.order[1,2],],main=paste(location.NA[fdr.
order[1,2],1],location.NA[fdr.order[1,2],2],location.NA[fdr.order
[1,2],3]),cex.lab=2,cex.main=2,cex.axis=2,ylab="Diversity")
822 plot(groupnames,Diversity.NA[fdr.order[2,2],],main=paste(location.NA[fdr.
order[2,2],1],location.NA[fdr.order[2,2],2],location.NA[fdr.order
[2,2],3]),cex.lab=2,cex.main=2,cex.axis=2,ylab="Diversity")
823 plot(groupnames,Diversity.NA[fdr.order[3,2],],main=paste(location.NA[fdr.
order[3,2],1],location.NA[fdr.order[3,2],2],location.NA[fdr.order
[3,2],3]),cex.lab=2,cex.main=2,cex.axis=2,ylab="Diversity")
824 plot(groupnames,Diversity.NA[fdr.order[4,2],],main=paste(location.NA[fdr.
order[4,2],1],location.NA[fdr.order[4,2],2],location.NA[fdr.order
[4,2],3]),cex.lab=2,cex.main=2,cex.axis=2,ylab="Diversity")
825 plot(groupnames,Diversity.NA[fdr.order[5,2],],main=paste(location.NA[fdr.
order[5,2],1],location.NA[fdr.order[5,2],2],location.NA[fdr.order
[5,2],3]),cex.lab=2,cex.main=2,cex.axis=2,ylab="Diversity")
826 dev.off()
827
828
829 library(xtable)
830 apply(t(Diversity.NA[fdr.order[c(1:5),2],GroupGVT]),2,FUN=median,na.rm=TRUE)
831 perttest.table<-cbind(location.NA[fdr.order[c(1:5),2],],apply(t(Diversity.NA
[fdr.order[c(1:5),2],GroupGVT]),2,FUN=median,na.rm=TRUE),apply(t(
Diversity.NA[fdr.order[c(1:5),2],GroupGVHD]),2,FUN=median,na.rm=TRUE),
fdr.order[c(1:5),1])
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832 colnames(perttest.table)<-c("JGene","VGene","DGene", "Median No GVHD
Perturbation", "Median GVHD Perturbation", "FDR")
833 xtable(perttest.table,digits=3)
834
835
836
837 ######################################################
838 #This section calculated Shannon Diversity Index
839 ######################################################
840
841
842 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
843 load("TcellRPM.RData")
844
845 #Function that does the Diversity test for the VDJ families x is the J gene,
w is V gene and z is d gene and y=1 is donor and y=2 is recipient
846 diversitytest<-function(x,w,z,y){
847 #this part calculates the number of unique CDR3 lengths
848 L=length(unique(c(unique(pt11rpm[[y]]$cdr3Length[which(pt11rpm[[y]]$
JGeneName==J[x] & pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName
==d[z])]),
849 unique(pt12rpm[[y]]$cdr3Length[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z])]),
850 unique(pt13rpm[[y]]$cdr3Length[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z])]),
851 unique(pt14rpm[[y]]$cdr3Length[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z])]),
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852 unique(pt16rpm[[y]]$cdr3Length[which(pt16rpm[[y]]$JGeneName==J[x]&
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z])]),
853 unique(pt24rpm[[y]]$cdr3Length[which(pt24rpm[[y]]$JGeneName==J[x]&
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z])]),
854 unique(pt3rpm[[y]]$cdr3Length[which(pt3rpm[[y]]$JGeneName==J[x] &
pt3rpm[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z])]),
855 unique(pt4rpm[[y]]$cdr3Length[which(pt4rpm[[y]]$JGeneName==J[x] &
pt4rpm[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z])]),
856 unique(pt5rpm[[y]]$cdr3Length[which(pt5rpm[[y]]$JGeneName==J[x] &
pt5rpm[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z])]),
857 unique(pt6rpm[[y]]$cdr3Length[which(pt6rpm[[y]]$JGeneName==J[x] &
pt6rpm[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z])]),
858 unique(pt7rpm[[y]]$cdr3Length[which(pt7rpm[[y]]$JGeneName==J[x] &
pt7rpm[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z])]),
859 unique(pt8rpm[[y]]$cdr3Length[which(pt8rpm[[y]]$JGeneName==J[x] &
pt8rpm[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z])]),
860 unique(pt9rpm[[y]]$cdr3Length[which(pt9rpm[[y]]$JGeneName==J[x] &
pt9rpm[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z])]))))
861 #print(L)
862 #this sets the perturbation statistic to zero if the VDJ combination is not
present
863 if (L==0){
864 Diversity<-rep(0,13)
865 Diversity
866 }
867
868 else {
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869 #This list the peak lengths
870 Peaks=unique(c(unique(pt11rpm[[y]]$cdr3Length[which(pt11rpm[[y]]$JGeneName
==J[x] & pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName==d[z])])
,
871 unique(pt12rpm[[y]]$cdr3Length[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z])]),
872 unique(pt13rpm[[y]]$cdr3Length[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z])]),
873 unique(pt14rpm[[y]]$cdr3Length[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z])]),
874 unique(pt16rpm[[y]]$cdr3Length[which(pt16rpm[[y]]$JGeneName==J[x]&
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z])]),
875 unique(pt24rpm[[y]]$cdr3Length[which(pt24rpm[[y]]$JGeneName==J[x]&
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z])]),
876 unique(pt3rpm[[y]]$cdr3Length[which(pt3rpm[[y]]$JGeneName==J[x] &
pt3rpm[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z])]),
877 unique(pt4rpm[[y]]$cdr3Length[which(pt4rpm[[y]]$JGeneName==J[x] &
pt4rpm[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z])]),
878 unique(pt5rpm[[y]]$cdr3Length[which(pt5rpm[[y]]$JGeneName==J[x] &
pt5rpm[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z])]),
879 unique(pt6rpm[[y]]$cdr3Length[which(pt6rpm[[y]]$JGeneName==J[x] &
pt6rpm[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z])]),
880 unique(pt7rpm[[y]]$cdr3Length[which(pt7rpm[[y]]$JGeneName==J[x] &
pt7rpm[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z])]),
881 unique(pt8rpm[[y]]$cdr3Length[which(pt8rpm[[y]]$JGeneName==J[x] &
pt8rpm[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z])]),
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882 unique(pt9rpm[[y]]$cdr3Length[which(pt9rpm[[y]]$JGeneName==J[x] &
pt9rpm[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z])])))
883 #print(Peaks)
884 #this calculates the total rpm in each peak
885 Peaksi<-matrix(ncol=13,nrow=L)
886 for (i in 1:L){
887 Peaksi[i,]<-c(sum(pt11rpm[[y]]$RPM[which(pt11rpm[[y]]$JGeneName==J[x] &
pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName==d[z] & pt11rpm[[y
]]$cdr3Length==Peaks[i])]),
888 sum(pt12rpm[[y]]$RPM[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z]
& pt12rpm[[y]]$cdr3Length==Peaks[i])]),
889 sum(pt13rpm[[y]]$RPM[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z]
& pt13rpm[[y]]$cdr3Length==Peaks[i])]),
890 sum(pt14rpm[[y]]$RPM[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z]
& pt14rpm[[y]]$cdr3Length==Peaks[i])]),
891 sum(pt16rpm[[y]]$RPM[which(pt16rpm[[y]]$JGeneName==J[x] &
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z]
& pt16rpm[[y]]$cdr3Length==Peaks[i])]),
892 sum(pt24rpm[[y]]$RPM[which(pt24rpm[[y]]$JGeneName==J[x] &
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z]
& pt24rpm[[y]]$cdr3Length==Peaks[i])]),
893 sum(pt3rpm[[y]]$RPM[which(pt3rpm[[y]]$JGeneName==J[x] & pt3rpm
[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z] & pt3rpm
[[y]]$cdr3Length==Peaks[i])]),
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894 sum(pt4rpm[[y]]$RPM[which(pt4rpm[[y]]$JGeneName==J[x] & pt4rpm
[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z] & pt4rpm
[[y]]$cdr3Length==Peaks[i])]),
895 sum(pt5rpm[[y]]$RPM[which(pt5rpm[[y]]$JGeneName==J[x] & pt5rpm
[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z] & pt5rpm
[[y]]$cdr3Length==Peaks[i])]),
896 sum(pt6rpm[[y]]$RPM[which(pt6rpm[[y]]$JGeneName==J[x] & pt6rpm
[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z] & pt6rpm
[[y]]$cdr3Length==Peaks[i])]),
897 sum(pt7rpm[[y]]$RPM[which(pt7rpm[[y]]$JGeneName==J[x] & pt7rpm
[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z] & pt7rpm
[[y]]$cdr3Length==Peaks[i])]),
898 sum(pt8rpm[[y]]$RPM[which(pt8rpm[[y]]$JGeneName==J[x] & pt8rpm
[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z] & pt8rpm
[[y]]$cdr3Length==Peaks[i])]),
899 sum(pt9rpm[[y]]$RPM[which(pt9rpm[[y]]$JGeneName==J[x] & pt9rpm
[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z] & pt9rpm
[[y]]$cdr3Length==Peaks[i])]))
900 }
901 #print(Peaksi)
902 #total rpm per patient
903 Peakssum<-apply(Peaksi,2,sum)
904 #print(Peakssum)
905 #calculates the diversity statistic
906 Diversity<-matrix(nrow=1,ncol=13)
907 for (j in 1:13) {
908 Diversity[j]<-(-1)*sum((Peaksi[,j]*log(Peaksi[,j])),na.rm=TRUE)
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909 }
910 #print(Diversity)
911
912 Diversity
913 }
914 }
915 #list of VDJ combinations
916 location<-expand.grid(J,V,d)
917 #calculates diversity statistic for each VDJ combination
918 #a is VDJ combination
919 Diversity<-matrix(nrow=(length(J)*length(V)*length(d)),ncol=13)
920 for (a in 1:1248){
921 Diversity[a,]<-diversitytest(which(J==location[a,1]),which(V==location[a,2])
,which(d==location[a,3]),2)
922 print(a)
923 }
924
925 save(Diversity,location,file="ShannaonDiversity.RData")
926
927
928 #############################################
929 #Run the permutation tests for the Diversity index
930 #############################################
931
932 GroupGVT<-c(2,5,7,8,11)
933 GroupGVHD<-c(1,3,4,6,9,10,12,13)
934
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935 #GVT is 0 and GVHD is 1
936 Group<-c(1,0,1,1,0,1,0,0,1,1,0,1,1)
937
938 #for referencing which VDJ combination
939 rownames(Diversity)<-c(1:1248)
940 #load NA values for tests
941 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
942 load("VDJNAs.RData")
943
944 Diversity.NA<-Diversity[-NAs,] }
945
946 set.seed(123)
947 B <- 1000
948 test.stat<-pval<-numeric()
949 test.stat.b<-matrix(nrow=dim(Diversity.NA)[1], ncol=B)
950 for (i in 1:dim(Diversity.NA)[1]) {
951
952 test.stat[i]<-mean(Diversity.NA[i,Group==1],na.rm=TRUE) - mean(
Diversity.NA[i,Group==0],na.rm=TRUE)
953 for (j in 1:B) {
954
955 sample<-sample(Group, replace=FALSE)
956 test.stat.b[i,j]<-mean(Diversity.NA[i,sample==1],na.rm=TRUE)
- mean(Diversity.NA[i,sample==0],na.rm=TRUE)
957 }
958 pval[i]<-sum(abs(test.stat.b[i,]>abs(test.stat[i])))/B
959 }
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960
961 fdr<-cbind(p.adjust(pval, method="BH"),c(1:dim(Diversity.NA)[1]))
962 length(which(fdr[,1]<0.05))
963 fdr.order<-fdr[order(pval),]
964 location.NA<-location[-NAs,]
965
966 groupnames<-factor(Group,levels=c(0,1),labels=c("No GVHD","GVHD"))
967 #make some plots
968 png(file = "DiversityShannon.png", width = 1200, height = 1000, units = "px"
)
969 par(mfrow=c(3,2),mar=c(5.1,4.5,4.1,2.1))
970 plot(groupnames,Diversity.NA[fdr.order[1,2],],main=paste(location.NA[fdr.
order[1,2],1],location.NA[fdr.order[1,2],2],location.NA[fdr.order
[1,2],3]),cex.lab=2,cex.main=2,cex.axis=2,ylab="Diversity")
971 plot(groupnames,Diversity.NA[fdr.order[2,2],],main=paste(location.NA[fdr.
order[2,2],1],location.NA[fdr.order[2,2],2],location.NA[fdr.order
[2,2],3]),cex.lab=2,cex.main=2,cex.axis=2,ylab="Diversity")
972 plot(groupnames,Diversity.NA[fdr.order[3,2],],main=paste(location.NA[fdr.
order[3,2],1],location.NA[fdr.order[3,2],2],location.NA[fdr.order
[3,2],3]),cex.lab=2,cex.main=2,cex.axis=2,ylab="Diversity")
973 plot(groupnames,Diversity.NA[fdr.order[4,2],],main=paste(location.NA[fdr.
order[4,2],1],location.NA[fdr.order[4,2],2],location.NA[fdr.order
[4,2],3]),cex.lab=2,cex.main=2,cex.axis=2,ylab="Diversity")
974 plot(groupnames,Diversity.NA[fdr.order[5,2],],main=paste(location.NA[fdr.
order[5,2],1],location.NA[fdr.order[5,2],2],location.NA[fdr.order
[5,2],3]),cex.lab=2,cex.main=2,cex.axis=2,ylab="Diversity")
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975 plot(groupnames,Diversity.NA[fdr.order[6,2],],main=paste(location.NA[fdr.
order[6,2],1],location.NA[fdr.order[6,2],2],location.NA[fdr.order
[6,2],3]),cex.lab=2,cex.main=2,cex.axis=2,ylab="Diversity")
976 dev.off()
977
978
979 library(xtable)
980 apply(t(Diversity.NA[fdr.order[c(1:5),2],GroupGVT]),2,FUN=median,na.rm=TRUE)
981 perttest.table<-cbind(location.NA[fdr.order[c(1:6),2],],apply(t(Diversity.NA
[fdr.order[c(1:6),2],GroupGVT]),2,FUN=median,na.rm=TRUE),apply(t(
Diversity.NA[fdr.order[c(1:6),2],GroupGVHD]),2,FUN=median,na.rm=TRUE),
pval[fdr.order[c(1:6),2]])
982 colnames(perttest.table)<-c("JGene","VGene","DGene", "Median No GVHD
Perturbation", "Median GVHD Perturbation", "p-value")
983 xtable(perttest.table,digits=3)
984
985
986
987 #########################################################
988 #This section computes tke K-L Divergence test statistics
989 #########################################################
990
991 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
992 load("TcellRPM.RData")
993
994 #Function that does the distribution test for the VDJ families x is the J
gene v is the Vgene and w is the d gene and y=1 is donor and y=2 is
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recipient
995 VDJKLtest<-function(x,v,w,y){
996 #this part calculates the number of unique CDR3 lengths
997 L=length(unique(c(unique(pt11rpm[[y]]$cdr3Length[which(pt11rpm[[y]]$
JGeneName==J[x] & pt11rpm[[y]]$VGeneName==V[v] & pt11rpm[[y]]$DGeneName
==d[w])]),
998 unique(pt12rpm[[y]]$cdr3Length[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[v] & pt12rpm[[y]]$DGeneName==d[w])]),
999 unique(pt13rpm[[y]]$cdr3Length[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[v] & pt13rpm[[y]]$DGeneName==d[w])]),
1000 unique(pt14rpm[[y]]$cdr3Length[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[v] & pt14rpm[[y]]$DGeneName==d[w])]),
1001 unique(pt16rpm[[y]]$cdr3Length[which(pt16rpm[[y]]$JGeneName==J[x] &
pt16rpm[[y]]$VGeneName==V[v] & pt16rpm[[y]]$DGeneName==d[w])]),
1002 unique(pt24rpm[[y]]$cdr3Length[which(pt24rpm[[y]]$JGeneName==J[x] &
pt24rpm[[y]]$VGeneName==V[v] & pt24rpm[[y]]$DGeneName==d[w])]),
1003 unique(pt3rpm[[y]]$cdr3Length[which(pt3rpm[[y]]$JGeneName==J[x] &
pt3rpm[[y]]$VGeneName==V[v] & pt3rpm[[y]]$DGeneName==d[w])]),
1004 unique(pt4rpm[[y]]$cdr3Length[which(pt4rpm[[y]]$JGeneName==J[x] &
pt4rpm[[y]]$VGeneName==V[v] & pt4rpm[[y]]$DGeneName==d[w])]),
1005 unique(pt5rpm[[y]]$cdr3Length[which(pt5rpm[[y]]$JGeneName==J[x] &
pt5rpm[[y]]$VGeneName==V[v] & pt5rpm[[y]]$DGeneName==d[w])]),
1006 unique(pt6rpm[[y]]$cdr3Length[which(pt6rpm[[y]]$JGeneName==J[x] &
pt6rpm[[y]]$VGeneName==V[v] & pt6rpm[[y]]$DGeneName==d[w])]),
1007 unique(pt7rpm[[y]]$cdr3Length[which(pt7rpm[[y]]$JGeneName==J[x] &
pt7rpm[[y]]$VGeneName==V[v] & pt7rpm[[y]]$DGeneName==d[w])]),
170
1008 unique(pt8rpm[[y]]$cdr3Length[which(pt8rpm[[y]]$JGeneName==J[x] &
pt8rpm[[y]]$VGeneName==V[v] & pt8rpm[[y]]$DGeneName==d[w])]),
1009 unique(pt9rpm[[y]]$cdr3Length[which(pt9rpm[[y]]$JGeneName==J[x] &
pt9rpm[[y]]$VGeneName==V[v] & pt9rpm[[y]]$DGeneName==d[w])]))))
1010 #print(L)
1011
1012 #files2 <- ls(pattern="rpm$")
1013 #files2<-files2[c(-1,-15)]
1014 #keeps only VDJ combinations that have at least 2 peaks
1015 if (L<2){
1016 VDJdist<-c("NA","NA","NA")
1017 list(VDJdist[1],VDJdist[2],VDJdist[3])
1018 }
1019
1020 else {
1021
1022 #This lists the CDR3 lengths
1023 cdr3L<-unique(c(unique(pt11rpm[[y]]$cdr3Length[which(pt11rpm[[y]]$JGeneName
==J[x] & pt11rpm[[y]]$VGeneName==V[v] & pt11rpm[[y]]$DGeneName==d[w])])
,
1024 unique(pt12rpm[[y]]$cdr3Length[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[v] & pt12rpm[[y]]$DGeneName==d[w])]),
1025 unique(pt13rpm[[y]]$cdr3Length[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[v] & pt13rpm[[y]]$DGeneName==d[w])]),
1026 unique(pt14rpm[[y]]$cdr3Length[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[v] & pt14rpm[[y]]$DGeneName==d[w])]),
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1027 unique(pt16rpm[[y]]$cdr3Length[which(pt16rpm[[y]]$JGeneName==J[x] &
pt16rpm[[y]]$VGeneName==V[v] & pt16rpm[[y]]$DGeneName==d[w])]),
1028 unique(pt24rpm[[y]]$cdr3Length[which(pt24rpm[[y]]$JGeneName==J[x] &
pt24rpm[[y]]$VGeneName==V[v] & pt24rpm[[y]]$DGeneName==d[w])]),
1029 unique(pt3rpm[[y]]$cdr3Length[which(pt3rpm[[y]]$JGeneName==J[x] &
pt3rpm[[y]]$VGeneName==V[v] & pt3rpm[[y]]$DGeneName==d[w])]),
1030 unique(pt4rpm[[y]]$cdr3Length[which(pt4rpm[[y]]$JGeneName==J[x] &
pt4rpm[[y]]$VGeneName==V[v] & pt4rpm[[y]]$DGeneName==d[w])]),
1031 unique(pt5rpm[[y]]$cdr3Length[which(pt5rpm[[y]]$JGeneName==J[x] &
pt5rpm[[y]]$VGeneName==V[v] & pt5rpm[[y]]$DGeneName==d[w])]),
1032 unique(pt6rpm[[y]]$cdr3Length[which(pt6rpm[[y]]$JGeneName==J[x] &
pt6rpm[[y]]$VGeneName==V[v] & pt6rpm[[y]]$DGeneName==d[w])]),
1033 unique(pt7rpm[[y]]$cdr3Length[which(pt7rpm[[y]]$JGeneName==J[x] &
pt7rpm[[y]]$VGeneName==V[v] & pt7rpm[[y]]$DGeneName==d[w])]),
1034 unique(pt8rpm[[y]]$cdr3Length[which(pt8rpm[[y]]$JGeneName==J[x] &
pt8rpm[[y]]$VGeneName==V[v] & pt8rpm[[y]]$DGeneName==d[w])]),
1035 unique(pt9rpm[[y]]$cdr3Length[which(pt9rpm[[y]]$JGeneName==J[x] &
pt9rpm[[y]]$VGeneName==V[v] & pt9rpm[[y]]$DGeneName==d[w])])))
1036
1037 #this calculates an overall abundance for each CDR3 length
1038 overall<-function(z){
1039 sum(sum(pt11rpm[[y]]$RPM[which(pt11rpm[[y]]$JGeneName==J[x] & pt11rpm[[y]]$
cdr3Length==cdr3L[z] & pt11rpm[[y]]$VGeneName==V[v] & pt11rpm[[y]]$
DGeneName==d[w])]),
1040 sum(pt12rpm[[y]]$RPM[which(pt12rpm[[y]]$JGeneName==J[x] & pt12rpm[[y]]$
cdr3Length==cdr3L[z] & pt12rpm[[y]]$VGeneName==V[v] & pt12rpm[[y]]$
DGeneName==d[w])]),
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1041 sum(pt13rpm[[y]]$RPM[which(pt13rpm[[y]]$JGeneName==J[x] & pt13rpm[[y]]$
cdr3Length==cdr3L[z] & pt13rpm[[y]]$VGeneName==V[v] & pt13rpm[[y]]$
DGeneName==d[w])]),
1042 sum(pt14rpm[[y]]$RPM[which(pt14rpm[[y]]$JGeneName==J[x] & pt14rpm[[y]]$
cdr3Length==cdr3L[z] & pt14rpm[[y]]$VGeneName==V[v] & pt14rpm[[y]]$
DGeneName==d[w])]),
1043 sum(pt16rpm[[y]]$RPM[which(pt16rpm[[y]]$JGeneName==J[x] & pt16rpm[[y]]$
cdr3Length==cdr3L[z] & pt16rpm[[y]]$VGeneName==V[v] & pt16rpm[[y]]$
DGeneName==d[w])]),
1044 sum(pt24rpm[[y]]$RPM[which(pt24rpm[[y]]$JGeneName==J[x] & pt24rpm[[y]]$
cdr3Length==cdr3L[z] & pt24rpm[[y]]$VGeneName==V[v] & pt24rpm[[y]]$
DGeneName==d[w])]),
1045 sum(pt3rpm[[y]]$RPM[which(pt3rpm[[y]]$JGeneName==J[x] & pt3rpm[[y]]$
cdr3Length==cdr3L[z] & pt3rpm[[y]]$VGeneName==V[v] & pt3rpm[[y]]$
DGeneName==d[w])]),
1046 sum(pt4rpm[[y]]$RPM[which(pt4rpm[[y]]$JGeneName==J[x] & pt4rpm[[y]]$
cdr3Length==cdr3L[z] & pt4rpm[[y]]$VGeneName==V[v] & pt4rpm[[y]]$
DGeneName==d[w])]),
1047 sum(pt5rpm[[y]]$RPM[which(pt5rpm[[y]]$JGeneName==J[x] & pt5rpm[[y]]$
cdr3Length==cdr3L[z] & pt5rpm[[y]]$VGeneName==V[v] & pt5rpm[[y]]$
DGeneName==d[w])]),
1048 sum(pt6rpm[[y]]$RPM[which(pt6rpm[[y]]$JGeneName==J[x] & pt6rpm[[y]]$
cdr3Length==cdr3L[z] & pt6rpm[[y]]$VGeneName==V[v] & pt6rpm[[y]]$
DGeneName==d[w])]),
1049 sum(pt7rpm[[y]]$RPM[which(pt7rpm[[y]]$JGeneName==J[x] & pt7rpm[[y]]$
cdr3Length==cdr3L[z] & pt7rpm[[y]]$VGeneName==V[v] & pt7rpm[[y]]$
DGeneName==d[w])]),
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1050 sum(pt8rpm[[y]]$RPM[which(pt8rpm[[y]]$JGeneName==J[x] & pt8rpm[[y]]$
cdr3Length==cdr3L[z] & pt8rpm[[y]]$VGeneName==V[v] & pt8rpm[[y]]$
DGeneName==d[w])]),
1051 sum(pt9rpm[[y]]$RPM[which(pt9rpm[[y]]$JGeneName==J[x] & pt9rpm[[y]]$
cdr3Length==cdr3L[z] & pt9rpm[[y]]$VGeneName==V[v] & pt9rpm[[y]]$
DGeneName==d[w])]))
1052 }
1053
1054 #create matrix to store all these values
1055 rbar<-matrix(nrow=L)
1056
1057 for (i in 1:L){
1058 rbar[i]<-overall(i)/13
1059 }
1060 #print(rbar)
1061
1062 #these two functions calculate the relative abundances for each group
1063 GVT<-function(z){
1064 sum(sum(pt12rpm[[y]]$RPM[which(pt12rpm[[y]]$JGeneName==J[x] & pt12rpm[[y]]$
cdr3Length==cdr3L[z] & pt12rpm[[y]]$VGeneName==V[v] & pt12rpm[[y]]$
DGeneName==d[w])]),
1065 sum(pt16rpm[[y]]$RPM[which(pt16rpm[[y]]$JGeneName==J[x] & pt16rpm[[y]]$
cdr3Length==cdr3L[z] & pt16rpm[[y]]$VGeneName==V[v] & pt16rpm[[y]]$
DGeneName==d[w])]),
1066 sum(pt3rpm[[y]]$RPM[which(pt3rpm[[y]]$JGeneName==J[x] & pt3rpm[[y]]$
cdr3Length==cdr3L[z] & pt3rpm[[y]]$VGeneName==V[v] & pt3rpm[[y]]$
DGeneName==d[w])]),
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1067 sum(pt4rpm[[y]]$RPM[which(pt4rpm[[y]]$JGeneName==J[x] & pt4rpm[[y]]$
cdr3Length==cdr3L[z] & pt4rpm[[y]]$VGeneName==V[v] & pt4rpm[[y]]$
DGeneName==d[w])]),
1068 sum(pt7rpm[[y]]$RPM[which(pt7rpm[[y]]$JGeneName==J[x] & pt7rpm[[y]]$
cdr3Length==cdr3L[z] & pt7rpm[[y]]$VGeneName==V[v] & pt7rpm[[y]]$
DGeneName==d[w])]))
1069 }
1070
1071 GVHD<-function(z){
1072 sum(sum(pt11rpm[[y]]$RPM[which(pt11rpm[[y]]$JGeneName==J[x] & pt11rpm[[y]]$
cdr3Length==cdr3L[z] & pt11rpm[[y]]$VGeneName==V[v] & pt11rpm[[y]]$
DGeneName==d[w])]),
1073 sum(pt13rpm[[y]]$RPM[which(pt13rpm[[y]]$JGeneName==J[x] & pt13rpm[[y]]$
cdr3Length==cdr3L[z] & pt13rpm[[y]]$VGeneName==V[v] & pt13rpm[[y]]$
DGeneName==d[w])]),
1074 sum(pt14rpm[[y]]$RPM[which(pt14rpm[[y]]$JGeneName==J[x] & pt14rpm[[y]]$
cdr3Length==cdr3L[z] & pt14rpm[[y]]$VGeneName==V[v] & pt14rpm[[y]]$
DGeneName==d[w])]),
1075 sum(pt24rpm[[y]]$RPM[which(pt24rpm[[y]]$JGeneName==J[x] & pt24rpm[[y]]$
cdr3Length==cdr3L[z] & pt24rpm[[y]]$VGeneName==V[v] & pt24rpm[[y]]$
DGeneName==d[w])]),
1076 sum(pt5rpm[[y]]$RPM[which(pt5rpm[[y]]$JGeneName==J[x] & pt5rpm[[y]]$
cdr3Length==cdr3L[z] & pt5rpm[[y]]$VGeneName==V[v] & pt5rpm[[y]]$
DGeneName==d[w])]),
1077 sum(pt6rpm[[y]]$RPM[which(pt6rpm[[y]]$JGeneName==J[x] & pt6rpm[[y]]$
cdr3Length==cdr3L[z] & pt6rpm[[y]]$VGeneName==V[v] & pt6rpm[[y]]$
DGeneName==d[w])]),
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1078 sum(pt8rpm[[y]]$RPM[which(pt8rpm[[y]]$JGeneName==J[x] & pt8rpm[[y]]$
cdr3Length==cdr3L[z] & pt8rpm[[y]]$VGeneName==V[v] & pt8rpm[[y]]$
DGeneName==d[w])]),
1079 sum(pt9rpm[[y]]$RPM[which(pt9rpm[[y]]$JGeneName==J[x] & pt9rpm[[y]]$
cdr3Length==cdr3L[z] & pt9rpm[[y]]$VGeneName==V[v] & pt9rpm[[y]]$
DGeneName==d[w])]))
1080 }
1081
1082 G=2
1083 #get average for each group
1084 rgroup<-matrix(nrow=L,ncol=G)
1085 for (i in 1:L){
1086 rgroup[i,1]<-GVT(i)/5
1087 rgroup[i,2]<-GVHD(i)/8
1088 }
1089 #print(rgroup)
1090 #this calculated abundances for each subject
1091 indiv<-function(z){
1092 cbind(sum(pt11rpm[[y]]$RPM[which(pt11rpm[[y]]$JGeneName==J[x] & pt11rpm[[y]]
$cdr3Length==cdr3L[z] & pt11rpm[[y]]$VGeneName==V[v] & pt11rpm[[y]]$
DGeneName==d[w])]),
1093 sum(pt12rpm[[y]]$RPM[which(pt12rpm[[y]]$JGeneName==J[x] & pt12rpm[[y]]$
cdr3Length==cdr3L[z] & pt12rpm[[y]]$VGeneName==V[v] & pt12rpm[[y]]$
DGeneName==d[w])]),
1094 sum(pt13rpm[[y]]$RPM[which(pt13rpm[[y]]$JGeneName==J[x] & pt13rpm[[y]]$
cdr3Length==cdr3L[z] & pt13rpm[[y]]$VGeneName==V[v] & pt13rpm[[y]]$
DGeneName==d[w])]),
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1095 sum(pt14rpm[[y]]$RPM[which(pt14rpm[[y]]$JGeneName==J[x] & pt14rpm[[y]]$
cdr3Length==cdr3L[z] & pt14rpm[[y]]$VGeneName==V[v] & pt14rpm[[y]]$
DGeneName==d[w])]),
1096 sum(pt16rpm[[y]]$RPM[which(pt16rpm[[y]]$JGeneName==J[x] & pt16rpm[[y]]$
cdr3Length==cdr3L[z] & pt16rpm[[y]]$VGeneName==V[v] & pt16rpm[[y]]$
DGeneName==d[w])]),
1097 sum(pt24rpm[[y]]$RPM[which(pt24rpm[[y]]$JGeneName==J[x] & pt24rpm[[y]]$
cdr3Length==cdr3L[z] & pt24rpm[[y]]$VGeneName==V[v] & pt24rpm[[y]]$
DGeneName==d[w])]),
1098 sum(pt3rpm[[y]]$RPM[which(pt3rpm[[y]]$JGeneName==J[x] & pt3rpm[[y]]$
cdr3Length==cdr3L[z] & pt3rpm[[y]]$VGeneName==V[v] & pt3rpm[[y]]$
DGeneName==d[w])]),
1099 sum(pt4rpm[[y]]$RPM[which(pt4rpm[[y]]$JGeneName==J[x] & pt4rpm[[y]]$
cdr3Length==cdr3L[z] & pt4rpm[[y]]$VGeneName==V[v] & pt4rpm[[y]]$
DGeneName==d[w])]),
1100 sum(pt5rpm[[y]]$RPM[which(pt5rpm[[y]]$JGeneName==J[x] & pt5rpm[[y]]$
cdr3Length==cdr3L[z] & pt5rpm[[y]]$VGeneName==V[v] & pt5rpm[[y]]$
DGeneName==d[w])]),
1101 sum(pt6rpm[[y]]$RPM[which(pt6rpm[[y]]$JGeneName==J[x] & pt6rpm[[y]]$
cdr3Length==cdr3L[z] & pt6rpm[[y]]$VGeneName==V[v] & pt6rpm[[y]]$
DGeneName==d[w])]),
1102 sum(pt7rpm[[y]]$RPM[which(pt7rpm[[y]]$JGeneName==J[x] & pt7rpm[[y]]$
cdr3Length==cdr3L[z] & pt7rpm[[y]]$VGeneName==V[v] & pt7rpm[[y]]$
DGeneName==d[w])]),
1103 sum(pt8rpm[[y]]$RPM[which(pt8rpm[[y]]$JGeneName==J[x] & pt8rpm[[y]]$
cdr3Length==cdr3L[z] & pt8rpm[[y]]$VGeneName==V[v] & pt8rpm[[y]]$
DGeneName==d[w])]),
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1104 sum(pt9rpm[[y]]$RPM[which(pt9rpm[[y]]$JGeneName==J[x] & pt9rpm[[y]]$
cdr3Length==cdr3L[z] & pt9rpm[[y]]$VGeneName==V[v] & pt9rpm[[y]]$
DGeneName==d[w])]))
1105 }
1106
1107 #puts the values for each subject into a matrix
1108 rindiv<-matrix(ncol=13,nrow=L)
1109 for (i in 1:L) {
1110 rindiv[i,]<-indiv(i)
1111 }
1112
1113 #print(rindiv)
1114
1115 #set 0 values to a minimum detection threshold
1116 for (m in 1:L){
1117 rindiv[m,which(rindiv[m,]==0)]<-1e-6
1118 }
1119
1120 for (m in 1:L){
1121 rgroup[m,which(rgroup[m,]==0)]<-1e-6
1122 }
1123
1124 for (m in 1:L){
1125 rbar[which(rbar==0)]<-1e-6
1126 }
1127
1128 #Calculates the between group and within group divergence
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1129 bgd<-abs(sum(rgroup*log(rgroup/cbind(rbar,rbar))))
1130 #print(bgd)
1131 wgd<-sum(sum(rindiv[,c(2,5,11,7,8)]*log(rindiv[,c(2,5,11,7,8)]/cbind(rgroup
[,1],rgroup[,1],rgroup[,1],rgroup[,1],rgroup[,1])),
1132 rindiv[,c(-2,-5,-11,-7,-8)]*log(rindiv[,c(-2,-5,-11,-7,-8)]/cbind(rgroup
[,2],rgroup[,2],rgroup[,2],rgroup[,2],rgroup[,2],rgroup[,2],rgroup[,2],
rgroup[,2])),na.rm=TRUE),na.rm=TRUE)
1133 #print(wgd)
1134
1135 ndot=13
1136 #uses all the parts to run the F-test
1137 Fstat<-((ndot-G+1)*bgd)/((G-1)*wgd)
1138
1139 Ftest<-Fstat/(qf(c(.025,.975), (L-1)*(G-1), (L-1)*(ndot-G+1)))
1140
1141 pval<- pf(c(.05), (L-1)*(G-1), (L-1)*(ndot-G+1))
1142
1143 list(Fstat,Ftest,pval)
1144 }
1145 }
1146
1147 VDJdist<-matrix(nrow=(length(J)*length(V)*length(d)),ncol=2)
1148 colnames(VDJdist)<-c("Fstat","pval")
1149
1150
1151 #list of VDJ combinations
1152 location<-expand.grid(J,V,d)
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1153
1154 # a is VDJ combination
1155 #runs KL divergence test for each VDJ combination
1156 for (a in 1:1248){
1157 VDJKL<- VDJKLtest(which(J==location[a,1]),which(V==location[a,2]),which(d==
location[a,3]),2)
1158 VDJdist[a,1]<-VDJKL[[1]]
1159 VDJdist[a,2]<-VDJKL[[3]]
1160 print(a)
1161 }
1162
1163 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
1164 save(VDJdist,location,file="KLtest.RData")
1165
1166 #save(VDJdist,file="VDJKLtest.RData")
1167 #remove missing values
1168 load("VDJNAs.RData")
1169 rownames(VDJdist)<-c(1:1248)
1170 #run the FDR correction on pvalues
1171 results.dist<-p.adjust(as.numeric(VDJdist[-NAs,2]), method="BH")
1172 results.dist<-data.frame(pval=results.dist,index=c(1:(1248-length(NAs))))
1173 results.dist<-results.dist[order(as.numeric(VDJdist[-NAs,2])),]
1174
1175
1176
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1178
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1179 #######################################################
1180 #This section calculates the non-parametric test
1181 #######################################################
1182
1183 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
1184 load("TcellRPM.RData")
1185
1186 #Function that does the non-parametric test for the VDJ families x is the J
gene, w is V gene and z is d gene and y=1 is donor and y=2 is recipient
1187 alphatest<-function(x,w,z,y){
1188 #this part calculates the number of unique CDR3 lengths
1189 L=length(unique(c(unique(pt11rpm[[y]]$cdr3Length[which(pt11rpm[[y]]$
JGeneName==J[x] & pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName
==d[z])]),
1190 unique(pt12rpm[[y]]$cdr3Length[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z])]),
1191 unique(pt13rpm[[y]]$cdr3Length[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z])]),
1192 unique(pt14rpm[[y]]$cdr3Length[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z])]),
1193 unique(pt16rpm[[y]]$cdr3Length[which(pt16rpm[[y]]$JGeneName==J[x]&
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z])]),
1194 unique(pt24rpm[[y]]$cdr3Length[which(pt24rpm[[y]]$JGeneName==J[x]&
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z])]),
1195 unique(pt3rpm[[y]]$cdr3Length[which(pt3rpm[[y]]$JGeneName==J[x] &
pt3rpm[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z])]),
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1196 unique(pt4rpm[[y]]$cdr3Length[which(pt4rpm[[y]]$JGeneName==J[x] &
pt4rpm[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z])]),
1197 unique(pt5rpm[[y]]$cdr3Length[which(pt5rpm[[y]]$JGeneName==J[x] &
pt5rpm[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z])]),
1198 unique(pt6rpm[[y]]$cdr3Length[which(pt6rpm[[y]]$JGeneName==J[x] &
pt6rpm[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z])]),
1199 unique(pt7rpm[[y]]$cdr3Length[which(pt7rpm[[y]]$JGeneName==J[x] &
pt7rpm[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z])]),
1200 unique(pt8rpm[[y]]$cdr3Length[which(pt8rpm[[y]]$JGeneName==J[x] &
pt8rpm[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z])]),
1201 unique(pt9rpm[[y]]$cdr3Length[which(pt9rpm[[y]]$JGeneName==J[x] &
pt9rpm[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z])]))))
1202 #print(L)
1203 #keeps only VDJ combinations that have at least 2 non-zero peaks
1204 if (L<2){
1205 alphai<-rep(0,13)
1206 alphai
1207 }
1208
1209 else {
1210 #list present peaks
1211 Peaks=unique(c(unique(pt11rpm[[y]]$cdr3Length[which(pt11rpm[[y]]$JGeneName
==J[x] & pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName==d[z])])
,
1212 unique(pt12rpm[[y]]$cdr3Length[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z])]),
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1213 unique(pt13rpm[[y]]$cdr3Length[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z])]),
1214 unique(pt14rpm[[y]]$cdr3Length[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z])]),
1215 unique(pt16rpm[[y]]$cdr3Length[which(pt16rpm[[y]]$JGeneName==J[x]&
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z])]),
1216 unique(pt24rpm[[y]]$cdr3Length[which(pt24rpm[[y]]$JGeneName==J[x]&
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z])]),
1217 unique(pt3rpm[[y]]$cdr3Length[which(pt3rpm[[y]]$JGeneName==J[x] &
pt3rpm[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z])]),
1218 unique(pt4rpm[[y]]$cdr3Length[which(pt4rpm[[y]]$JGeneName==J[x] &
pt4rpm[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z])]),
1219 unique(pt5rpm[[y]]$cdr3Length[which(pt5rpm[[y]]$JGeneName==J[x] &
pt5rpm[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z])]),
1220 unique(pt6rpm[[y]]$cdr3Length[which(pt6rpm[[y]]$JGeneName==J[x] &
pt6rpm[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z])]),
1221 unique(pt7rpm[[y]]$cdr3Length[which(pt7rpm[[y]]$JGeneName==J[x] &
pt7rpm[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z])]),
1222 unique(pt8rpm[[y]]$cdr3Length[which(pt8rpm[[y]]$JGeneName==J[x] &
pt8rpm[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z])]),
1223 unique(pt9rpm[[y]]$cdr3Length[which(pt9rpm[[y]]$JGeneName==J[x] &
pt9rpm[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z])])))
1224 #print(Peaks)
1225 #calculates total rpm per peak
1226 Peaksi<-matrix(ncol=13,nrow=L)
1227 for (i in 1:L){
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1228 Peaksi[i,]<-c(sum(pt11rpm[[y]]$RPM[which(pt11rpm[[y]]$JGeneName==J[x] &
pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName==d[z] & pt11rpm[[y
]]$cdr3Length==Peaks[i])]),
1229 sum(pt12rpm[[y]]$RPM[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z]
& pt12rpm[[y]]$cdr3Length==Peaks[i])]),
1230 sum(pt13rpm[[y]]$RPM[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z]
& pt13rpm[[y]]$cdr3Length==Peaks[i])]),
1231 sum(pt14rpm[[y]]$RPM[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z]
& pt14rpm[[y]]$cdr3Length==Peaks[i])]),
1232 sum(pt16rpm[[y]]$RPM[which(pt16rpm[[y]]$JGeneName==J[x] &
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z]
& pt16rpm[[y]]$cdr3Length==Peaks[i])]),
1233 sum(pt24rpm[[y]]$RPM[which(pt24rpm[[y]]$JGeneName==J[x] &
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z]
& pt24rpm[[y]]$cdr3Length==Peaks[i])]),
1234 sum(pt3rpm[[y]]$RPM[which(pt3rpm[[y]]$JGeneName==J[x] & pt3rpm
[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z] & pt3rpm
[[y]]$cdr3Length==Peaks[i])]),
1235 sum(pt4rpm[[y]]$RPM[which(pt4rpm[[y]]$JGeneName==J[x] & pt4rpm
[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z] & pt4rpm
[[y]]$cdr3Length==Peaks[i])]),
1236 sum(pt5rpm[[y]]$RPM[which(pt5rpm[[y]]$JGeneName==J[x] & pt5rpm
[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z] & pt5rpm
[[y]]$cdr3Length==Peaks[i])]),
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1237 sum(pt6rpm[[y]]$RPM[which(pt6rpm[[y]]$JGeneName==J[x] & pt6rpm
[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z] & pt6rpm
[[y]]$cdr3Length==Peaks[i])]),
1238 sum(pt7rpm[[y]]$RPM[which(pt7rpm[[y]]$JGeneName==J[x] & pt7rpm
[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z] & pt7rpm
[[y]]$cdr3Length==Peaks[i])]),
1239 sum(pt8rpm[[y]]$RPM[which(pt8rpm[[y]]$JGeneName==J[x] & pt8rpm
[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z] & pt8rpm
[[y]]$cdr3Length==Peaks[i])]),
1240 sum(pt9rpm[[y]]$RPM[which(pt9rpm[[y]]$JGeneName==J[x] & pt9rpm
[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z] & pt9rpm
[[y]]$cdr3Length==Peaks[i])]))
1241 }
1242 #print(Peaksi)
1243 #calculates total rpm for patient with VDJ combination
1244 Peakssum<-apply(Peaksi,2,sum)
1245
1246 #print(Peakssum)
1247 #calculates probability of each peak
1248 Probabilityi<-matrix(ncol=13,nrow=L)
1249 for (j in 1:L) {
1250 Probabilityi[j,]<-Peaksi[j,]/Peakssum
1251 }
1252 #set NaN to zero
1253 for (m in 1:L){
1254 Probabilityi[m,which(Probabilityi[m,]=="NaN")]<-0
1255 }
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1256
1257 #print(Probabilityi)
1258
1259 #calculate variance of each peak
1260 sigma<-sqrt(Probabilityi*(1-Probabilityi))
1261 #print(sigma)
1262 #set p for linear model
1263 p<-matrix(rep(c(0.1,0.2,0.3,0.4,0.5,0.6,0.7,0.8,0.9),1),nrow=9,ncol=1)
1264
1265 cdf<-matrix(nrow=9,ncol=13)
1266 #calculate cdf for each peak
1267 for(k in 1:13){
1268 for(o in 1:9){
1269 cdf[o,k]<-(1/L)*sum(pnorm(p[o]-Probabilityi[,k],0,sigma[,k]))
1270 }
1271 }
1272
1273
1274 #print(cdf)
1275
1276 alphai<-matrix(nrow=1,ncol=13)
1277 #calculate alpha value using lm
1278 for(l in 1:13){
1279 alpha<-lm(log10(cdf[,l])~log10(p))
1280 alphai[l]<-alpha$coef[1]
1281 }
1282 #print(alphai)
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1283
1284
1285 #plot(log10(p),log10(cdf[,1]))
1286
1287 alphai
1288 }
1289 }
1290 #list of VDJ combinations
1291 location<-expand.grid(J,V,d)
1292
1293 # a is VDJ combination
1294 #calculates alpha values for each VDJ combination
1295 alphapower<-matrix(nrow=(length(J)*length(V)*length(d)),ncol=13)
1296 for (a in 1:1248){
1297 alphapower[a,]<-alphatest(which(J==location[a,1]),which(V==location[a,2]),
which(d==location[a,3]),2)
1298 print(a)
1299 }
1300
1301 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
1302 save(alphapower,location,file="AlphaTest.RData")
1303
1304
1305
1306
1307
1308
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1309 #############################################
1310 #Run the permutation tests for group differences
1311 #############################################
1312
1313
1314 GroupGVT<-c(2,5,7,8,11)
1315 GroupGVHD<-c(1,3,4,6,9,10,12,13)
1316
1317 #GVT is 0 and GVHD is 1
1318 Group<-c(1,0,1,1,0,1,0,0,1,1,0,1,1)
1319
1320 #for referencing which VDJ combination
1321 rownames(alphapower)<-c(1:1248)
1322 #load NA values for tests
1323 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
1324 load("VDJNAs.RData")
1325
1326 alphapower.NA<-alphapower[-NAs,]
1327
1328 set.seed(123)
1329 B <- 1000
1330 test.stat<-pval<-numeric()
1331 test.stat.b<-matrix(nrow=dim(alphapower.NA)[1], ncol=B)
1332 for (i in 1:dim(alphapower.NA)[1]) {
1333
1334 test.stat[i]<-mean(alphapower.NA[i,Group==1],na.rm=TRUE) - mean(
alphapower.NA[i,Group==0],na.rm=TRUE)
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1335 for (j in 1:B) {
1336
1337 sample<-sample(Group, replace=FALSE)
1338 test.stat.b[i,j]<-mean(alphapower.NA[i,sample==1],na.rm=TRUE
) - mean(alphapower.NA[i,sample==0],na.rm=TRUE)
1339 }
1340 pval[i]<-sum(abs(test.stat.b[i,]>abs(test.stat[i])))/B
1341 }
1342
1343 fdr<-cbind(p.adjust(pval, method="BH"),c(1:dim(alphapower.NA)[1]))
1344 length(which(fdr[,1]<0.05))
1345 fdr.order<-fdr[order(pval),]
1346 location.NA<-location[-NAs,]
1347
1348 groupnames<-factor(Group,levels=c(0,1),labels=c("No GVHD","GVHD"))
1349 #make some plots
1350 png(file = "nonparametrictest.png", width = 1200, height = 1000, units = "px
")
1351 par(mfrow=c(1,1),mar=c(5.1,4.5,4.1,2.1))
1352 plot(groupnames,alphapower.NA[fdr.order[1,2],],main=paste(location.NA[fdr.
order[1,2],1],location.NA[fdr.order[1,2],2],location.NA[fdr.order
[1,2],3]),cex.lab=2,cex.main=2,cex.axis=2,ylab="Alpha")
1353 dev.off()
1354
1355
1356 library(xtable)
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1357 apply(t(alphapower.NA[fdr.order[c(1:1),2],GroupGVT]),2,FUN=median,na.rm=TRUE
)
1358 perttest.table<-cbind(location.NA[fdr.order[c(1:1),2],],median(alphapower.NA
[fdr.order[c(1:1),2],GroupGVT],na.rm=TRUE),median(alphapower.NA[fdr.
order[c(1:1),2],GroupGVHD],na.rm=TRUE),fdr.order[c(1:1),1])
1359 colnames(perttest.table)<-c("JGene","VGene","DGene", "Median No GVHD
Perturbation", "Median GVHD Perturbation", "FDR")
1360 xtable(perttest.table,digits=3)
1361
1362 ##########################################################
1363 #This section runs the logit transformation
1364 ##########################################################
1365
1366 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
1367 load("TcellRPM.RData")
1368
1369 #function to pull out unique and shared counts
1370 countrpm<-function(patient){
1371 counta<-matrix(nrow=624,ncol=5)
1372 for (i in 1:48) {
1373 for (j in 1:13) {
1374 for (d in 2:2) {
1375 pt3d.VJ<-subset(patient[[1]],VGeneName==V[i] & JGeneName==J[j] & DGeneName==
Dg[d])
1376 pt3r.VJ<-subset(patient[[2]],VGeneName==V[i] & JGeneName==J[j] & DGeneName==
Dg[d])
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1377 pt3<-merge(pt3d.VJ,pt3r.VJ,by.x="aminoAcid",by.y="aminoAcid",all.x=TRUE,all.
y=TRUE)
1378 unique.3<-sum(pt3$RPM.y[which(!is.na(pt3$RPM.y)=="TRUE" & !is.na(pt3$RPM.x)
=="FALSE")])
1379 shared.3<-sum(pt3$RPM.y[which(!is.na(pt3$RPM.y)=="TRUE" & !is.na(pt3$RPM.x)
=="TRUE")])
1380 counta[((i-1)*13)+j,]<-cbind(V[i],J[j],Dg[d],unique.3,shared.3)
1381 }
1382 }
1383 }
1384
1385 countb<-matrix(nrow=624,ncol=5)
1386 for (i in 1:48) {
1387 for (j in 1:13) {
1388 for (d in 3:3) {
1389 pt3d.VJ<-subset(patient[[1]],VGeneName==V[i] & JGeneName==J[j] & DGeneName==
Dg[d])
1390 pt3r.VJ<-subset(patient[[2]],VGeneName==V[i] & JGeneName==J[j] & DGeneName==
Dg[d])
1391 pt3<-merge(pt3d.VJ,pt3r.VJ,by.x="aminoAcid",by.y="aminoAcid",all.x=TRUE,all.
y=TRUE)
1392 unique.3<-sum(pt3$RPM.y[which(!is.na(pt3$RPM.y)=="TRUE" & !is.na(pt3$RPM.x)
=="FALSE")])
1393 shared.3<-sum(pt3$RPM.y[which(!is.na(pt3$RPM.y)=="TRUE" & !is.na(pt3$RPM.x)
=="TRUE")])
1394 countb[((i-1)*13)+j,]<-cbind(V[i],J[j],Dg[d],unique.3,shared.3)
1395 }
191
1396 }
1397 }
1398
1399 count<- rbind(counta,countb)
1400 colnames(count)<-c("VGene","JGene","Dgene","Unique","Shared")
1401 list(count)
1402 }
1403
1404
1405 count3<-countrpm(pt3rpm)
1406 count4<-countrpm(pt4rpm)
1407 count5<-countrpm(pt5rpm)
1408 count6<-countrpm(pt6rpm)
1409 count7<-countrpm(pt7rpm)
1410 count8<-countrpm(pt8rpm)
1411 count9<-countrpm(pt9rpm)
1412 count11<-countrpm(pt11rpm)
1413 count12<-countrpm(pt12rpm)
1414 count13<-countrpm(pt13rpm)
1415 count14<-countrpm(pt14rpm)
1416 count16<-countrpm(pt16rpm)
1417 count24<-countrpm(pt24rpm)
1418
1419 save(count3,count4,count5,count6,count7,count8,count9,count11,count12,
count13,count14,count16,count24,file="TcellCount.RData")
1420
1421 #function to do calculate proportion and logit transformation
192
1422 fam2<-function(fam){
1423 fam<-cbind(fam[[1]],as.numeric(fam[[1]][,4])/(as.numeric(fam[[1]][,4])+as.
numeric(fam[[1]][,5])))
1424 colnames(fam)[6]<-"proportion"
1425 fam<-cbind(fam,as.numeric(fam[,6])/(1-as.numeric(fam[,6])))
1426 colnames(fam)[7]<-"transform"
1427 return(fam)
1428 }
1429
1430 fam11<-fam2(count11)
1431 fam12<-fam2(count12)
1432 fam13<-fam2(count13)
1433 fam14<-fam2(count14)
1434 fam16<-fam2(count16)
1435 fam24<-fam2(count24)
1436 fam3<-fam2(count3)
1437 fam4<-fam2(count4)
1438 fam5<-fam2(count5)
1439 fam6<-fam2(count6)
1440 fam7<-fam2(count7)
1441 fam8<-fam2(count8)
1442 fam9<-fam2(count9)
1443
1444 famVDJ<-cbind(as.numeric(fam11[,7]),
1445 as.numeric(fam12[,7]),
1446 as.numeric(fam13[,7]),
1447 as.numeric(fam14[,7]),
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1448 as.numeric(fam16[,7]),
1449 as.numeric(fam24[,7]),
1450 as.numeric(fam3[,7]),
1451 as.numeric(fam4[,7]),
1452 as.numeric(fam5[,7]),
1453 as.numeric(fam6[,7]),
1454 as.numeric(fam7[,7]),
1455 as.numeric(fam8[,7]),
1456 as.numeric(fam9[,7]))
1457
1458 colnames(famVDJ)<-cbind("fam11$transform",
1459 "fam12$transform",
1460 "fam13$transform",
1461 "fam14$transform",
1462 "fam16$transform",
1463 "fam24$transform",
1464 "fam3$transform",
1465 "fam4$transform",
1466 "fam5$transform",
1467 "fam6$transform",
1468 "fam7$transform",
1469 "fam8$transform",
1470 "fam9$transform")
1471
1472
1473 #replace inf and NaN with 0
1474 for (i in 1:1248){
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1475 for (j in 1:13){
1476 if (is.nan(famVDJ[i,j])=="TRUE"){
1477 famVDJ[i,j]<-0
1478 }
1479 else if (famVDJ[i,j]=="Inf"){
1480 famVDJ[i,j]<-0
1481 }
1482 }
1483 }
1484
1485 #Reorder rows to match other analyses
1486 load("VDJobjects.RData")
1487 location<-expand.grid(J,V,d)
1488
1489 order.logit<-matrix(nrow=1248,ncol=1)
1490 for (i in 1:1248) {
1491 order.logit[i]<-which(location[,1]==count3[[1]][i,2] & location[,2]==count3
[[1]][i,1] & location[,3]==count3[[1]][i,3])
1492 }
1493
1494 #for referencing which VDJ combination
1495 rownames(famVDJ)<-c(1:1248)
1496 #load NA values for tests
1497 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
1498 load("VDJNAs.RData")
1499
1500 famVDJ.NAs<-famVDJ[-NAs,]
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1501
1502 #group indicator
1503 group<-c("GVHD","GVT","GVHD","GVHD","GVT","GVHD","GVT","GVT","GVHD","GVHD","
GVT","GVHD","GVHD")
1504 #run linear model to test differences
1505 res.lm<-matrix(nrow=1248-length(NAs),ncol=2)
1506 for (i in 1:(1248-length(NAs))){
1507 prop.lm<-lm(famVDJ.NAs[i,]~as.factor(group))
1508 pv.lm<-summary(prop.lm)$coef[2, "Pr(>|t|)"]
1509 cv.lm<-coef(prop.lm)[2]
1510 res.lm[i,]<-cbind(pv.lm,cv.lm)
1511 }
1512
1513 colnames(res.lm)<-c("pvalue","coefficient")
1514
1515 fdr<-cbind(p.adjust(res.lm[,1], method="BH"),c(1:dim(famVDJ.NAs)[1]))
1516 length(which(fdr[,1]<0.05))
1517 fdr.order<-fdr[order(res.lm[,1]),]
1518 location.NA<-location[-NAs,]
1519 #GVT is 0 and GVHD is 1
1520 Group<-c(1,0,1,1,0,1,0,0,1,1,0,1,1)
1521 groupnames<-factor(Group,levels=c(0,1),labels=c("No GVHD","GVHD"))
1522 #make some plots
1523 png(file = "famVDJ.png", width = 1200, height = 1000, units = "px")
1524 par(mfrow=c(1,2),mar=c(5.1,4.5,4.1,2.1))
1525 plot(groupnames,famVDJ.NAs[fdr.order[1,2],],main=paste(location.NA[fdr.order
[1,2],1],location.NA[fdr.order[1,2],2],location.NA[fdr.order[1,2],3]),
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cex.lab=2,cex.main=2,cex.axis=2,ylab="Logit Proportion Shared")
1526 plot(groupnames,famVDJ.NAs[fdr.order[2,2],],main=paste(location.NA[fdr.order
[2,2],1],location.NA[fdr.order[2,2],2],location.NA[fdr.order[2,2],3]),
cex.lab=2,cex.main=2,cex.axis=2,ylab="Logit Proportion Shared")
1527 dev.off()
1528
1529 GroupGVT<-c(2,5,7,8,11)
1530 GroupGVHD<-c(1,3,4,6,9,10,12,13)
1531
1532 library(xtable)
1533 apply(t(famVDJ.NAs[fdr.order[c(1:2),2],GroupGVT]),2,FUN=median,na.rm=TRUE)
1534 perttest.table<-cbind(location.NA[fdr.order[c(1:2),2],],apply(t(famVDJ.NAs[
fdr.order[c(1:2),2],GroupGVT]),2,FUN=median,na.rm=TRUE),apply(t(famVDJ.
NAs[fdr.order[c(1:2),2],GroupGVHD]),2,FUN=median,na.rm=TRUE),res.lm[fdr.
order[c(1:2),2],1])
1535 colnames(perttest.table)<-c("JGene","VGene","DGene", "Median No GVHD
Perturbation", "Median GVHD Perturbation", "FDR")
1536 xtable(perttest.table,digits=3)
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6.2 Compositional Code
1
2 setwd("C:/Users/makowski/Desktop/Archer Code and Files")
3 load("TcellRPM.RData")
4 load("VDJobjects.RData")
5 library(compositions)
6
7 #Sum all VDJ combinations
8 location<-expand.grid(J,V,d)
9 VDJcomp<-matrix(ncol=1248,nrow=13)
10 for (i in 1:1248){
11 y<-2
12 x<-which(J==location[i,1])
13 w<-which(V==location[i,2])
14 z<-which(d==location[i,3])
15 VDJcomp[,i]<-c(sum(pt11rpm[[y]]$RPM[which(pt11rpm[[y]]$JGeneName==J[x] &
pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName==d[z])]),
16 sum(pt12rpm[[y]]$RPM[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z])
]),
17 sum(pt13rpm[[y]]$RPM[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z])
]),
18 sum(pt14rpm[[y]]$RPM[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z])
]),
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19 sum(pt16rpm[[y]]$RPM[which(pt16rpm[[y]]$JGeneName==J[x] &
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z])
]),
20 sum(pt24rpm[[y]]$RPM[which(pt24rpm[[y]]$JGeneName==J[x] &
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z])
]),
21 sum(pt3rpm[[y]]$RPM[which(pt3rpm[[y]]$JGeneName==J[x] & pt3rpm
[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z])]),
22 sum(pt4rpm[[y]]$RPM[which(pt4rpm[[y]]$JGeneName==J[x] & pt4rpm
[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z])]),
23 sum(pt5rpm[[y]]$RPM[which(pt5rpm[[y]]$JGeneName==J[x] & pt5rpm
[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z])]),
24 sum(pt6rpm[[y]]$RPM[which(pt6rpm[[y]]$JGeneName==J[x] & pt6rpm
[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z])]),
25 sum(pt7rpm[[y]]$RPM[which(pt7rpm[[y]]$JGeneName==J[x] & pt7rpm
[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z])]),
26 sum(pt8rpm[[y]]$RPM[which(pt8rpm[[y]]$JGeneName==J[x] & pt8rpm
[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z])]),
27 sum(pt9rpm[[y]]$RPM[which(pt9rpm[[y]]$JGeneName==J[x] & pt9rpm
[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z])]))
28 }
29
30 #check to see where 0’s are
31 Diversity.check<-matrix(rep(0,(1248*13)),ncol=1248,nrow=13)
32 for (i in 1:13){
33 for (j in 1:1248){
34
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35 if (VDJcomp[i,j]=="0"){
36 Diversity.check[i,j]<-1
37 }
38 else {
39 Diversity.check[i,j]<-0
40 }
41 }
42 }
43
44 #keep only VDJ combinations that 7 or more of the sample contain
45 NAs<-c(which(apply(Diversity.check,2,sum)==13),which(apply(Diversity.check
,2,sum)==12),which(apply(Diversity.check,2,sum)==11),which(apply(
Diversity.check,2,sum)==10),which(apply(Diversity.check,2,sum)==9),which
(apply(Diversity.check,2,sum)==8),which(apply(Diversity.check,2,sum)==7)
,which(apply(Diversity.check,2,sum)==6))
46
47 #save(NAs,file="VDJNAs.RData")
48
49 VDJcomp.NA<-VDJcomp[,-NAs]
50
51 #set zeros to 1e-6
52 for (i in 1:13){
53 for (j in 1:(1248-length(NAs))){
54 if (VDJcomp.NA[i,j]=="0")
55 VDJcomp.NA[i,j]<-1e-6
56 }
57 }
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58
59 #top 10% most variable VDJ combinations
60 var.top<-order(apply(VDJcomp.NA,2,var))[852:947]
61
62 #tell package we are working with compositional data
63 VDJcomp.NA.a<-acomp(VDJcomp.NA)
64 rownames(VDJcomp.NA.a)<-groupnames
65 VDJcomp.mean<-mean(VDJcomp.NA.a)
66
67 #run clustering on the top 10% most variable VDJ combinations
68 Group<-c(1,0,1,1,0,1,0,0,1,1,0,1,1)
69 groupnames<-factor(Group,levels=c(0,1),labels=c("No GVHD","GVHD"))
70 dd<-dist(VDJcomp.NA.a[,var.top])
71 hc = hclust(dd, method="ward.D")
72
73 png(file = ’compcluster.png’, width = 1200, height = 1000, units = "px")
74 plot(hc,xlab="Group",ylab="Aitchison Distance",main="")
75 dev.off()
76
77 save.image("compositions.RData")
78
79 ######################################################
80
81 #Function that does the composition test for the VDJ families; x is the J
gene, w is V gene and z is d gene and y=1 is donor and y=2 is recipient
82 prob.calc<-function(x,w,z,y){
83 #this part calculates the number of unique CDR3 lengths
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84 L=length(unique(c(unique(pt11rpm[[y]]$cdr3Length[which(pt11rpm[[y]]$
JGeneName==J[x] & pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName
==d[z])]),
85 unique(pt12rpm[[y]]$cdr3Length[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z])]),
86 unique(pt13rpm[[y]]$cdr3Length[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z])]),
87 unique(pt14rpm[[y]]$cdr3Length[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z])]),
88 unique(pt16rpm[[y]]$cdr3Length[which(pt16rpm[[y]]$JGeneName==J[x]&
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z])]),
89 unique(pt24rpm[[y]]$cdr3Length[which(pt24rpm[[y]]$JGeneName==J[x]&
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z])]),
90 unique(pt3rpm[[y]]$cdr3Length[which(pt3rpm[[y]]$JGeneName==J[x] &
pt3rpm[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z])]),
91 unique(pt4rpm[[y]]$cdr3Length[which(pt4rpm[[y]]$JGeneName==J[x] &
pt4rpm[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z])]),
92 unique(pt5rpm[[y]]$cdr3Length[which(pt5rpm[[y]]$JGeneName==J[x] &
pt5rpm[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z])]),
93 unique(pt6rpm[[y]]$cdr3Length[which(pt6rpm[[y]]$JGeneName==J[x] &
pt6rpm[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z])]),
94 unique(pt7rpm[[y]]$cdr3Length[which(pt7rpm[[y]]$JGeneName==J[x] &
pt7rpm[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z])]),
95 unique(pt8rpm[[y]]$cdr3Length[which(pt8rpm[[y]]$JGeneName==J[x] &
pt8rpm[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z])]),
96 unique(pt9rpm[[y]]$cdr3Length[which(pt9rpm[[y]]$JGeneName==J[x] &
pt9rpm[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z])]))))
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97 #print(L)
98
99 #this sets the perturbation statistic to zero if the VDJ combination is not
present
100 if (L==0){
101 AbsoluteDeviancei<-rep(0,13)
102 AbsoluteDeviancei
103 }
104
105 else {
106 #This list the peak lengths
107 Peaks=unique(c(unique(pt11rpm[[y]]$cdr3Length[which(pt11rpm[[y]]$JGeneName
==J[x] & pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName==d[z])])
,
108 unique(pt12rpm[[y]]$cdr3Length[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z])]),
109 unique(pt13rpm[[y]]$cdr3Length[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z])]),
110 unique(pt14rpm[[y]]$cdr3Length[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z])]),
111 unique(pt16rpm[[y]]$cdr3Length[which(pt16rpm[[y]]$JGeneName==J[x]&
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z])]),
112 unique(pt24rpm[[y]]$cdr3Length[which(pt24rpm[[y]]$JGeneName==J[x]&
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z])]),
113 unique(pt3rpm[[y]]$cdr3Length[which(pt3rpm[[y]]$JGeneName==J[x] &
pt3rpm[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z])]),
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114 unique(pt4rpm[[y]]$cdr3Length[which(pt4rpm[[y]]$JGeneName==J[x] &
pt4rpm[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z])]),
115 unique(pt5rpm[[y]]$cdr3Length[which(pt5rpm[[y]]$JGeneName==J[x] &
pt5rpm[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z])]),
116 unique(pt6rpm[[y]]$cdr3Length[which(pt6rpm[[y]]$JGeneName==J[x] &
pt6rpm[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z])]),
117 unique(pt7rpm[[y]]$cdr3Length[which(pt7rpm[[y]]$JGeneName==J[x] &
pt7rpm[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z])]),
118 unique(pt8rpm[[y]]$cdr3Length[which(pt8rpm[[y]]$JGeneName==J[x] &
pt8rpm[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z])]),
119 unique(pt9rpm[[y]]$cdr3Length[which(pt9rpm[[y]]$JGeneName==J[x] &
pt9rpm[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z])])))
120 #print(Peaks)
121 #this calculates the total rpm in each peack
122 Peaksi<-matrix(ncol=13,nrow=L)
123 for (i in 1:L){
124 Peaksi[i,]<-c(sum(pt11rpm[[y]]$RPM[which(pt11rpm[[y]]$JGeneName==J[x] &
pt11rpm[[y]]$VGeneName==V[w] & pt11rpm[[y]]$DGeneName==d[z] & pt11rpm[[y
]]$cdr3Length==Peaks[i])]),
125 sum(pt12rpm[[y]]$RPM[which(pt12rpm[[y]]$JGeneName==J[x] &
pt12rpm[[y]]$VGeneName==V[w] & pt12rpm[[y]]$DGeneName==d[z]
& pt12rpm[[y]]$cdr3Length==Peaks[i])]),
126 sum(pt13rpm[[y]]$RPM[which(pt13rpm[[y]]$JGeneName==J[x] &
pt13rpm[[y]]$VGeneName==V[w] & pt13rpm[[y]]$DGeneName==d[z]
& pt13rpm[[y]]$cdr3Length==Peaks[i])]),
127 sum(pt14rpm[[y]]$RPM[which(pt14rpm[[y]]$JGeneName==J[x] &
pt14rpm[[y]]$VGeneName==V[w] & pt14rpm[[y]]$DGeneName==d[z]
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& pt14rpm[[y]]$cdr3Length==Peaks[i])]),
128 sum(pt16rpm[[y]]$RPM[which(pt16rpm[[y]]$JGeneName==J[x] &
pt16rpm[[y]]$VGeneName==V[w] & pt16rpm[[y]]$DGeneName==d[z]
& pt16rpm[[y]]$cdr3Length==Peaks[i])]),
129 sum(pt24rpm[[y]]$RPM[which(pt24rpm[[y]]$JGeneName==J[x] &
pt24rpm[[y]]$VGeneName==V[w] & pt24rpm[[y]]$DGeneName==d[z]
& pt24rpm[[y]]$cdr3Length==Peaks[i])]),
130 sum(pt3rpm[[y]]$RPM[which(pt3rpm[[y]]$JGeneName==J[x] & pt3rpm
[[y]]$VGeneName==V[w] & pt3rpm[[y]]$DGeneName==d[z] & pt3rpm
[[y]]$cdr3Length==Peaks[i])]),
131 sum(pt4rpm[[y]]$RPM[which(pt4rpm[[y]]$JGeneName==J[x] & pt4rpm
[[y]]$VGeneName==V[w] & pt4rpm[[y]]$DGeneName==d[z] & pt4rpm
[[y]]$cdr3Length==Peaks[i])]),
132 sum(pt5rpm[[y]]$RPM[which(pt5rpm[[y]]$JGeneName==J[x] & pt5rpm
[[y]]$VGeneName==V[w] & pt5rpm[[y]]$DGeneName==d[z] & pt5rpm
[[y]]$cdr3Length==Peaks[i])]),
133 sum(pt6rpm[[y]]$RPM[which(pt6rpm[[y]]$JGeneName==J[x] & pt6rpm
[[y]]$VGeneName==V[w] & pt6rpm[[y]]$DGeneName==d[z] & pt6rpm
[[y]]$cdr3Length==Peaks[i])]),
134 sum(pt7rpm[[y]]$RPM[which(pt7rpm[[y]]$JGeneName==J[x] & pt7rpm
[[y]]$VGeneName==V[w] & pt7rpm[[y]]$DGeneName==d[z] & pt7rpm
[[y]]$cdr3Length==Peaks[i])]),
135 sum(pt8rpm[[y]]$RPM[which(pt8rpm[[y]]$JGeneName==J[x] & pt8rpm
[[y]]$VGeneName==V[w] & pt8rpm[[y]]$DGeneName==d[z] & pt8rpm
[[y]]$cdr3Length==Peaks[i])]),
136 sum(pt9rpm[[y]]$RPM[which(pt9rpm[[y]]$JGeneName==J[x] & pt9rpm
[[y]]$VGeneName==V[w] & pt9rpm[[y]]$DGeneName==d[z] & pt9rpm
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[[y]]$cdr3Length==Peaks[i])]))
137 }
138 #print(Peaksi)
139 #total rpm per patient
140 Peakssum<-apply(Peaksi,2,sum)
141
142 #print(Peakssum)
143 #calculates the probability of each peak
144 Probabilityi<-matrix(ncol=13,nrow=L)
145 for (j in 1:L) {
146 Probabilityi[j,]<-Peaksi[j,]/Peakssum
147 }
148
149 #replace zero values with below limit of detection value 1e-6
150 for (m in 1:L){
151 Probabilityi[m,which(Probabilityi[m,]=="NaN")]<-1e-6
152 Probabilityi[m,which(Probabilityi[m,]==0)]<-1e-6
153 }
154
155 Probabilityi
156 }
157 }
158
159
160 Group<-c(1,0,1,1,0,1,0,0,1,1,0,1,1)
161 groupnames<-factor(Group,levels=c(0,1),labels=c("No GVHD","GVHD"))
162
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163 #Run linear model for each VDJ combination
164 comp.pval<-matrix(nrow=1,ncol=(1248-length(NAs)))
165 location.NA<-location[-NAs,]
166 for (a in 1:947){
167 tryCatch({
168 prob.test<-prob.calc(which(J==location.NA[a,1]),which(V==location.NA[a,2]),
which(d==location.NA[a,3]),2)
169 prob.test.a<-acomp(prob.test)
170 (model = lm(ilr(t(prob.test.a))~groupnames))
171 comp.pval[a]<-anova(model)[2,6]
172 print(a)},error=function(e){})
173 }
174
175 save(comp.pval,file="comppval.RData")
176
177 #identify significant values
178 fdr<-cbind(p.adjust(comp.pval, method="BH"),c(1:dim(comp.pval)[2]))
179 length(which(fdr[,1]<0.05))
180 fdr.order<-fdr[order(comp.pval),]
181 location.NA<-location[-NAs,]
182
183 #make table
184 GroupGVT<-c(2,5,7,8,11)
185 GroupGVHD<-c(1,3,4,6,9,10,12,13)
186 load("VDJobjects.RData")
187 location<-expand.grid(J,V,d)
188 library(xtable)
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189 diversitytest.table<-cbind(location.NA[fdr.order[c(1:20),2],],comp.pval[fdr.
order[c(1:20),2]])
190 colnames(diversitytest.table)<-c("JGene","VGene","DGene", "p-value")
191 xtable(diversitytest.table,digits=3)
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6.3 GMIFS code
6.3.1 GMIFS and Related Functions
1 poisson.theta<-function (par, w, x, y, offset, beta) {
2 if (is.null(x)) {
3 if (!is.null(offset)) {
4 Xb <- cbind(offset, w) %*% c(1, par)
5 } else {
6 Xb <- w %*% par
7 }
8 } else {
9 if (!is.null(offset)) {
10 Xb <- cbind(offset, w, x) %*% c(1, par, beta)
11 } else {
12 Xb <- cbind(w, x) %*% c(par, beta)
13 }
14 }
15 contri.LL<-y*Xb-exp(Xb)-lgamma(y+1) #likelihood function
16 loglik <- sum(contri.LL)
17 -loglik
18 }
19
20 poisson.gmifs<-function (formula, data, x=NULL, offset, subset, epsilon
=0.001, tol=1e-5, scale=TRUE, verbose=FALSE, ...) {
21 mf <- match.call(expand.dots = FALSE)
22 cl <- match.call()
23 m <- match(c("formula", "data", "subset", "offset"), names(mf), 0L)
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24 mf <- mf[c(1L, m)]
25 mf[[1L]] <- as.name("model.frame")
26 mf <- eval(mf, parent.frame())
27 mt <- attr(mf, "terms")
28 y <- model.response(mf)
29 w <- model.matrix(mt, mf)
30 offset <- model.offset(mf)
31 if (!is.null(x)) { ############## Subset code
32 if (missing(subset))
33 r <- TRUE
34 else {
35 e <- substitute( subset)
36 r <- eval( e, data)
37 if (!is.logical(r))
38 stop("’subset’ must evaluate to logical" )
39 r <- r & !is.na(r)
40 }
41 if (class(x)=="character") {
42 nl <- as.list( 1:ncol(data))
43 names(nl) <- names( data)
44 vars <- eval(substitute(x), nl, parent.frame())
45 x <- data [r , vars, drop=FALSE ]
46 x <- as.matrix(x )
47 } else if (class(x)== "matrix" || class(x)== "data.frame") {
48 x <- x[r,, drop =FALSE]
49 x <- as.matrix(x)
50 }
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51 } ################ End subset code
52 data <- data.matrix(data)
53 theta <- rep(0, dim(w)[2]) #initiate non-penalized coefficients
54 if (!is.null(x)) {
55 vars <- dim(x)[2]
56 oldx <- x
57 if (scale) {
58 x <- scale(x, center = TRUE, scale = TRUE)
59 }
60 x <- cbind(x, -1 * x)
61 beta <- rep(0, dim(x)[2])
62 names(beta) <- dimnames(x)[[2]]
63 theta.update <- matrix(theta, ncol = length(theta))
64 step <- 0
65 Estimates <- matrix(0,ncol=vars)
66 Likelihood <- numeric()
67 AIC <- numeric()
68 #initialize theta and (Intercept)
69 step <- 0
70 # initialize <- nlm(poisson.theta, p=theta, w=w, x=x, y=y, offset=offset,
beta=beta)
71 # theta <- initialize$estimate
72 initialize<-glm(y~w-1, offset=offset, family=poisson)
73 theta <- coef(initialize)
74 theta.update <- matrix(theta, ncol = length(theta))
75 repeat {
76 if (!is.null(offset)) {
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77 Xb <- cbind(offset, w, x) %*% c(1,theta,beta)
78 } else {
79 Xb <- cbind(w, x) %*% c(theta,beta)
80 }
81 u <- t(x)%*%(y-exp(Xb)) #likelihood gradient value
82
83
84 update.j <- which.min(-u) #choose coeffiecient to update
85 if (-u[update.j] < 0) {
86 beta[update.j] <- beta[update.j] + epsilon #update beta
87 }
88 Estimates<-rbind(Estimates,beta[1:vars]-beta[(vars+1):length(beta)
]) #keep track of beta changes
89 out <- optim(theta, poisson.theta, w=w, x=x, y=y, offset=offset,
beta=beta,method="BFGS") #update intercept and non-penalized
subset using new beta values
90 theta <- out$par
91 theta.update <- rbind(theta.update, theta) #keep track of new theta
values
92 p <- sum(Estimates[step+2,]!=0) + length(theta)
93 Likelihood[step+1]<- LL1<- -out$value
94 AIC[step+1]<- 2*p-2*Likelihood[step+1]
95 if (verbose) cat("step = ", step, "\n")
96 if (step >= 1 && LL1 - LL0 < tol) { #decide when to stop repeat
97 break
98 }
99 LL0 <- LL1
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100 step <- 1 + step
101 }
102 beta.final <- Estimates[-1,] #final values
103 theta<-theta.update[-1,]
104 if (dim(w)[2]==grep("(Intercept)",colnames(w))) {
105 names(theta)<-colnames(w)
106 } else {
107 colnames(theta)<-colnames(w)
108 }
109 model.select<-which.min(AIC)
110 output<-list(beta = beta.final, theta=theta, x=oldx, y=y, scale=scale,
Likelihood=Likelihood, AIC=AIC, model.select=model.select,w=w,
offset=offset)
111 } else {
112 # out <- nlm(poisson.theta, p=theta, w=w, x=NULL, y=y, offset=offset, beta=
NULL)
113 # output<- out$estimate
114 out<-glm(y~w-1, offset=offset, family=poisson)
115 output <- coef(out)
116 }
117 class(output) <- "poisson.gmifs"
118 output
119 }
120
121
122
123
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124 ##############################
125 #Predict function#########
126 ##############################
127 predict.poisson.gmifs<- function(fit, newx=NULL, newoffset=NULL, model.
select=NA) {
128 y<-fit$y
129
130 if (is.null(newx)) {
131 x<-fit$x
132 }
133 else { x<-newx
134 }
135
136 w<-fit$w
137
138 if (is.null(newoffset)){
139 offset<-fit$offset
140 }
141 else {offset<-newoffset
142 }
143
144 if (is.numeric(model.select)) {
145 model.select = model.select
146 }
147 else if (is.na(model.select)) {
148 model.select=dim(fit$beta)[1]
149 }
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150 else if (model.select=="AIC") {
151 model.select = fit$model.select
152 }
153
154
155 if (is.null(dim(fit$theta))) {
156 beta<-fit$beta[model.select,]
157 theta<-fit$theta[model.select]
158 offset<-fit$offset
159
160 if (is.null(offset)) {
161 y.pred <- exp(c(theta,beta) %*% t(cbind(w, x)))
162 }
163 else {
164 offset<-fit$offset
165 y.pred <- exp(c(1,theta,beta) %*% t(cbind(offset, w, x)))
166 }
167 }
168
169 else if (is.numeric(fit$theta[,-1])){
170 beta<-fit$beta[model.select,]
171 theta<-fit$theta[model.select,]
172 offset<-fit$offset
173
174 if (is.null(offset)) {
175 y.pred <- exp(c(theta,beta) %*% t(cbind(w, x)))
176 }
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177 else {
178 y.pred <- exp(c(1,theta,beta) %*% t(cbind(offset, w, x)))
179 }
180 }
181
182 output<-list(pred=y.pred,theta=theta,beta=beta,offset=offset,w=w,x=x)
183 output
184 }
185
186
187 ##############################
188 #Coefficient function#########
189 ##############################
190 coef.poisson.gmifs<- function(fit, model.select=NA) {
191
192 if (is.numeric(model.select)) {
193
194 if (is.null(dim(fit$theta))) {
195 beta<-fit$beta[model.select,]
196 theta<-fit$theta[model.select]
197 c.coef<-cbind(theta,beta)
198 colnames(c.coef)<- c("intercept",colnames(fit$w)[-1],colnames(fit$x))
199 rownames(c.coef)<-as.character(1:dim(beta)[1])
200 }
201 else {
202 beta<-fit$beta[model.select,]
203 theta<-fit$theta[model.select,]
216
204 c.coef<-cbind(theta,beta)
205 colnames(c.coef)<- c("intercept",colnames(fit$w)[-1],colnames(fit$x))
206 rownames(c.coef)<-as.character(1:dim(beta)[1])
207 }
208 }
209
210
211 else if (is.na(model.select)) {
212 model.select=dim(fit$beta)[1]
213 if (is.null(dim(fit$theta))) {
214 beta<-fit$beta[model.select,]
215 theta<-fit$theta[model.select]
216 c.coef<-c(theta,beta)
217
218 }
219 else {
220 beta<-fit$beta[model.select,]
221 theta<-fit$theta[model.select,]
222 c.coef<-c(theta,beta)
223
224 }
225 }
226
227 else if (model.select == "AIC") {
228 model.select = fit$model.select
229 if (is.null(dim(fit$theta))) {
230 beta<-fit$beta[model.select,]
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231 theta<-fit$theta[model.select]
232 c.coef<-c(theta,beta)
233
234 }
235 else {
236 beta<-fit$beta[model.select,]
237 theta<-fit$theta[model.select,]
238 c.coef<-c(theta,beta)
239
240 }
241 }
242
243 else if (model.select == "all") {
244
245 beta<-fit$beta
246 theta<-fit$theta
247 c.coef<-cbind(theta,beta)
248 colnames(c.coef)<- c("intercept",colnames(fit$w)[-1],colnames(fit$x))
249 rownames(c.coef)<-as.character(1:dim(beta)[1])
250 }
251
252
253
254 output<-list(coef=c.coef)
255 output
256 }
257
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258 ##############################
259 #summary function#########
260 ##############################
261
262 summary.poisson.gmifs<- function(fit, model.select=NA) {
263 #browser()
264 if (is.na(model.select)) {
265 model.select=dim(fit$beta)[1]
266 Likelihood<-fit$Likelihood[model.select]
267 AIC<-fit$AIC[model.select]
268 summary<-c(Likelihood,AIC)
269 names(summary)<- c("Likelihood","AIC")
270 }
271 else if (model.select == "AIC") {
272 model.select = fit$model.select
273 Likelihood<-fit$Likelihood[model.select]
274 AIC<-fit$AIC[model.select]
275 summary<-c(Likelihood,AIC)
276 names(summary)<- c("Likelihood","AIC")
277 }
278 else if (model.select=="all") {
279 Likelihood<-fit$Likelihood
280 AIC<-fit$AIC
281 summary<-cbind(Likelihood,AIC)
282 colnames(summary)<- c("Likelihood","AIC")
283 }
284
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285 else {
286 Likelihood<-fit$Likelihood[model.select]
287 AIC<-fit$AIC[model.select]
288 summary<-cbind(Likelihood,AIC)
289 colnames(summary)<- c("Likelihood","AIC")
290 }
291
292 output<-list(summary=summary)
293 output
294 }
295
296 ##############################
297 #plot function#########
298 ##############################
299
300 plot.poisson.gmifs<- function(fit, type,main=type,beta="All") {
301 #browser()
302 if (type=="coefficients") {
303 if (beta=="All"){
304 n<-which(fit$beta[dim(fit$beta)[1],] != 0)
305 plot(1:dim(fit$beta)[1],fit$beta[,n[1]],xlab="Step",ylab="Beta",main=main,
col=500+n[1],type="l",ylim=c(min(fit$beta[dim(fit$beta)[1],]),max(fit$
beta[dim(fit$beta)[1],])))
306 for (i in 2:length(n)){
307 lines(fit$beta[,n[i]],col=500+n[i])
308 }
309 }
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310 else {
311 n<-beta
312 plot(1:dim(fit$beta)[1],fit$beta[,n[1]],xlab="Step",ylab="Beta",main=main,
col=500+n[1],type="l",ylim=c(min(fit$beta[dim(fit$beta)[1],]),max(fit$
beta[dim(fit$beta)[1],])))
313 for (i in 2:length(n)){
314 lines(fit$beta[,n[i]],col=500+n[i])
315 }
316 }
317 }
318 else if (type == "AIC") {
319 plot(1:length(fit$AIC),fit$AIC,xlab="Step",ylab="AIC",main=main)
320 }
321 else { type = "Likelihood"
322 plot(1:length(fit$Likelihood),fit$Likelihood,xlab="Step",ylab="-
logLikelihood",main=main)
323 }
324
325 }
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6.3.2 GMIFS Simulations
1 ##############################
2 # No offset simulations
3 ##############################
4 #create matrix to save results in
5 sims<-matrix(nrow=100,ncol=27)
6 colnames(sims)<-c("no.correct.gmifs","beta1.gmifs","beta2.gmifs","beta3.
gmifs","beta4.gmifs","beta5.gmifs","no.incorrect.gmifs","sum.incorrect.
gmifs","res.sqr.gmifs","no.correct.path","beta1.path","beta2.path","
beta3.path","beta4.path","beta5.path","no.incorrect.path","sum.incorrect
.path","res.sqr.path","no.correct.path.norm","beta1.path.norm","beta2.
path.norm","beta3.path.norm","beta4.path.norm","beta5.path.norm","no.
incorrect.path.norm","sum.incorrect.path.norm","res.sqr.path.norm")
7 y.sims<-matrix(nrow=30,ncol=100)
8 library(glmpath) #load glmpath library
9 #loop 100 times or some other number
10
11 for (i in 1:100) {
12 #number of samples
13 n<-30
14
15 #generate related coefficients - these can be changed
16 beta0<-1
17 beta1<-0.3
18 beta2<-0.2
19 beta3<- -0.7
20 beta4<-0.5
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21 beta5<-0.1
22 beta<-cbind(beta1,beta2,beta3,beta4,beta5)
23
24 #generate covariates related to response
25 set.seed(i*23) #set seed to replicate sims
26 x1<-runif(n=n, min=0, max=1)
27 x2<-runif(n=n, min=0, max=1)
28 x3<-runif(n=n, min=0, max=1)
29 x4<-runif(n=n, min=0, max=1)
30 x5<-runif(n=n, min=0, max=1)
31
32 #generate lambda value using the five covariates related to response
33 mu<-exp(beta0 + (beta1*x1) + (beta2*x2) + (beta3*x3) + (beta4*x4) + (beta5
*x5))
34
35
36 #generate poisson variable using mu
37 y<-rpois(n=n, lambda=mu)
38 y.sims[,i]<-y
39
40
41 #create data frame
42 x<-cbind(x1,x2,x3,x4,x5)
43 data<-data.frame(y=y,x=x)
44
45 #create 95 covariates not related to response for a total of 100
46 x.unrelated<-matrix(nrow=n, ncol=95)
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47 for (j in 1:95) {
48 x.unrelated[,j]<-runif(n=n,min=0,max=1)
49 }
50
51
52
53 #final data frame
54 data<-data.frame(data,x.unrelated)
55
56
57
58 #############################
59 #Create test data set
60 #############################
61
62 #generate covariates related to response
63 #set seed to replicate sims
64 x1.test<-runif(n=n, min=0, max=1)
65 x2.test<-runif(n=n, min=0, max=1)
66 x3.test<-runif(n=n, min=0, max=1)
67 x4.test<-runif(n=n, min=0, max=1)
68 x5.test<-runif(n=n, min=0, max=1)
69
70
71
72 #generate lambda value using the five covariates related to response
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73 mu.test<-exp(beta0 + (beta1*x1.test) + (beta2*x2.test) + (beta3*x3.test) +
(beta4*x4.test) + (beta5*x5.test))
74
75
76 #generate poisson variable using mu
77 y.test<-rpois(n=n, lambda=mu.test)
78
79
80 #create data frame
81 x.test<-cbind(x1.test,x2.test,x3.test,x4.test,x5.test)
82 data.test<-data.frame(y.test=y.test,x.test=x.test)
83
84 #create 95 covariates not related to response for a total of 100
85 x.unrelated.test<-matrix(nrow=n, ncol=95)
86 for (j in 1:95) {
87 x.unrelated.test[,j]<-runif(n=n,min=0,max=1)
88 }
89
90
91
92 #final data frame
93 data.test<-data.frame(data.test,x.unrelated.test)
94
95
96 #############################
97 #run gmifs
98 fit<-poisson.gmifs(y~1, x=data[,-1], data=data)
225
99 pred<-exp(c(fit$theta[fit$model.select],fit$beta[fit$model.select,]) %*% t(
cbind(fit$w,data.test[,-1]))) #get predicted values of test data
100
101 fit.path<-glmpath(x=as.matrix(data[,-1]),y=as.matrix(data[,1]),family=
poisson,lambda2=0)
102 pred.path<- predict(fit.path, newx=as.matrix(data.test[,-1]), type="response
") #get response values using test data
103 coef.path<- predict(fit.path, newx=as.matrix(data[,-1]), type="coefficients"
)
104 fit.path.norm<- glmpath(x=as.matrix(data[,-1]),y=as.matrix(data[,1]),family=
gaussian)
105 pred.path.norm<- predict(fit.path.norm, newx=as.matrix(data.test[,-1]), type
="response") #get response values using test data
106 coef.path.norm<- predict(fit.path.norm, newx=as.matrix(data[,-1]), type="
coefficients")
107
108 #different results to save from sims...
109 #keeping beta values, number nonzero that should be and number nonzero that
should not be
110 no.correct<- sum(fit$beta[fit$model.select,1:5] != 0)
111 sims[i,1]<-no.correct
112 sims[i,2:6]<-fit$beta[fit$model.select,1:5]
113 no.incorrect<- sum(fit$beta[fit$model.select,-(1:5)] != 0)
114 sims[i,7]<-no.incorrect
115 sims[i,8]<- sum(abs(fit$beta[fit$model.select,which(fit$beta[fit$model.
select,-(1:5)] != 0)+5]))
116 sims[i,9]<-sum((data.test[,1] - pred)^2)
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117 ####
118 no.correct.path<- sum(coef.path[which.min(summary(fit.path)$AIC),2:6] != 0)
119 sims[i,10]<-no.correct.path
120 sims[i,11:15]<-coef.path[which.min(summary(fit.path)$AIC),2:6]
121 no.incorrect.path<-sum(coef.path[which.min(summary(fit.path)$AIC),-(1:6)] !=
0)
122 sims[i,16]<-no.incorrect.path
123 sims[i,17]<- sum(abs(coef.path[which.min(summary(fit.path)$AIC),which(coef.
path[which.min(summary(fit.path)$AIC),-(1:6)] != 0)+6]))
124 sims[i,18]<-sum((data.test[,1] - pred.path[,which.min(summary(fit.path)$AIC)
])^2)
125 ####
126 no.correct.path.norm<- sum(coef.path.norm[which.min(summary(fit.path.norm)$
AIC),2:6] != 0)
127 sims[i,19]<-no.correct.path.norm
128 sims[i,20:24]<-coef.path.norm[which.min(summary(fit.path.norm)$AIC),2:6]
129 no.incorrect.path.norm<-sum(coef.path.norm[which.min(summary(fit.path.norm)$
AIC),-(1:6)] != 0)
130 sims[i,25]<-no.incorrect.path.norm
131 sims[i,26]<- sum(abs(coef.path.norm[which.min(summary(fit.path.norm)$AIC),
which(coef.path.norm[which.min(summary(fit.path.norm)$AIC),-(1:6)] != 0)
+6]))
132 sims[i,27]<-sum((data.test[,1] - pred.path.norm[,which.min(summary(fit.path.
norm)$AIC)])^2)
133 print(i)
134 }
135
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136 save(sims,y.sims,file="simsnoffset30independent.RData")
137
138
139
140 #####################################
141 #Sims using an offset #
142 #####################################
143 sims<-matrix(nrow=100,ncol=27)
144 colnames(sims)<-c("no.correct.gmifs","beta1.gmifs","beta2.gmifs","beta3.
gmifs","beta4.gmifs","beta5.gmifs","no.incorrect.gmifs","sum.incorrect.
gmifs","res.sqr.gmifs","no.correct.path","beta1.path","beta2.path","
beta3.path","beta4.path","beta5.path","no.incorrect.path","sum.incorrect
.path","res.sqr.path","no.correct.path.norm","beta1.path.norm","beta2.
path.norm","beta3.path.norm","beta4.path.norm","beta5.path.norm","no.
incorrect.path.norm","sum.incorrect.path.norm","res.sqr.path.norm")
145 y.sims<-matrix(nrow=30,ncol=100)
146 library(glmpath) #load glmpath library
147 #loop 100 times or some other number
148 for (i in 1:100) {
149 #number of samples
150 n<-30
151 set.seed(i*34)
152 #generate related coefficients - these can be changed
153 beta0<--7
154 beta1<-0.3
155 beta2<-0.2
156 beta3<- -0.7
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157 beta4<-0.5
158 beta5<-0.1
159 beta<-cbind(beta1,beta2,beta3,beta4,beta5)
160
161 #generate covariates related to response
162 x1<-runif(n=n, min=0, max=1)
163 x2<-runif(n=n, min=0, max=1)
164 x3<-runif(n=n, min=0, max=1)
165 x4<-runif(n=n, min=0, max=1)
166 x5<-runif(n=n, min=0, max=1)
167
168 #Generate offset
169 offset<- round(2000 + runif(n=n,min=-200,max=200))
170
171 #generate lambda value using the five covariates related to response
172 mu<-exp(beta0 + log(offset) + (beta1*x1) + (beta2*x2) + (beta3*x3) + (beta4*
x4) + (beta5*x5))
173
174
175 #generate poisson variable using mu
176 y<-rpois(n=n, lambda=mu)
177 y.sims[,i]<-y
178
179
180 #create data frame
181 x<-cbind(x1,x2,x3,x4,x5)
182 data<-data.frame(y=y,x=x)
229
183
184 #create 95 covariates not related to response for a total of 100
185 x.unrelated<-matrix(nrow=n, ncol=95)
186 for (j in 1:95) {
187 x.unrelated[,j]<-runif(n=n,min=0,max=1)
188 }
189
190
191
192 #final data frame
193 data<-data.frame(data,x.unrelated,offset=offset)
194
195
196 #####################################
197 #Generate test data set
198 ######################################
199
200 #generate covariates related to response
201 x1.test<-runif(n=n, min=0, max=1)
202 x2.test<-runif(n=n, min=0, max=1)
203 x3.test<-runif(n=n, min=0, max=1)
204 x4.test<-runif(n=n, min=0, max=1)
205 x5.test<-runif(n=n, min=0, max=1)
206
207
208
209 #Generate offset
230
210 offset.test<- round(2000 + runif(n=n,min=-200,max=200))
211
212 #generate lambda value using the five covariates related to response
213 mu.test<-exp(beta0 + log(offset.test) + (beta1*x1.test) + (beta2*x2.test) +
(beta3*x3.test) + (beta4*x4.test) + (beta5*x5.test))
214
215
216 #generate poisson variable using mu
217 y.test<-rpois(n=n, lambda=mu.test)
218
219
220 #create data frame
221 x.test<-cbind(x1.test,x2.test,x3.test,x4.test,x5.test)
222 data.test<-data.frame(y.test=y.test,x.test=x.test)
223
224 #create 95 covariates not related to response for a total of 100
225 x.unrelated.test<-matrix(nrow=n, ncol=95)
226 for (j in 1:95) {
227 x.unrelated.test[,j]<-runif(n=n,min=0,max=1)
228 }
229
230
231
232 #final test data frame
233 data.test<-data.frame(data.test,x.unrelated.test,offset.test=offset.test)
234
235 #test gmifs
231
236 fit<-poisson.gmifs(y~1, x=data[,-c(1,102)], data=data,offset=log(offset))
237 offset.test<-data.test[,102]
238 pred<-exp(c(fit$theta[fit$model.select],1,fit$beta[fit$model.select,]) %*% t
(cbind(fit$w,log(offset.test),data.test[,-c(1,102)])))
239 offset<-fit$offset
240
241 #run glmpath
242 fit.path<-glmpath(x=as.matrix(data[,-c(1,102)]),y=as.matrix(data[,1]),offset
=offset,family=poisson,lambda2=0)
243 pred.path<- predict(fit.path, newx=as.matrix(data.test[,-c(1,102)]),offset=
offset.test, type="response")
244 coef.path<- predict(fit.path, newx=as.matrix(data[,-c(1,102)]),offset=offset
, type="coefficients")
245 fit.path.norm<- glmpath(x=as.matrix(data[,-c(1,102)]),y=as.matrix(data[,1]),
family=gaussian,offset=offset)
246 pred.path.norm<- predict(fit.path.norm, newx=as.matrix(data.test[,-c(1,102)
]),offset=offset.test, type="response")
247 coef.path.norm<- predict(fit.path.norm, newx=as.matrix(data[,-c(1,102)]),
offset=offset, type="coefficients")
248
249 #different results to save from sims...
250 #keeping beta values, number nonzero that should be and number nonzero that
should not be
251 no.correct<- sum(fit$beta[fit$model.select,1:5] != 0)
252 sims[i,1]<-no.correct
253 sims[i,2:6]<-fit$beta[fit$model.select,1:5]
254 no.incorrect<- sum(fit$beta[fit$model.select,-(1:5)] != 0)
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255 sims[i,7]<-no.incorrect
256 sims[i,8]<- sum(abs(fit$beta[fit$model.select,which(fit$beta[fit$model.
select,-(1:5)] != 0)+5]))
257 sims[i,9]<-sum((data[,1] - pred)^2)
258 ####
259 no.correct.path<- sum(coef.path[which.min(summary(fit.path)$AIC),2:6] != 0)
260 sims[i,10]<-no.correct.path
261 sims[i,11:15]<-coef.path[which.min(summary(fit.path)$AIC),2:6]
262 no.incorrect.path<-sum(coef.path[which.min(summary(fit.path)$AIC),-(1:6)] !=
0)
263 sims[i,16]<-no.incorrect.path
264 sims[i,17]<- sum(abs(coef.path[which.min(summary(fit.path)$AIC),which(coef.
path[which.min(summary(fit.path)$AIC),-(1:6)] != 0)+6]))
265 sims[i,18]<-sum((data.test[,1] - pred.path[,which.min(summary(fit.path)$AIC)
])^2)
266 ####
267 no.correct.path.norm<- sum(coef.path.norm[which.min(summary(fit.path.norm)$
AIC),2:6] != 0)
268 sims[i,19]<-no.correct.path.norm
269 sims[i,20:24]<-coef.path.norm[which.min(summary(fit.path.norm)$AIC),2:6]
270 no.incorrect.path.norm<-sum(coef.path.norm[which.min(summary(fit.path.norm)$
AIC),-(1:6)] != 0)
271 sims[i,25]<-no.incorrect.path.norm
272 sims[i,26]<- sum(abs(coef.path.norm[which.min(summary(fit.path.norm)$AIC),
which(coef.path.norm[which.min(summary(fit.path.norm)$AIC),-(1:6)] != 0)
+6]))
233
273 sims[i,27]<-sum((data.test[,1] - pred.path.norm[,which.min(summary(fit.path.
norm)$AIC)])^2)
274 print(i)
275 }
276
277 save.image("simsoffset30alphaindependent.RData")
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6.3.3 Gene Expression Code
1 ##############################################
2 #Set up Gene Expression Data
3 ##############################################
4 library("GEOquery")
5 data<-getGEO("GSE31836")[[1]]
6 setwd("C:/Users/makowski/Desktop/Dissertation/TCRdata/micronuclei/codes")
7 mn.data<-read.csv("MNdataCEBPpaper.csv")
8 pData(data)$Array<-substr(pData(data)$supplementary_file,93,98)
9 mn.data$ID<-paste(mn.data$Array,mn.data$Lane,sep="")
10 names(mn.data)[2]<-"Chip"
11 pheno.frame<-merge(pData(data),mn.data,by.x="Array",by.y="ID",all.x=TRUE,all
.y=TRUE)
12 pheno.sorted<-pheno.frame[match(pData(data)$geo_accession,pheno.frame$geo_
accession),]
13 pData(data)$C_NMNCB_VUB<-pheno.sorted$C_NMNCB_VUB
14 pData(data)$Chip<-pheno.sorted$Chip
15 pData(data)$Lane<-pheno.sorted$Lane
16 mn.exprs.data<-data[,!is.na(pData(data)$C_NMNCB_VUB)]
17 hist(pData(data)$C_NMNCB_VUB)
18 pData(data)$characteristics_ch2.1 # gender
19 nas<-apply(exprs(mn.exprs.data),1,function(x) sum(is.na(x)))
20 mn.exprs<-mn.exprs.data[nas==0,]
21 mn.gender<-pData(data)$characteristics_ch2.1[which(pData(data)$C_NMNCB_VUB!=
"NA")]
22 all.equal(as.character(pData(mn.exprs)$geo_accession),sampleNames(mn.exprs))
23
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24 # Fit model where pData(mn.exprs)$C_NMNCB_VUB ~pData(data)$characteristics_
ch2.1(not penalized) + expression (penalized)
25
26 gexpr<-t(exprs(mn.exprs))
27 mn.gender.num<-rep(0,29)
28 mn.gender.num[grep("female",mn.gender)]=1 #male=0 female=1
29 pheno<-as.data.frame(cbind(pData(mn.exprs)$C_NMNCB_VUB,mn.gender.num))
30 colnames(pheno)<-c("MN","gender")
31
32
33
34 GErun<-poisson.gmifs(MN~gender, data=pheno, x=gexpr, epsilon=0.001, tol=1e
-5, scale=TRUE, verbose=TRUE) #GMIFS run
35
36 pred<-exp(c(GErun$theta[GErun$model.select,],GErun$beta[GErun$model.select
,]) %*% t(cbind(GErun$w,scale(GErun$x,center=TRUE,scale=TRUE)))) #get
the predicted values from GMIFS at AIC value
37 sum(coef.poisson.gmifs(GErun,model.select="AIC")$coef != 0) #how many are
non-zero using function
38 summary.poisson.gmifs(GErun) #test of function
39 plot.poisson.gmifs(GErun,type="coefficients") #test of plot function
40
41 save(GErun,file="GErun.RData")
42
43
44
45
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46 ################################
47 ### GLMpath run #########
48 ################################
49
50 library(glmpath)
51 x<- gexpr
52 y<-pheno[,1]
53 x.nopenalty<-cbind(pheno[,2],x)
54
55 fit.path<-glmpath(x=as.matrix(x.nopenalty),y=y,nopenalty.subset=c(1),family=
poisson,lambda2=0) #glmpath run
56
57 save.image("GErun.RData")
58
59 coef.path<- predict(fit.path, newx=as.matrix(x.nopenalty), type="
coefficients") #get the ceofficients from glmpath
60 hist(coef.path[which.min(summary(fit.path)$AIC),]) #look at histogram
61 sum(coef.path[which.min(summary(fit.path)$AIC),] != 0) #non-zero at AIC
value
62 sum(coef.path[dim(coef.path)[1],] != 0) #non-zero at full model
63
64 #############################
65 # Comparison
66 #############################
67
68 glmcoef<-which(coef.path[which.min(summary(fit.path)$AIC),] != 0) #23 non-
zero ceofficients
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69 poisscoef<-which(coef.poisson.gmifs(GErun,model.select="AIC")$coef != 0) #
17 non-zero ceofficients
70
71 length(intersect(glmcoef[-c(1,2)],poisscoef[-c(1,2)])) #10 of them are in
common
72
73 glmpathnon<-names(coef.path[which.min(summary(fit.path)$AIC),])[glmcoef[-c
(1,2)]] #get the names of the glmpath
74 gmifsnon<-names(coef.poisson.gmifs(GErun,model.select="AIC")$coef[poisscoef
[-c(1,2)]])
75
76 common<-intersect(names(coef.path[which.min(summary(fit.path)$AIC),])[
glmcoef[-c(1,2)]], names(coef.poisson.gmifs(GErun,model.select="AIC")$
coef[poisscoef[-c(1,2)]]))
77
78 union(names(coef.path[which.min(summary(fit.path)$AIC),])[glmcoef[-c(1,2)]],
names(coef.poisson.gmifs(GErun,model.select="AIC")$coef[poisscoef[-c
(1,2)]]))
79
80 outersect <- function(x, y, ...) {
81 big.vec <- c(x, y, ...)
82 duplicates <- big.vec[duplicated(big.vec)]
83 setdiff(big.vec, unique(duplicates))
84 }
85
86 gmifsonly<-outersect(gmifsnon,common)
87 glmpathonly<-outersect(glmpathnon,common)
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88
89 ###########################
90 #prediction
91 ###########################
92
93 pred.path<- predict(fit.path, newx=as.matrix(x.nopenalty), type="response")
94
95 pred.path[,which.min(summary(fit.path)$AIC)]
96
97 png(file = "glmpathplot.png", width = 1080, height = 768, units = "px")
98 par(mar = c(10,10,1,1))
99 plot(y,pred.path[,which.min(summary(fit.path)$AIC)],xlab="",ylab="",cex.axis
= 1.5,xlim=c(0,25))
100 myylab="Predicted MN count"
101 myxlab="Actual MN count"
102 mtext(myylab, side = 2, line = 7, cex = 3)
103 mtext(myxlab, side = 1, line = 7, cex = 3)
104 abline(lm(pred.path[,which.min(summary(fit.path)$AIC)]~y)$coef)
105 dev.off()
106
107 png(file = "gmifsplot.png", width = 1080, height = 768, units = "px")
108 par(mar = c(10,10,1,1))
109 plot(y,pred,xlab="",ylab="",cex.axis = 1.5,xlim=c(0,25))
110 myylab="Predicted MN count"
111 myxlab="Actual MN count"
112 mtext(myylab, side = 2, line = 7, cex = 3)
113 mtext(myxlab, side = 1, line = 7, cex = 3)
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114 abline(lm(pred[1,]~y)$coef)
115 dev.off()
116
117 png(file = "GEMNhist.png", width = 1200, height = 768, units = "px")
118 par(mar = c(8,7,4,2) + 0.1)
119 hist(y,main="",xlab="MN Frequency",ylab="Number of Subjects",cex.lab=2,cex.
main=2,cex.axis=2)
120 dev.off()
121
122 SSR.glmpath=sum((y-pred.path[,which.min(summary(fit.path)$AIC)])^2)
123 SSR.GMIFS=sum((y-pred[1,])^2)
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6.3.4 Buds Code
1 setwd("C:/Users/makowski/Desktop/Dissertation/TCRdata/micronuclei")
2 load("BreastCa.RData")
3
4 age<-phenoData$age
5 smoking.status<-phenoData$CurrentlySmoking
6 MNfreq<-apply(phenoData[,grep("mn_Bi_w_mn",names(phenoData))], 1, sum)+apply
(phenoData[,grep("mn_MN",names(phenoData))], 1, sum)
7 BNcells<-apply(phenoData[,grep("mn_Binucleate",names(phenoData))], 1, sum) +
MNfreq
8 head(phenoData[,grep("mn_Mononucleate_w_MN", names(phenoData))])
9 Mono.cells<-apply(phenoData[,grep("mn_Mononucleate_w_MN",names(phenoData))],
1, sum)
10 Tri.cells<-apply(phenoData[,grep("mn_Trinucleate",names(phenoData))], 1, sum
) + apply(phenoData[,grep("mn_tri_w_mn",names(phenoData))], 1, sum)
11 Total.cells<-BNcells+Mono.cells+Tri.cells
12 Bud.cells<-apply(phenoData[,grep("mn_Buds",names(phenoData))], 1, sum)
13 Bridge.cells<-apply(phenoData[,grep("mn_Bridges",names(phenoData))], 1, sum)
14 Total.cells<-BNcells+Mono.cells+Tri.cells+Bud.cells+Bridge.cells
15
16 #check distribution of Bud and Bridge counts
17 #both look skewed but Bridge.cells has 54/73 0 values whereas Bud.cells only
has 16/73 0 values...run analysis on Buds
18 hist(Bud.cells)
19 hist(Bridge.cells)
20
21 NAs<-which(is.na(Bud.cells))
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22
23 #filter out CpG sites that are all above 80% or below 20%
24 x.eighty<-matrix(nrow=dim(beta.corrected)[1],ncol=1)
25 for (i in 1:dim(beta.corrected)[1]){
26 x.eighty[i,1]<-sum(beta.corrected[i,] > 0.8)
27 }
28 x.eighty.pos<-which(x.eighty[,1]==73)
29
30 x.twenty<-matrix(nrow=dim(beta.corrected)[1],ncol=1)
31 for (i in 1:dim(beta.corrected)[1]){
32 x.twenty[i,1]<-sum(beta.corrected[i,] < 0.2)
33 }
34 x.twenty.pos<-which(x.twenty[,1]==73)
35
36 x.twenty.eighty.pos<-c(x.twenty.pos,x.eighty.pos)
37
38 methyl.filter<-t(beta.corrected[-(x.twenty.eighty.pos),])
39
40 #Remove observations with NA’s... 70 observations now
41 Bud.cells<-Bud.cells[-NAs]
42 age<-age[-NAs]
43 smoking.status<-smoking.status[-NAs]
44 BNcells<-BNcells[-NAs]
45 methyl.filter<-methyl.filter[-NAs,]
46
47
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48 ## Identify CpG sites associated with Buds for (1) general conclusions and
(2) use for filtering in multivariable modeling step
49 pvalue<-numeric()
50 for (i in 1:dim(methyl.filter)[2]) {
51 fit<-glm(Bud.cells ~ age + smoking.status + methyl.filter[,i] +
offset(log(BNcells)), family=poisson)
52 summary.fit<-summary(fit)
53
54 pvalue[i]<-summary.fit$coefficients[4, "Pr(>|z|)"]
55 print(i)
56 }
57
58 pvalue<-cbind(pvalue,colnames(methyl.filter))
59 colnames(pvalue)<-c("p-value","CpG")
60
61
62
63
64 ## Use a generous p-value threshold to filter CpG sites are associated with
Buds
65 pval<-(as.numeric(pvalue[,1]))
66 sum(pval<0.05) #leaves 10860 CpG sites;
67 sum(pval<0.01) #would reduce to 1728
68
69
70 methyl.filter.pval<-methyl.filter[,which(pval < .05)]
71
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72 smoke<-rep(1,70)
73 smoke[which(smoking.status == "No")] <- 0
74
75 pheno<-data.frame(age=age, smoke=smoke,binucleate_total=BNcells,binucleate_
Buds=Bud.cells)
76
77 #save image that has everything needed to do the test run including GMIFS
function
78 save.image("filterBudsrun.RData")
79
80 #GMIFS run using Buds
81 system.time(Budsrun<-poisson.gmifs(binucleate_Buds~age + smoke, data=pheno,
x=methyl.filter.pval, offset=log(pheno$binucleate_total), epsilon=0.001,
tol=1e-5, scale=TRUE, verbose=TRUE))
82 # user system elapsed
83 #12858.81 1689.74 14582.69
84
85 pred<-exp(c(Budsrun$theta[Budsrun$model.select,],1,Budsrun$beta[Budsrun$
model.select,]) %*% t(cbind(Budsrun$w,Budsrun$offset,scale(Budsrun$x,
center=TRUE,scale=TRUE)))) #get the predicted values from GMIFS at AIC
value
86 sum(coef.poisson.gmifs(Budsrun,model.select="AIC")$coef != 0) #how many are
non-zero using function
87 coef.poisson.gmifs(Budsrun,model.select="AIC")$coef[which(coef.poisson.gmifs
(Budsrun,model.select="AIC")$coef != 0)]
88
89
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90 ######################
91 #plots
92 ########################
93
94 png(file = "gmifsplotbuds.png", width = 1080, height = 768, units = "px")
95 par(mar = c(10,10,1,1))
96 plot(y,pred,xlab="",ylab="",cex.axis = 1.5,xlim=c(0,7))
97 myylab="Predicted Bud count"
98 myxlab="Actual Bud count"
99 mtext(myylab, side = 2, line = 7, cex = 3)
100 mtext(myxlab, side = 1, line = 7, cex = 3)
101 abline(lm(pred[1,]~y)$coef)
102 dev.off()
103
104 png(file = "Budshist.png", width = 1200, height = 768, units = "px")
105 par(mar = c(8,7,4,2) + 0.1)
106 hist(y,main="",xlab="Buds Frequency",ylab="Number of Subjects",cex.lab=2,cex
.main=2,cex.axis=2)
107 dev.off()
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